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n Chapter 1: Enantio- and Diastereoselective 1,2-Additions to a-Ketoesters with 1,1-
Diborylalkanes. The copper-catalyzed enantio- and diastereoselective 1,2-addition of 1,1-
diborylalkanes to a-ketoesters is described herein. The resulting 1,2-hydroxyboronates are isolated 
in up to 70% yield, >20:1 dr, and 99:1 er. Numerous subsequent functionalizations are disclosed 
on both substituted and unsubstituted products. Mechanistic experiments performed suggest the 
presence of an enantioenriched a-boryl alkylcopper intermediate. 
 
 
n Chapter 2: Enantio- and Diastereoselective Synthesis of Hydroxy Bis(boronates) via Cu-
Catalyzed Tandem Borylation/1,2-Addition: Catalytic, enantioselective synthesis of 1-hydroxy-
2,3-bisboronates from vinyl boronic esters and various electrophiles is discussed. This method 
utilizes an in situ generated chiral non-racemic copper-boryl complex ligated by a chiral bis-
phosphine. This species undergoes regioselective borylcupration of vinyl boronic esters before it 
is trapped by various aryl and alkyl aldehydes and ketones. Inter- and intramolecular examples are 


























n Chapter 3: Regio- and Stereoselective Nucleophilic Allylation of Aldimines Utilizing 
Highly Substituted Allylic gem-Diboronate Esters. The enantioselective synthesis of 1-amino-
3-alkenylboronates via a copper-catalyzed allylation pathway is disclosed. A variety of novel, 
bench-stable allylic gem-diboronate esters are synthesized, including those bearing non-symmetric 
disubstituted olefins. Reactions involving these substrates generate two contiguous stereocenters, 
including an all-carbon quaternary center, as well as revealing multiple synthetically relevant 
functional handles for further downstream reactivity. Products are isolated in up to 82% yield, 














































>20:1 d.r., >99:1 e.r.
n Two contiguous stereocenters
n One all-carbon quaternary center
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Stereodefined secondary alkyl boronic esters represent a highly desired chemical target due 
to their impressive stability and unparalleled synthetic versatility.1,2 Alkyl boronic esters’ 
decreased sensitivity to air and moisture (compared to analogous organoboranes) can be attributed 
to their two flanking oxygen atoms, which donate electron density into the empty p-orbital of boron 
and temper its electrophilicity.3 In addition to molecular stability, enantioenriched sp3-
organoboron compounds exhibit greater configurational stability than other organometallic 
reagents (e.g. organolithiums, organomagnesiums, etc.).4–6 Molecules containing these C–B bonds 
may be stereospecifically transformed into a wide variety of synthetically relevant functional 
handles, including alcohols, amines, and halogens (Figure 1.1). Due to these attributes, the 
development of methods that stereoselectively incorporate an organoboron moiety into small 
molecules would significantly improve synthetic design and efficiency.3 
																																																						
* A portion of this chapter appeared as a communication in Angewandte Chemie: International 
Edition, the reference is as follows: Murray, S. A.; Green, J. C.; Tailor, S. B.; Meek, S. J. Angew. 
Chem. Int. Ed. 2016, 55, 9065-9069 
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Figure 1.1 Stereospecific functionalizations of secondary boronic esters 
Our lab has previously addressed this area of need through the use of 1,1-diborylalkanes, 
which react readily with aldehydes in the presence of a copper catalyst and a stoichiometric amount 
of an alkoxide activator.7 As depicted in Scheme 1.1, oxidation of the resulting 1,2-
hydroxyboronate (1.4) provides 1,2-diols (1.5) in high yields and selectivity. However, there exist 
a number of shortcomings with this method, including (1) a substrate scope limited to aryl and 
vinyl aldehydes, such as 1.1, (2) the use of only a single 1,1-diborylalkane (diborylethane, 1.2), 
and (3) products were only isolated in their oxidized 1,2-diol form (1.5). We sought to improve 
our first generation 1,2-addition manifold, while also addressing many of these limitations. We 
envisioned that, through catalyst modification, the copper-catalyzed 1,2-addition of 1,1-
diborylalkanes could be improved to accommodate a wider variety of organodiboron reagents, as 
well as a more hindered class of carbonyl electrophile (ketones) (Figure 1.2). Products of this 























within many biologically active molecules8–13, and a secondary organoboronate ester amenable to 
further downstream functionalization. 
Scheme 1.1 Enantio- and diastereoselective 1,2-addition of diborylmethane to aldehydes 
 
1.2 Background 
1.2.1 Enantioselective Synthesis of Secondary Organoboronate Esters 
Since H. C. Brown’s seminal work detailing the asymmetric hydroboration of 1,2-cis-
substituted alkenes over half a century ago14, a wide variety of catalytic methods that generate an 
enantioenriched sp3-organoboronate ester have been developed. These include enantioselective 
diboration15–29, direct borylation of C=X bonds (e.g. carbonyls and imines)30–34, and conjugate 
borylation35–42, as well as significantly improved hydroboration technology43. Many of these 
transformations can be grouped together under the same mechanistic umbrella (Figure 1.3): a late 
transition metal complex bearing a mono- or bidentate chiral ligand (I) reacts with a common 
boron (II) source via oxidative addition or transmetalation. The resulting metal-boryl species III 
coordinates to an unsaturated electrophile (e.g. terminal olefin) IV before undergoing migratory 





























and catalyst regeneration occurs via protonation by an external proton source (VI, depicted) or 
reductive elimination. 
 
Figure 1.2 Proposed expansion to ketone electrophiles 
When discussing the catalytic generation of stereodefined C–B bonds, no mechanism 
dominates the literature like the general cycle described above. However, many catalytic 
borylation methods limit themselves to the generation of a single stereocenter. Catalytic 
enantioselective borylations that generate multiple stereocenters in a single chemical step are few 
and far between, although some examples do exist.18,19,24,26,43 Our group recognized this limitation, 
and have worked to address this area of need through the utilization of 1,1-organodiboron reagents. 
 




















































1.2.2 Synthesis and Utility of 1,1-Diborylalkanes 
 The first 1,1-organodiboronate (1.7, 1,1-diborylethane, or DBE) was synthesized by 
Matteson and co-workers back in 1964 from the hydroboration of 1.6 with excess borane (Scheme 
1.2).44 Upon exposure to hindered amide base, such as lithium 2,2,6,6-tetramethylpiperidide, these 
gem-1,1-diborylalkanes were efficiently deprotonated. Subsequent quenching of the resulting 
carbanion provided a variety of alkylated organodiboronate substrates.45,46 
Scheme 1.2 Initial synthesis of 1,1-diborylmethane by Matteson and co-workers 
 
An alternative synthesis was proposed by Brown and co-workers47 a few years later, in 
which he posits (despite the lack of definitive experimental evidence), “…that the [rhodium-
catalyzed] hydroboration of terminal acetylenes proceeds cleanly to the formation of the 1,1-dibora 
derivative.” Decades later, Shibata and co-workers confirmed Brown’s conclusions by describing 
the sequential regioselective hydroboration of terminal alkynes via rhodium (I) catalysis (Scheme 
1.3).48 Mechanistic experiments revealed that the reaction was likely proceeding through  trans-
alkenylboronate intermediate 1.12, and that the second hydroboration generated an a-boryl 
rhodium species 1.14 exclusively. A variety of phenylacetylene derivatives (1.9) were compatible 
under these catalytic conditions, as well as a few specific alkyl-substituted alkynes, providing the 
corresponding 1,1-diborylalkanes (1.13) in good to excellent yields. A complimentary synthesis 
was disclosed by Srebnik and co-workers, although only one organodiboron reagent 
(diborylmethane, or DBM) was synthesized, and the reaction required the use of harsh reagents 











44% isolated yield (combined)
1.6 1.7 1.8
	 6 
Scheme 1.3 Rhodium(I)-catalyzed regioselective double hydroboration of terminal alkynes 
 
Shibata and co-workers highlighted some of the unique properties of 1,1-diborylalkanes in 
their application to simple Suzuki-Miyaura cross couplings.50 They observed that Suzuki couplings 
involving 1,1-diborylalkanes proceeded efficiently at room temperature, unlike classic Suzuki 
couplings with monoborylated compounds (which often required temperatures north of 60 °C). 
Additionally, only a single boronic ester unit was activated and underwent productive coupling; 
only monoborylated products were observed in all instances. In the specific case of 1,1-
diborylalkane 1.15 reacting with aryl bromide 1.16, only monocoupled product 1.17 was observed 
in 85% conversion (Scheme 1.4). The complete lack of activation of the primary boronic ester 
under these conditions confirmed that 1,1-diborylalkanes required less energy to undergo 
transmetalation as opposed to their monoboryl counterparts. 
Shibata attributed these phenomena to the additional boronic ester moiety present in gem-
diborylalkanes. DFT calculations on a DBE analog showed a large LUMO distribution across both 



































Exclusive formation of α-boryl alkylrhodium
1.14
	 7 
helped stabilize the resulting a-boryl alkylpalladium intermediate. This claim is supported by 
previous research conducted by Knochel, in which a-halo alkylboronates underwent facile 
insertion with zinc powder at room temperature in THF. Knochel postulates that the boronic ester 
moiety is non-innocent in this process, as unsubstituted alkyl bromides do not react with zinc in 
THF, and alkyl iodides require elevated temperatures.51 
Scheme 1.4 Suzuki-Miyaura cross coupling of 1,1-diborylalkanes and aryl halides 
 
Morken and co-workers later reported the enantioselective variant of the Suzuki cross-
coupling of gem-diborylalkanes (1.18) with aryl and vinyl halides, employing a TADDOL-derived 
chiral phosphoramidite (1.20) and a modified Josiphos ligand, respectively.52,53 Both systems 
enjoyed wide substrate tolerance and high levels of selectivity, and an aryl coupling was employed 
in the efficient total synthesis of urinary incontinence drug (R)-Tolterodine. The use of an enriched 
10B-labeled 1,1-diborylalkane (S)-10B-1.18 and both enantiomers of bis-phosphine ligand 1.20 
shed some light on the origins of this catalytic system’s high enantioselectivity (Scheme 1.5). 
Application of (R,R)-1.20 resulted in the generation of (R)-1.22, which contained no 10B-labeled 
group, in 75% yield and 92:8 e.r. Switching to (S,S)-1.20 caused only 10B-enriched (S)-1.22 to be 
produced in high selectivity (60% yield, 92:8 e.r.). These data indicated that the palladium/bis-
phosphine catalyst was undergoing enantioselective transmetalation with one of the enantiotopic 
























lab was interested in expanding the application of these a-boryl stabilized organometallic reagents 
in enantioselective catalysis, and found success in the use of a copper-phosphoramidite system. 
Scheme 1.5 Enantioselective Suzuki cross-coupling of 1,1-diborylalkanes and aryl iodides 
 
1.3 Copper Catalyzed Diastero- and Enantioselective 1,2-Addition of 1,1-Diborylalkanes 
to a-Ketoesters 
 
1.3.1 Catalyst and Reaction Optimization 
As discussed previously, our group developed an enantio- and diastereoselective 1,2- 
addition reaction between DBE and various aryl and vinyl aldehydes (see Scheme 1.1), producing 
1,2-hydroxyboronates in good yields and great selectivity.7 In situ generation of the active copper 
catalyst was achieved through the mixing of Cu(MeCN)4PF6, chiral phosphoramidite (R)-
Monophos ((R)-1.3), and a catalytic quantity of lithium alkoxide prior to substrate addition. Our 
group envisioned that this same catalytic protocol could be applied to a more hindered class of 
electrophile, while still maintaining high levels of selectivity (see Figure 1.2).  
Application of this Cu/phosphoramidite/alkoxide catalyst system to the reaction between 




























































22 °C, 12 h
Ar
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desired 1,2-addition product 1.25 in 91:9 e.r (Table 1.1, Entry 1). Unfortunately, the reaction was 
plagued by product decomposition via boron-Wittig elimination (27% conversion to 1.26), likely 
due to the implementation of superstoichiometric amounts of LiOt-Bu. This unproductive pathway 
was successfully suppressed by lowering the reaction temperature to -10 °C (Entry 3), which 
fortuitously coincided with a rise in enantioselectivity. The identity of a-ketoester proved to be 
inconsequential, as both the t-Bu ester (Entry 5) and methyl ester (Entry 6) gave similar results to 
that of the initial ethyl ester. In all cases, the starting ketoester was completely consumed, with 
only t-Bu a-ketoester 1.27 present upon reaction analysis. This suggests that the first equivalent 
of LiOt-Bu is required to invoke a transesterification event prior to 1,2-addition, a concept further 
supported by the fact that one equivalent of alkoxide results in poor reactivity (Entry 7). Switching 
to a more active alkoxide base (e.g. NaOt-Bu) resulted in sluggish reactivity and poor 
enantioselectivity (Entry 8). Ethyl ester variants were chosen as model substrates for this 











Table 1.1 Copper-catalyzed enantioselective 1,2-addition of diborylmethane to a-ketoesters: 
reaction optimizationa 
 
Variants of parent ligand (R)-1.3 were synthesized and tested in our model catalytic system 
in an attempt to increase the enantioselectivity beyond 96:4 e.r (Scheme 1.6). Selectively 
hydrogenating the back rings of (R)-Monophos to give (R)-H8-Monophos ((R)-H8-1.3) 
significantly hindered both product conversion and selectivity. Exchanging the dimethylamine 
moiety out for a larger group, such as diethyl amine ((R)-1.28) and morpholine ((R)-1.29) had a 
minimal effect on product conversion, but did not result in any positive enantioselectivity change. 






















































































aReactions performed under an N2 atmosphere; see Experimental Section for 
details. bDetermined using 1H NMR spectroscopy; dimethylformamide was used 
as an internal standard. cDetermined by chiral HPLC analysis of the corresponding 




down reactivity. Most bidentate phosphine ligands tested in this system proved incompatible, with 
Josiphos ligand (R,S)-1.33  giving the only positive result, albeit in low enantioselectivity. 
Scheme 1.6 Enantioselective 1,2-addition of DBM to a-ketoesters: ligand screening 
 
1.3.2 Scope of Diborylmethane Addition to a-Ketoesters 
With optimal conditions in hand, the scope of the 1,2-addition reaction between DBM and 
a variety of aryl a-ketoesters was explored (Scheme 1.7). Due to varying stability of these 1,2-
hydroxyboronates, as well as ease of purification and chiral HPLC analysis, crude reaction 
mixtures were oxidized using NaBO3•4H2O and products were isolated as 1,2-diols. Para-
substituted a-ketoesters bearing electron-poor (1.35, 1.36), electron-rich (1.37), and halogen 
(1.38) substituents were well-tolerated, although a slight decrease in enantioselectivity was 
observed for p-OMe product 1.37 (85:15 e.r.). Sterics proved inconsequential in both the para and 



















(R)-H8-1.3 (R = NMe2): 43% conversion, 83:17 e.r. 
(R)-1.28 (R = NEt2): 72% conversion, 74:26 e.r. 
(R)-1.29 (R = morpholine): 76% conversion, 94:6 e.r. 
















(R,S)-1.33: 60% conversion, 60:40 e.r.
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yield, as well as 92:8 and 96:4 e.r., respectively. Other meta-substituted ketoesters proved 
compatible as well; Electron withdrawing m-OMe substituted ketoester delivered desired product 
1.41 in 62% yield and 96:4 e.r., m-Cl substituted ketoester gave 64% yield of diol 1.42 in 97:3 e.r, 
and sterically significant 2-naphthyl substituted ketoester resulted in 62% yield of 1.43 in 96:4 e.r. 
Unfortunately, o-Me product 1.44 proved too much for this catalytic protocol, giving low yield 
(27%) and enantioselectivity (66:34 e.r.). N-heterocyclic 1,2-hydroxyboronate product was 
generated in high conversion (72%) and was indeed selective (97:3 e.r.). Despite issues with 
isolation (36% isolated yield of 1.45), this shows that heterocyclic ketoesters are viable substrates 
















Scheme 1.7 a-Ketoester scope for the enantioselective 1,2-addition of diborylmethane 
 
It should be noted that isolation of 1,2-hydroxyboronate products may be achieved through 
trimethylsilyl protection of the tertiary alcohol moiety. This prevents any undesired decomposition 
via boron-Wittig elimination, and allows protected 1,2-hydroxyboronates to be isolated through 
simple silica gel chromatogoraphy. A representative example is shown in Scheme 1.8, in which 
crude phenyl-substituted 1,2-hydroxyboronate 1.25 is taken up in DMF and stirred with TMS-Cl 
and imidazole for 12 hours. Desired 1,2-silyloxyboronate TMS-1.25 was successfully purified in 





















































































Scheme 1.8 Isolation of silyl-protected 1,2-hydroxyboronate products  
 
1.3.3 Scope of 1,1-Diborylalkane Additions to Ethyl Benzoylformate 
After demonstrating the ability of this copper/(R)-Monophos catalyst system to generate a 
new quaternary substituted stereogenic center utilizing diborylmethane, we envisaged expanding 
this method to include substituted 1,1-diborylalkanes. Employment of these substrates would 
create a highly congested stereodiad consisting of a tertiary alcohol adjacent to a secondary alkyl 
boronic ester (see Figure 1.2). Such a molecule would be amenable to the myriad of stereospecific 
functionalizations available to organoboronate esters (as described in Figure 1.1), while also 
containing a biologically relevant motif, making these molecules attractive synthetic targets.3,54 
Initial attempts to directly translate the optimal DBM conditions to methyl-substituted 
diborylethane (1.2) were promising (Scheme 1.9). Using the same catalytic conditions at ambient 
temperature, 1.2 reacted cleanly with 1.23a to give desired 1,2-hydroxyboronate 1.46 in 64% yield 
as a single diastereomer and 98:2 e.r. It should be noted that all products generated from reactions 
between ethyl benzoylformate and 1,1-diborylalkanes were isolated with the organoboron group 
intact. This was attributed to heightened steric interactions between the two vicinal stereocenters, 
preventing intramolecular interaction between the alcohol and the boronic ester and slowing down 






















46% yield (2 steps)
96:4 e.r.
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Scheme 1.9 Direct translation of optimized DBM conditions to substituted 1,1-diborylalkanes 
 
Integration of other substituted gem-diborylalkanes proved to be more of a challenge. 
Substrates bearing a pendant silyl-protected alcohol (1.47), a t-butyl ester (1.48) and a benzyl 
group (1.49) only gave 22%, 15%, and <2% conversion to product, respectively, although 1.47 
was produced in excellent diastereo- and enantioselectivity. Significant re-optimization was 
needed in order for substituted 1,1-diborylalkanes to be viable substrates for this transformation 
(See Table 1.2). Increasing the reaction temperature slightly increased product conversion, but at 
the expense of diastereoselectivity (Entry 2). Doubling the catalyst loading proved even more 
fruitful (Entry 3), but it was clear that (R)-1.3 would not be able to deliver 1.47 in synthetically 
significant quantities. A small screen of other monodentate phosphoramidite ligands showed that 
partially-hydrogenated (R)-H8-1.3 was able to generate the desired 1,2-hydroxyboronate in 57% 
conversion, 3.0:1 d.r. and 98:2 e.r. (Entry 5). This significant increase in conversion was attributed 
to the larger bite angle of (R)-H8-1.3, which opens up the catalyst pocket and accommodates the 
more sterically encumbered substituted 1,1-diborylalkane substrates.55–57 Optimal conditions were 





































respectively. Under these conditions, 1.47 was produced in 74% conversion and a 3.4:1 d.r., where 
the major diastereomer was created in an excellent 98:2 enantiomeric ratio.  
Table 1.2 Optimization of the copper-catalyzed enantio- and diastereoselective 1,2-addition of 
substituted 1,1-diborylalkanes to a-ketoesters 
 
Exchanging (R)-1.3 for (R)-H8-1.3 led to a dramatic increase in conversion and selectivity 
for other substituted 1,1-diborylalkanes as well (Scheme 1.10). 1.50 reacted cleanly to give the 
corresponding 1,2-hydroxyboronate 1.47 in 51% yield, 3.3:1 d.r., and 98:2 e.r. of the major 
diastereomer. Larger alkyl groups were able to be accommodated, as diborylbutane (DBB) reacted 
to give 1.51 in 30% yield, 3.5:1 d.r. and 98:2 e.r. Prenyl-substituted 1,2-hydroxyboronate 1.52 was 
isolated in 60% yield, 7.3:1 d.r. and 99:1 e.r. 1,1-Diborylalkanes bearing a range of synthetically 
important functional handles, including allyl (1.53), t-Bu ester (1.48), and phenethyl (1.54) groups, 
were all tolerated. Interestingly, benzyl-substituted organodiboron reagent gave <2% conversion 





(pin)B B(pin) [Cu(MeCN)4]PF6 (5 mol%)(R)-1.3 (10 mol%)
LiOt-Bu (2.05 equiv)

















Deviation from Previous Conditions
None
45 °C instead of 22 °C
10 mol% [Cu], 20 mol% (R)-1.3
(R)-1.29 instead of (R)-1.3
(R)-H8-1.3 instead of (R)-1.3


















aReactions performed under an N2 atmosphere; see Experimental Section for details. 
bDetermined using 1H NMR spectroscopy; dimethylformamide was used as an internal 
standard. cDetermined by 1H NMR spectroscopy. dDetermined by chiral HPLC analysis 
of the corresponding 1,2-diol.
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reactivity on and off illustrates how sensitive this catalytic system is to changes in the steric 
environment of the gem-diboronate ester. 
Scheme 1.10 1,1-Diborylalkane scope for the enantioselective 1,2-addition to 1.23a 
 
1.3.4 Mechanistic Investigation 
In order to determine the absolute and relative stereochemistry of the 1,2-hydroxyboronate 
products, compound 1.46 was recrystallized and subjected to X-Ray crystallographic analysis. 
According to the crystal structure obtained, the stereochemical assignment of 1.46 is (R,R), which 
places the hydroxyl group of the tertiary alcohol anti to the boronate ester (Figure 1.4). This 




















3.3:1 d.r., 98:2 e.r.
1.53
50% yield
>20:1 d.r., 99:1 e.r.
1.52
60% yield
7.3:1 d.r., 99:1 e.r.
1.51
30% yield
3.5:1 d.r., 98:2 e.r.
1.48
15% yield
>20:1 d.r., 94:6 e.r.
1.54 (n = 1)
33% yield
4:1 d.r., 98:2 e.r.



















Figure 1.4 X-Ray crystallographic analysis of 1.46 
To further investigate the transmetalation step of the catalytic cycle, benzophenone was 
employed as a symmetric ketone substrate. Reaction between benzophenone and 1.2 yielded 
diphenyl-substituted hydroxyboronate 1.56 in 42% 1H NMR yield and 97:3 e.r. (Scheme 1.11). 
The new stereocenter produced in this reaction must originate from the a-boryl alkylcopper 







Scheme 1.11 Copper-catalyzed 1,2-addition reaction between DBE and benzophenone 
 
This high enantioselectivity most likely originates via one of two pathways (Figure 1.5). 
One possibility is that an activated 1,1-diborylalkane undergoes stereoselective transmetalation 
with a single enantiotopic boron group, creating an enantioenriched a-boryl alkylcopper species 
in high e.r. Another option involves a racemic transmetalation event, where the resulting 
alkylcopper rapidly equilibrates between enantiomers. Paralleling a classic dynamic kinetic 
resolution, the (R)-enantiomer adds rapidly to a ketone or ketoester, and continues to generate 
product until all starting material is consumed. Based on previous research conducted by the 
Morken group52 (see Scheme 1.5), our hypothesis is that the former statement is true, and that our 
catalyst undergoes a stereoselective transmetalation with substituted 1,1-diborylalkanes to 
generate an enantioenriched a-boryl alkylcopper species. 
 

























catalyst shows no preference



















Mechanism 1 = Enantioselective Transmetallation





From this experimental evidence, we constructed a working catalytic cycle for the 1,2-
addition reaction between 1,1-diborylalkanes and a-ketoesters, highlighted in Figure 1.6. In situ 
generated copper (I) alkoxide/phosphoramidite catalyst I undergoes stereoselective 
transmetalation with gem-diboronate ester II, creating the enantioenriched nucleophilic species 
III. Diastereoselective addition to a-ketoester 1.23b (which undergoes transesterification with an 
equivalent of LiOt-Bu prior to entering the cycle) generates copper alkoxide IV, which may 
undergo deleterious boron-Wittig elimination to produce olefin V. Catalyst turnover is achieved 
when this species reacts with a second equivalent of LiOt-Bu, releasing lithium alkoxide VI, which 
is quenched via acid workup to give desired 1,2-hydroxyboronate product VII. 
 









































1.3.5 Product Functionalization 
In order to highlight their incredible versatility, the 1,2-hydroxyboronates were subjected 
to a range of post-reaction transformations (Scheme 1.12). As emphasized previously, 
enantioenriched secondary boronic esters may be stereospecifically converted into a variety of 
valuable functional handles.54 Oxidation of 1.47 yields trans diol 1.57 in 91% isolated yield. 
Synthesizing this diol through asymmetric dihydroxylation of a stereodefined trisubstituted olefin 
would be incredibly challenging, highlighting the utility of this two-step process. Additionally, 
after initial silyl protection, secondary boronic ester TMS-1.52 may be stereospecifically 
homologated under Matteson-type conditions, yielding primary alkylboronic ester 1.56 in 50% 
isolated yield. 
Scheme 1.12 Functionalizations of C(sp3)–B bonds contained in isolated 1,2-hydroxyboronates 
 
Due to their congested nature, the secondary boronate esters created were unable to 
participate in other, more demanding functionalizations, including Suzuki cross-couplings. 
However, this added stability allowed us to showcase the utility of other pendant functional groups 
on the isolated organoboron products (Scheme 1.13). Allyl-substituted tertiary alcohol 1.53 
underwent clean cross-metathesis with cis-2-butene-1,4-diol (1.59) in the presence of ruthenium 






















THF, -78 °C to 22 °C
2 h
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63% yield in a 16:1 E/Z ratio. Prenyl-substituted organoboron product 1.52 was converted into 
densely functionalized tetrahydropyran 1.62 via an iodoetherification reaction.59 Treatment of 1.52 
with I2 and NaHCO3 in MeCN at –35 °C furnishes 1.62 in 53% conversion and 3:1 d.r., which 
improves to >20:1 d.r. after silica gel purification (45% isolated yield). 
Scheme 1.13 Transformations of isolated 1,2-hydroxyboronates involving preservation of the 
enantioenriched secondary boronic ester 
 
1.4 Conclusions 
In conclusion, we have developed an enantio- and diastereoselective 1,2-addition reaction 
between aryl a-ketoesters and 1,1-diborylalkanes. A copper(I)/(R)-Monophos catalytic system is 
optimal for the addition of DBM to a-ketoesters, which proceeds in up to 70% yield and up to 
97:3 e.r. Expansion to higher order gem-diborylalkanes bearing alkyl substitution requires the 
employment of partially hydrogenated (R)-H8-Monophos. Using this modified system, small 
molecules containing a tertiary alcohol adjacent to a secondary boronic ester may be synthesized 
































enantioselective transmetalation event as a key component of the catalytic cycle. The resulting 1,2-
hydroxyboronates are amenable to subsequent transformations, including some that leave an 
organoboron moiety intact for further downstream functionalization. 
 
1.5 Experimental 
n General: All reactions were carried out in oven-dried (150 ˚C) or flame-dried glassware 
under an inert atmosphere of dried nitrogen unless otherwise noted.  Analytical thin-layer 
chromatography was performed on glass plates coated with 0.25 mm of 60 Å mesh silica gel.  
Plates were visualized by exposure to UV light (254 nm) and/or immersion into Seebach’s or 
KMnO4 stain followed by heating.  Column chromatography using regular silica gel was 
performed using silica gel P60 (mesh 230-400) supplied by Silicycle. Deactivated silica gel was 
prepared by mixing silica gel and deionized water (65:35 by weight) followed by vigorous shaking 
and stirring until a free-flowing powder was obtained. This was allowed to sit overnight. All 
solvents were sparged with argon and then purified under a positive pressure of argon through an 
SG Water, USA Solvent Purification System.  Tetrahydrofuran (OmniSolv) was passed 
successively through two columns of neutral alumina. The ambient temperature in the laboratory 
was approximately 22 °C.  Reactions were run at low temperatures using an isopropanol filled SP 
Scientific cryobath.  
 
n Instrumentation: All 1H NMR spectra were recorded on Bruker Spectrometers 
(AVANCE-600 and DRX 400).  Chemical shifts are reported in ppm from tetramethylsilane and 
referenced to the residual protio solvent peak (CDCl3: δ 7.26). Data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, qu = quartet, quint = quinttet, br = 
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broad, m = multiplet, app = apparent), integration, and coupling constants are given in Hz. 13C 
NMR spectra were recorded on Bruker Spectrometers (AVANCE-600 and DRX-400) with carbon 
and proton decoupling. Chemical shifts are reported in ppm from tetramethylsilane and referenced 
to the residual protio solvent peak (CDCl3: δ 77.16).  13B NMR spectra were recorded on a Bruker 
model 500 MHz spectrometer. All IR spectra were recorded on a Jasco 260 Plus Fourier transform 
infrared spectrometer.  Mass spectrometry samples were analyzed with a hybrid LTQ FT (ICR 7T) 
(ThermoFisher, Bremen, Germany) mass spectrometer. Samples were introduced via a 
microelectrospray source at a flow rate of 10 µL/min (solvent composition 10:1 MeOH:H2O). 
Xcalibur (ThermoFisher, Breman, Germany) was used to analyze the data. Molecular formula 
assignments were determined with Molecular Formula Calculator (v 1.2.3). Low-resolution mass 
spectrometry (linear ion trap) provided independent verification of molecular weight distributions. 
All observed species were singly charged, as verified by unit m/z separation between mass spectral 
peaks corresponding to the 12C and 13C12Cc-1 isotope for each elemental composition. Optical 
rotations were determined using a Jasco P1010 polarimeter and concentrations are reported in 
g/100mL.  Enantiomeric ratios were determined on an Agilent Technologies 1220 Infinity LC 
using the following columns: Diacel CHIRALPAK IA (4.6 mm x 250 mmL x 5 µm), Diacel 
CHIRALPAK IB (4.6 mm x 250 mmL x 5 µm), and Diacel CHIRALPAK IC (4.6 mm x 250 mmL 
x 5 µm).  
 
n Reagents  
Ammonium chloride was purchased from Alfa Aesar and used as received.  
nButyl lithium (1.6M in hexanes) was purchased from Strem Chemicals and titrated using sec-
butanol and phenanthroline prior to use.  
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Calcium hydride was purchased from Strem Chemicals and used without further purification. 
Copper(I) chloride was purchased from Strem Chemicals and kept in a nitrogen filled dry box.   
Copper(II) triflate was purchased from Strem Chemicals and kept in a nitrogen filled dry box.   
Copper(I) tetrakisacetonitrile hexafluorophosphate was purchased from Sigma-Aldrich and 
kept in a nitrogen filled dry box.  
Chloroform-d was purchased from Cambridge Isotope Laboratories and used without further 
purification.  
Chlorotrimethylsilane was purchased from Acros, dried over calcium hydride, distilled, stored 
under nitrogen at 0° C, and used within 2 weeks of distillation.  
Diboryl methane (1.24) was synthesized according to literature procedure7 and matched literature 
spectra. It was purified via column chromatography (20:1 Hexanes:Ethyl Acetate) to contain <7% 
B2(pin)2 by 1H NMR spectroscopy and dried via azeotropic distillation from benzene. 
Dibromomethane was purchased from Alfa Aesar and passed through a short column of neutral 
alumina and then sparged with dry nitrogen before use.  
Dimethylformamide (dry) was purchased from EMD and used as received. 
Ethyl benzoylformate was purchased from Sigma Aldrich and Alfa Aesar, dried via azeotropic 
distillation with benzene, and stored under nitrogen. 
Ethyl 4-nitrophenylglyoxylate was obtained from Lancaster Synthesis, dried via azeotropic 
distillation with benzene, and stored under nitrogen at -25° C. 
Ethyl mesitylglyoxylate was obtained from Lancaster Synthesis, dried via azeotropic distillation 
with benzene, and stored under nitrogen at -25° C. 
Ethyl-3-methylbenzoyl formate was obtained from Reike Specialty Chemicals, dried via 
azeotropic distillation with benzene, and stored under nitrogen at -25° C.  
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Hoveyda-Grubbs Catalyst 2nd Generation (1.60) was obtained from Sigma Aldrich and used as 
received. 
Imidazole was purchased from Alfa-Aesar and used as received.  
Iodine was purchased from EM Science and used as received. 
Lithium tert-butoxide was purchased from Strem Chemicals, stored in a nitrogen filled dry box 
and used as received. 
(R)-DTBM-Segphos (1.32) was purchased from Strem Chemicals, stored in a nitrogen filled dry 
box and used as received. 
(R)-MorphPhos (1.29), and (R)-H8-Monophos (H8-1.3) were synthesized according to published 
literature procedure.60,61  
(R)-BINAP (1.31) was purchased from Strem Chemicals and stored in a nitrogen filled dry box.  
(R,S)-josiphos (1.33) was purchased from Strem Chemicals and stored in a nitrogen filled dry box.  
Sodium bicarbonate was purchased from BDH and used as received. 
Sodium perborate tetrahydrate was purchased from Sigma Aldrich and used as received. 
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Ketoesters 1.63-1.71, were prepared according to literature procedure62 and matched the known 
1H NMR and 13C NMR spectra.62–66 All ketoesters were dried via azeotropic distillation with 
benzene and stored under nitrogen at -25 °C.  










































































Diboryl reagents 1.2, 1.50, and 1.72-1.76 were prepared according to the literature method and 
matched literature spectra.7 
 
 
Diboryl reagents 1.77 was prepared according to a literature method.6 In an N2-filled glove box, 
an oven-dried 50 mL round-bottom flask was charged with diboryl methane (500 mg, 1.9 mmol) 
and a magnetic stirbar, capped with a rubber septum, and sealed with electrical tape. A separate 
oven-dried, 25 mL conical flask was charged with lithium 2,2,6,6-tetramethylpiperidide (288 mg, 
1.96 mmol), capped with a rubber septum, and sealed with electrical tape. The two flasks were 
brought out of the glove box, where the diboryl methane flask was charged with 7.8 mL of dry 
THF and the LiTMP-containing flask was charged with 15.5 mL of dry THF (0.17 M total). Both 
flasks were allowed to cool to 0 °C (ice/water baths). The LiTMP solution was then transferred 
via cannula to the diboryl methane flask with stirring. After the transfer, the reaction mixture was 
allowed to stir at 0 °C for 10 min. Allyl bromide (0.403 mL, 4.67 mmol) was added to the reaction 
via a syringe. The reaction mixture was allowed to warm up to 22 °C over 18 h with stirring. The 
reaction was quenched with 10 mL of a saturated aqueous solution of NH4Cl. The biphasic mixture 
was extracted three times with diethyl ether (150 mL total), and the combined organic extracts 
were dried over MgSO4, filtered, and concentrated in vacuo. The crude reaction mixture was 
purified by silica gel chromatography (20:1 hexanes:EtOAc, Rf=0.20) to give the desired product 
as a clear, viscous oil in 77% isolated yield (445 mg). 1H NMR (600 MHz, CDCl3) δ 5.87 (ddt, J 
= 16.6, 10.1, 6.3 Hz, 1H), 4.99 (ddd, J = 17.1, 3.5, 1.7 Hz, 1H), 4.88 – 4.84 (m, 1H), 2.29 (dd, J = 








CDCl3) δ 140.70, 113.20, 83.07, 29.62, 24.88, 24.52. IR (u/cm-1): 2979 (s), 2931 (s), 1359 (m), 
1320 (m), 1141 (s). LRMS (ESI+) [M+Na] calcd for C16H30B2O4Na 331.22, found 331.27. 
 




In a nitrogen filled dry box, a stock solution of Cu(MeCN)4PF6 (0.017 M), (R)-1.3 (0.033 M) and 
LiOt-Bu (0.017 M) in THF was made in an 8-mL vial equipped with a magnetic stir bar. This was 
allowed to stir for 45 min at 22 °C. Diborylmethane (1.24, 40.2 mg, 0.15 mmol) and LiOt-Bu (16 
mg, 0.2 mmol) were weighed into a separate 8-mL vial and dissolved in THF (0.4 mL). An aliquot 
of the catalyst solution (0.3 mL) and stir bar was then transferred to the vial containing the 1.24 
and LiOt-Bu. The vial was sealed with a septa-lined cap, taped, removed from the glovebox, and 
cooled to -10 °C in a cryobath. After 5 minutes at -10 °C, ketoester was added to the vial via 
syringe. The reaction was kept at -10 °C for 24 hours and agitated periodically. The reaction was 
quenched with a saturated aqueous solution of NH4Cl (1.5 mL), and the aqueous layer extracted 
three times with diethyl ether.  The combined organic extracts were dried over MgSO4, filtered, 
and concentrated in vacuo.  Conversion was determined by 1H NMR using dimethylformamide as 
an internal standard. The crude reaction mixture was then taken on to Supplementary Procedure A 


















n General Procedure B: Cu-Catalyzed 1,2-Addition Reaction of Secondary Alkyl 
Boronates  
 
In a nitrogen filled dry box, an 8-mL vial equipped with a magnetic stir bar was charged with 
Cu(MeCN)4PF6 (1.9 mg, 0.005 mmol), (R)-1.3 (3.9 mg, 0.010 mmol), and LiOt-Bu (0.4 mg, 0.005 
mmol) and dissolved in THF (0.30 mL, 0.017M). This was allowed to stir for 45 min. 
Organodiboron reagent (0.15 to 0.20 mmol) and LiOt-Bu (16 mg, 0.2 mmol) were weighed into a 
separate 8-mL vial and dissolved in THF (0.4 mL). The catalyst solution and stir bar was then 
transferred to the vial containing the organodiboron reagent and LiOt-Bu. The vial was sealed with 
a septa-lined cap, taped, removed from the glovebox, and placed on a magnetic stir plate at 22 °C. 
1.23a (18 mg, 0.1 mmol) was added to the vial via syringe. The reaction was allowed to stir at 
room temperature for 24 hours. The reaction was quenched with a saturated aqueous solution of 
NH4Cl (1.5 mL), and the aqueous layer extracted three times with diethyl ether.  The combined 
organic extracts were dried over MgSO4, filtered, and concentrated in vacuo.  Conversion was 
determined by 1H NMR using dimethylformamide as an internal standard. The product was 
purified via silica gel chromatography.  
 





























In a nitrogen filled dry box, an 8-mL vial equipped with a magnetic stir bar was charged with 
Cu(MeCN)4PF6 (3.8 mg, 0.010 mmol), (R)-H8-1.3 (7.3 mg, 0.020 mmol), and LiOt-Bu (0.8 mg, 
0.010 mmol) and dissolved in THF (0.60 mL). This was allowed to stir for 45 min. Organodiboron 
reagent (0.15 to 0.20 mmol) and LiOt-Bu (16 mg, 0.2 mmol) were weighed into a separate 8-mL 
vial and dissolved in THF (0.1 mL). The catalyst solution and stir bar was then transferred to the 
vial containing the organodiboron reagent and LiOt-Bu. The vial was sealed with a septa-lined 
cap, taped, removed from the glovebox, and placed on a magnetic stir plate at 22 °C. 1.23a (18 
mg, 0.1 mmol) was added to the vial via syringe. The reaction allowed to stir at room temperature 
for 24 hours. The reaction was quenched with a saturated aqueous solution of NH4Cl (1.5 mL), 
and the aqueous layer extracted three times with diethyl ether.  The combined organic extracts 
were dried over MgSO4, filtered, and concentrated in vacuo.  Conversion was determined by 1H 
NMR using dimethylformamide as an internal standard. The product was purified via silica gel 
chromatography. 
 
n Supplementary Procedure A: Synthesis of Enantioenriched Diols  
 
The crude hydroxyboronate was combined with sodium perborate tetrahydrate (77 mg, 0.5 mmol), 
dissolved in a 1:1 mixture of THF and water (1 mL, 0.1M) and vigorously stirred for 2 hours at 22 
°C. The reaction was quenched with a saturated aqueous solution of NH4Cl (1.5 mL), and the 
aqueous layer extracted three times with diethyl ether, dried over MgSO4, filtered, and 





THF/H2O (1:1), 22 °C, 2 hrB(pin) OH
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Enantiomeric excess of the diol was determined by HPLC analysis compared to the authentic 
racemic material.   
 
 
n Supplementary Procedure B: Synthesis of Enantioenriched Diols  
The crude hydroxyboronate was passed through a silica gel column. The resulting oil was then 
combined with sodium perborate (77 mg, 0.5 mmol), dissolved in a 1:1 mixture of THF and water 
(1 mL, 0.1M) and vigorously stirred for 2 hours at 22 °C. The reaction was quenched with a 
saturated aqueous solution of NH4Cl (1.5 mL), and the aqueous layer extracted three times with 
diethyl ether, dried over MgSO4, filtered, and concentrated in vacuo. The product was purified via 
silica gel column chromatography. Enantiomeric excess of the diol was determined by HPLC 
analysis compared to the authentic racemic material.   
 
n Supplementary Procedure C: Synthesis of TMS-Protected β-Hydroxyboronates 
 
The crude hydroxyboronate (R=H) or purified hydroxyboronate (R=alkyl) was concentrated in an 
8 mL vial, capped with a septa-lined cap, and purged with nitrogen for 5 minutes. Imidazole (8 
mg, 0.12 mmol) and a magnetic stir bar were quickly added to the vial under a stream of nitrogen. 
The vial was purged with nitrogen for an addition 2 minutes and then vial was charged with DMF 
via syringe (0.2 mL, 0.15M). Chlorotrimethylsilane (15 µl, 0.4 mmol) was added via syringe to 
the vial. The vial was placed on a magnetic stir plate at 22 °C and allowed to stir for 18 hours. The 





DMF, 22 °C, 15 hrB(pin) B(pin)
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saturated sodium bicarbonate solution, washed with brine, dried over MgSO4 and concentrated in 
vacuo. The crude mixture was purified via silica gel column chromatography. MgSO4 
 
n Product Characterization 
 
 
Tert-butyl (S)-2,3-dihydroxy-2-phenylpropanoate (1.34). Following General Procedure A and 
Supplementary Procedure A, the crude oxidation mixture was purified by silica gel (regular) 
chromatography (4:1 hexanes:ethyl acetate, gravity) to yield diol 1.34 as a colorless oil in 65% 
isolated yield (15.5 mg). 1H NMR (600 MHz, CDCl3) d 7.65 - 7.59 (m, 2H), 7.39 (t, J = 7.6 Hz, 
2H), 7.34 (m, J = 7.2 Hz, 1H), 4.21 (t, J = 10.8 Hz, 1H), 4.14 (s, 1H), 3.74 (dd, J = 11.4, 3.0 Hz, 
1H), 2.39 (dd, J = 10.4, 3.5 Hz, 1H), 1.52 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.9, 138.6, 
128.3, 128.1, 125.4, 84.0, 79.4, 68.4, 27.9.  HRMS (ESI+) [2M+Na]+ calcd for C26H36O8Na+ 
499.2308, found 499.2296. IR (n/cm-1): 3446 (m, br), 2976 (m), 1732 (s), 1558 (m), 1541 (m), 
1369 (s), 1252 (m), 1140 (m).   [a]22D = -25.6° (c = 0.205, CH2Cl2, l = 100 mm).  [a]22D = -6.8° (c 
= 0.16, CH2Cl2, l = 100 mm). Absolute stereochemistry was confirmed by comparison of the 
optical rotation to that of the known R enantiomer.67 












Enantioenriched Material   
 
Major: 15.2 min; Minor: 19.8 min; 96:4 e.r. 
 
 
Tert-butyl (S)-2,3-dihydroxy-2-(4-nitrophenyl)propanoate (1.35). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography (4:1 hexanes: ethyl acetate, gravity) to 
yield diol 1.35 as a yellow oil in 46% yield (13.1 mg). 1H NMR (600 MHz, CDCl3) d 8.22 (d, J = 
8.9 Hz, 2H), 7.81 (d, J = 8.9 Hz, 2H), 4.26 (s, 1H), 4.18 (d, J = 11.3 Hz, 1H), 3.72 (d, J = 11.3 Hz, 
1H), 2.38 (s, 1H), 1.50 (s, 9H). 13C NMR (151 MHz, CDCl3) d 171.6, 147.8, 145.6, 126.8, 123.5, 






306.0945. IR (u/cm-1): 3443 (s), 2979 (w), 1726 (m), 1642 (m), 1522 (s), 1370 (m), 1349 (s), 1156 
(m). [a]22D = -34.9° (c = 0.53, CH2Cl2, l = 100 mm). 





Major: 81.7 min; Minor: 88.8 min; 94: 6 e.r. 
 
 
Tert-butyl (S)-2,3-dihydroxy-2-(4-(trifluoromethyl)phenyl)propanoate (1.36). Following 
General Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified 






54% yield (17.1 mg). 1H NMR (600 MHz, CDCl3) δ 7.74 (d, J = 8.2 Hz, 2H), 7.62 (d, J = 8.3 Hz, 
2H), 4.22 (d, J = 0.9 Hz, 1H), 4.17 (t, J = 10.7 Hz, 1H), 3.71 (dd, J = 11.3, 3.8 Hz, 1H), 2.43 (dd, 
J = 10.0, 3.9 Hz, 1H), 1.50 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 172.1, 142.5, 126.1, 125.3, 
125.3, 125.3, 125.2, 124.9, 123.1, 84.6, 79.3, 68.4, 27.8. LRMS (ESI+) [M+Na]+calcd for 
C14H17F3O4Na+ 329.10, found 329.18. IR (u/cm-1): 3457 (m, br), 2980 (m), 2934 (m), 1726 (s), 
1328 (s). [a]22D = -9.4° (c = 0.91, CH2Cl2, l = 100 mm). 












Tert-butyl (S)-2,3-dihydroxy-2-(4-methoxyphenyl)propanoate (1.37). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography (4:1 hexanes: ethyl acetate) to yield diol 
1.37 as a colorless oil in 60% yield (16.1 mg). 1H NMR (600 MHz, CDCl3) d 7.49 (d, J = 8.8 Hz, 
2H), 6.88 (d, J = 8.8 Hz, 2H), 4.15 (t, J = 10.7 Hz, 1H), 4.08 (s, 1H), 3.81 (s, 3H), 3.68 (dd, J = 
11.6, 2.6 Hz, 1H), 2.34 (dd, J = 10.4, 3.5 Hz, 1H), 1.49 (s, 9H). 13C NMR (151 MHz, CDCl3) d 
173.2, 159.5, 130.8, 126.8, 113.8, 84.0, 79.2, 68.5, 55.4, 28.0. HRMS (ESI+) [2M+Na]+ calcd for 
C28H40O10Na+ 559.2519, found 559.2510. IR (u/cm-1): 3465 (br, m), 2978 (m), 2931 (m), 1718 
(s), 1510 (s), 1251 (s), 1159 (s). [a]22D = -25.6° (c = 0.435, CH2Cl2, l = 100 mm). 


















Tert-butyl (S)-2-(4-chlorophenyl)-2,3-dihydroxypropanoate (1.38). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography  (6:1 hexanes: ethyl acetate) to yield diol 
1.38 as a colorless oil in 64% yield (17.6 mg). 1H NMR (600 MHz, CDCl3) d 7.53 (d, J = 8.6 Hz, 
2H), 7.33 (d, J = 8.6 Hz, 2H), 4.14 (m, J = 4.2 Hz, 2H), 3.68 (dd, J = 11.4, 2.7 Hz, 1H), 2.33 (dd, 
J = 9.6, 4.3 Hz, 1H), 1.49 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.6, 137.2, 134.3, 128.6, 
127.1, 84.5, 79.2, 68.4, 28.0. HRMS (ESI+) [M+Na]+ calcd for C13H17O4ClNa+ 295.0713, found 
295.0909. IR (u/cm-1): 3449 (m, br), 2978 (m), 1727 (s), 1492 (m), 1370 (m), 1254 (m), 1156 (s), 
1094 (s). [a]22D = -21.3° (c = 0.455, CH2Cl2, l = 100 mm). 












Major: 17.1 min; Minor: 18.4 min; 97:3 e.r. 
 
 
Tert-butyl (S)-2-(4-(tert-butyl)phenyl)-2,3-dihydroxypropanoate (1.39). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography (6:1 hexanes: ethyl acetate) to yield diol 
1.39 as a white solid in 70% yield (20.6 mg). 1H NMR (600 MHz, CDCl3) d 7.55 - 7.47 (m, 2H), 
7.42 - 7.33 (m, 2H), 4.15 (d, J = 10.3 Hz, 1H), 4.06 (s, 1H), 3.70 (d, J = 11.3 Hz, 1H), 2.37 (s, 1H), 






79.5, 68.7, 34.6, 31.4, 28.0. HRMS (ESI+) [2M+Na]+ calcd for C34H52O8Na+ 611.3560, found 
611.3553. IR (u/cm-1): 3472 (m, br), 2964 (s), 1722 (s), 1369 (m), 1274 (m), 1159 (s), 1112 (m). 
[a]22D = -25.3° (c = 0.680, CH2Cl2, l = 100 mm). 





Major: 12.4 min; Minor: 14.6 min; 92:8 e.r. 
 
 
Tert-butyl (S)-2,3-dihydroxy-2-(m-tolyl)propanoate (1.40). Following General Procedure A 






regular:deactivated, mixed) chromatography (6:1 hexanes: ethyl acetate) to yield diol 1.40 as a 
colorless oil in 63% yield (16.4 mg). 1H NMR (600 MHz, CDCl3) d 7.41 (d, J = 2.0 Hz, 1H), 7.36 
(d, J = 8.4 Hz, 1H), 7.24 (t, J = 7.7 Hz, 1H), 7.12 (d, J = 7.7 Hz, 1H), 4.17 (d, J = 10.5 Hz, 1H), 
4.07 (s, 1H), 3.71 (d, J = 11.3 Hz, 1H), 2.36 (s, 3H), 1.49 (s, 9H). 13C NMR (151 MHz, CDCl3) d 
173.1, 138.7, 138.1, 129.0, 128.3, 126.3, 122.6, 84.0, 79.5, 68.5, 28.0, 21.8. HRMS (ESI+) 
[2M+Na]+ calcd for C28H40O8Na+ 527.2621, found 527.2611. IR (u/cm-1): 3469 (m, br), 2978 (m), 
1722 (s), 1370 (m), 1275 (m), 1156 (s), 1059 (m). [a]22D = -31.9° (c = 0.625, CH2Cl2, l = 100mm). 










Tert-butyl (S)-2,3-dihydroxy-2-(3-methoxyphenyl)propanoate (1.41). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography (4:1 hexanes: ethyl acetate,) to yield diol 
1.41 as a colorless oil in 62% yield (16.7 mg). 1H NMR (600 MHz, CDCl3) d  7.30 - 7.24 (m, 1H), 
7.19 - 7.13 (m, 2H), 6.85 (ddd, J = 8.1, 2.6, 1.0 Hz, 1H), 4.16 (t, J = 10.3 Hz, 1H), 4.09 (s, 1H), 
3.81 (s, 3H), 3.70 (d, J = 11.3 Hz, 1H), 2.32 (d, J = 9.8 Hz, 1H), 1.50 (s, 9H). 13C NMR (151 MHz, 
CDCl3) d 172.8, 159.6, 140.2, 129.3, 117.8, 113.6, 111.3, 84.0, 79.4, 68.4, 55.2, 27.9. HRMS 
(ESI+) [2M+Na]+ calcd for C28H40O10Na+ 559.2512, found 559.2512. IR (u/cm-1): 3452 (m, br), 
2932 (m), 1725 (s), 1602 (m), 1401 (m), 1369 (m), 1255 (s), 1155 (s), 1052 (s).  [a]22D = -21.4° (c 
= 0.49, CH2Cl2, l = 100 mm). 














Major: 21.1 min; Minor: 25.9 min; 96:4 e.r. 
 
 
Tert-butyl (S)-2-(3-chlorophenyl)-2,3-dihydroxypropanoate (1.42). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography (6:1 hexanes: ethyl acetate) to yield diol 
1.42 as a colorless oil in 64% yield (17.6 mg). 1H NMR (600 MHz, CDCl3) d 7.62 (bs, J = 1.3 Hz, 
1H), 7.50 - 7.44 (m, 1H), 7.33 - 7.27 (m, 2H), 4.29 - 4.00 (m, 2H), 3.69 (dd, J = 11.5, 2.9 Hz, 1H), 
2.36 (dd, J = 10.1, 3.8 Hz, 1H), 1.50 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.2, 140.6, 134.3, 
129.5, 128.2, 125.9, 123.7, 84.4, 79.0, 68.3, 27.8. HRMS (ESI+) [2M+Na]+ calcd for 
C26H34O8Cl2Na+ 567.1528, found 567.1517. IR (u/cm-1): 3464 (s, br), 2979 (m), 2929 (m), 1724 
(s), 1370 (m), 1287 (m), 1258 (m), 1157 (s), 1079 (m). [a]22D = -32.7° (c = 0.725, CH2Cl2, l = 100 
mm). 












Major: 14.8 min; Minor: 19.6 min; 97:3 e.r. 
 
 
Tert-butyl (S)-2,3-dihydroxy-2-(napthalen-2-yl)propanoate (1.43). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography (6:1 hexanes: ethyl acetate, gravity) to 
yield diol 1.43 as a white solid in 62% yield (17.8 mg). 1H NMR (600 MHz, CDCl3) d 8.12 - 8.07 
(m, 1H), 7.90 - 7.81 (m, 3H), 7.68 (dd, J = 8.7, 1.9 Hz, 1H), 7.53 - 7.46 (m, 2H), 4.32 (t, J = 10.2 





NMR (151 MHz, CDCl3) d 173.0, 136.2, 133.2, 133.1, 128.5, 128.1, 127.7, 126.5, 126.4, 125.0, 
123.4, 84.3, 79.7, 68.5, 28.0. HRMS (ESI+) [2M+Na] calcd for C34H40O8Na+ 599.2621, found 
599.2614. IR (u/cm-1): 3469 (br, m), 2978 (m), 2929 (m), 1721 (s), 1370 (s), 1283 (s), 1249 (s), 
1156 (s), 1128 (s).   [a]22D = -24.3° (c = 0.740, CH2Cl2, l = 100 mm). 





Major: 32.2 min; Minor: 21.9 min; 96:4 e.r. 
 
 
Tert-butyl (S)-2,3-dihydroxy-2-(o-tolyl)propanoate (1.44). Following General Procedure A and 






chromatography (4:1 hexanes: ethyl acetate) to yield diol 1.44 as a colorless oil in 27% yield (6.8 
mg). 1H NMR (400 MHz, CDCl3) d 7.31 (dd, J = 7.6, 1.6 Hz, 1H), 7.23 - 7.13 (m, 3H), 4.33 - 4.20 
(m, 1H), 4.11 - 4.02 (m, 2H), 2.39 (s, 3H), 1.43 (s, 9H). ). 13C NMR (151 MHz, CDCl3) d 173.6, 
137.2, 136.7, 132.4, 128.3, 126.3, 125.9, 83.7, 79.1, 67.4, 27.9, 20.8. HRMS (ESI+) [2M+Na] 
calcd for C28H40O8Na+ 527.2611, found 527.2621. IR (u/cm-1): 3446 (m, br), 2977 (s), 2929 (s), 
1725 (s), 1458 (m), 1394 (m), 1369 (s), 1277 (s), 1159 (s), 1114 (s). [a]22D = -10.4° (c = 0.410, 
CH2Cl2, l = 100 mm). 





Major: 17.2 min; Minor: 19.5 min; 66:34.r. 
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Tert-butyl-2,3-dihydroxy-2-(pyridine-2-yl)propanoate (1.45). Following General Procedure A 
and Supplementary Procedure A, the crude oxidation mixture was purified by silica gel (50:50 
regular:deactivated, mixed) chromatography (4:1 hexanes: ethyl acetate) to yield diol 1.45 as a 
yellow oil in 36% yield (8.6 mg). 1H NMR (600 MHz, CDCl3) d 8.85 (d, J = 2.2 Hz, 1H), 8.57 
(dd, J = 4.9, 1.6 Hz, 1H), 7.94 (dt, J = 8.2, 1.9 Hz, 1H), 7.30 (dd, J = 8.1, 4.8 Hz, 1H), 4.17 (d, J 
= 11.4 Hz, 1H), 3.73 (d, J = 11.3 Hz, 1H), 1.50 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.3, 
149.5, 147.5, 134.4, 133.7, 123.3, 84.9, 78.3, 68.6, 28.0. HRMS (ESI+) [M+Na] calcd for 
C12H17NO4Na+ 262.1055, found 262.1054. IR (u/cm-1): 3385 (m, br), 2919 (m), 1730 (s), 1370 
(m), 1286 (m), 1251 (m), 1159 (s). [a]22D = -39.2° (c = 0.425, CH2Cl2, l = 100 mm). 


















((trimethylsilyl)oxy)propanoate (TMS-1.25). Following General Procedure A and 
Supplementary Procedure C, the crude material was purified by silica gel (regular) 
chromatography (75:1 pentane:diethyl ether) to yield TMS-1.25 as a colorless solid in 46% yield 
(58 mg). 1H NMR (600 MHz, CDCl3) d  7.51 - 7.46 (m, 2H), 7.28 (t, J = 7.7 Hz, 2H), 7.24 - 7.19 
(m, 1H), 1.77 (d, J = 15.3 Hz, 1H), 1.70 (d, J = 15.3 Hz, 1H), 1.44 (s, 9H), 1.16 (s, 6H), 1.15 (s, 
6H), 0.07 (s, 9H). 13C NMR (151 MHz, CDCl3) d 173.0, 145.2, 127.7, 127.0, 125.6, 83.0, 81.3, 
80.7, 27.9, 24.8, 24.7, 2.2. HRMS (ESI+) [M+Na]+ calcd for C22H37BO5SiNa+ 443.2401, found 
443.2389. IR (u/cm-1): 2979 (m), 1738 (s), 1366 (s), 1333 (m), 1248 (m), 1147 (s). [a]22D = +2.8° 









yl)butanoate (1.46). Following General Procedure B, the crude material was purified by silica gel 
(regular) chromatography (15:1 pentane:diethyl ether, gravity) to yield β-hydroxyboronate 1.46 as 
a white solid in 67% isolated yield (19.1 mg). On a 1.0 g (5.6 mmol) scale (with respect to 
ketoester), compound 1.46 was isolated in 60% yield (1.21 g, contains 5% diboryl ethane 
impurity).  1H NMR (600 MHz, CDCl3) d 7.58 - 7.51 (m, 2H), 7.31 (dd, J = 8.4, 7.0 Hz, 2H), 7.25 
- 7.20 (m, 1H), 3.86 (s, 1H), 2.08 (q, J = 7.6 Hz, 1H), 1.41 (s, 9H), 1.25 (s, 6H), 1.24 (s, 6H), 0.75 
(d, J = 7.6 Hz, 3H). 13C NMR (151 MHz, CDCl3) d 174.6, 141.5, 127.8, 126.9, 125.8, 83.4, 82.3, 
80.2, 27.8, 24.9, 24.6, 9.5. HRMS (ESI+) [2M+Na]+ calcd for C40H62B2O10Na+ 747.4427, found 
747.4451. IR (u/cm-1): 3401 (m, br), 2979 (s), 1693 (s), 1475 (m), 1373 (s). [a]22D = -1.6° (c = 




tetramethyl-1,3,2-dioxaborolan-2-yl)pentanoate (1.47). Following General Procedure C, the 
crude material was purified by silica gel (80:20 regular:deactivated, layered) chromatography 












mg). 1H NMR (600 MHz, CDCl3) δ 7.56 (d, J = 7.4 Hz, 2H), 7.30 (t, J = 7.7 Hz, 2H), 7.22 (t, J = 
7.3 Hz, 1H), 3.98 (s, 1H), 3.60 (ddd, J = 9.9, 8.3, 4.2 Hz, 1H), 3.46 – 3.40 (m, 1H), 2.16 (dd, J = 
11.0, 2.9 Hz, 1H), 1.59 – 1.53 (m, 1H), 1.40 (s, 9H), 1.36 – 1.28 (m, 1H), 1.25 (s, 6H), 1.24 (s, 
6H), 0.85 (s, 9H), -0.05 (d, J = 11.2 Hz, 6H). 13C NMR (151 MHz, CDCl3) δ 174.6, 141.6, 127.9, 
127.0, 126.1, 83.4, 82.4, 80.5, 62.7, 28.6, 27.7, 26.0, 25.0, 24.6, 18.3, -5.3, -5.4. HRMS (ESI+) 
[M+Na]+ calcd for C27H47BO6SiNa+ 529.3133, found 529.3126. IR (u/cm-1): 3489 (m, br), 2930 




yl)pentanedioate (1.48). Following General Procedure C, the crude mixture was purified by silica 
gel (80:20 regular:deactivated, layered) chromatography (benzene, gravity) to yield β-
hydroxyboronate 1.48 as a colorless oil in 14% isolated yield (6.6 mg). 1H NMR (600 MHz, 
CDCl3) δ 7.61 – 7.56 (m, 2H), 7.31 (dd, J = 10.5, 4.8 Hz, 2H), 7.26 – 7.21 (m, 1H), 3.95 (s, 1H), 
2.46 (dd, J = 11.7, 4.3 Hz, 1H), 2.34 (dd, J = 17.2, 11.8 Hz, 1H), 1.89 (dd, J = 17.2, 4.3 Hz, 1H), 
1.44 (s, J = 7.0 Hz, 9H), 1.36 (s, 9H), 1.25 (s, 6H), 1.21 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 
174.17, 173.76, 141.11, 128.00, 127.19, 126.06, 83.61, 83.07, 79.87, 79.14, 32.04, 28.04, 27.75, 
25.01, 24.54. HRMS (ESI+) [M+Na]+ calcd for C25H39BO7Na+ 485.2687, found 485.2683. IR 
(u/cm-1): 3482 (m, br), 2979 (s), 1724 (s), 1369 (m), 1141 (m). [a]22D = -5.7° (c = 0.38, CH2Cl2, l 










yl)hexanoate (1.51). Following General Procedure C, the crude mixture was purified by silica gel 
(80:20 regular:deactivated, layered) chromatography (benzene, gravity) to yield β-
hydroxyboronate 1.51 as a colorless oil in 30% isolated yield (11.8 mg).) 1H NMR (600 MHz, 
CDCl3) δ 7.56 – 7.52 (m, 2H), 7.31 (dd, J = 10.5, 4.8 Hz, 2H), 7.25 – 7.21 (m, 1H), 3.90 (s, 1H), 
1.97 (dd, J = 11.2, 3.6 Hz, 1H), 1.39 (s, 9H), 1.38 – 1.32 (m, 2H), 1.26 (s, 6H) 1.26 (s, 6H), 1.14 – 
1.05 (m, 1H), 1.00 – 0.92 (m, 1H), 0.74 (t, J = 7.3 Hz, 3H). 12C NMR (151 MHz, CDCl3) δ 174.63, 
141.68, 127.79, 126.89, 125.83, 83.42, 82.28, 80.49, 27.76, 27.64, 24.88, 24.78, 22.52, 14.36. 
HRMS (ESI+) [2M+Na]+ calcd for C44H70B2O10Na+ 803.5053, found 803.5065. IR (u/cm-1): 3492 




2-yl)hept-5-enoate (1.52). Following General Procedure C, the crude mixture was purified by 
silica gel (80:20 regular:deactivated, layered) chromatography (benzene, gravity) to yield β-
hydroxyboronate 1.52 as a white solid in 60% isolated yield (24.9 mg). 1H NMR (600 MHz, 













6.8, 5.4, 2.8, 1.4 Hz, 1H), 3.91 (s, 1H), 2.07 (dd, J = 13.1, 7.8 Hz, 1H), 2.01 (dd, J = 11.6, 3.7 Hz, 
1H), 1.60 (s, 3H), 1.42 (d, J = 1.3 Hz, 3H), 1.40 (s, 9H), 1.24 (s, 6H), 1.23 (s, 6H). 13C NMR (151 
MHz, CDCl3) d 174.4, 141.3, 131.6, 127.8, 127.0, 126.0, 124.0, 83.5, 82.5, 80.0, 27.8, 25.8, 24.9, 
24.7, 24.3, 17.7. HRMS (ESI+) [2M+Na]+ calcd for C48H74B2O10Na+ 855.5366, found 855.5387. 
IR (u/cm-1): 3489 (m, br), 2978 (s), 2926 (s), 1716 (s), 1370 (m). ). [a]22D = +8.3° (c = 0.65, 




5-enoate (1.53). Following General Procedure C, the crude mixture was purified by silica gel 
(80:20 regular:deactivated, layered) chromatography (benzene, gravity) to yield β-
hydroxyboronate 1.53 as a colorless oil in 50% isolated yield (19.3 mg). 1H NMR (600 MHz, 
CDCl3) d 7.59 - 7.54 (m, 2H), 7.32 (dd, J = 8.4, 7.0 Hz, 2H), 7.26 - 7.22 (m, 1H), 5.77 (ddt, J = 
17.1, 10.1, 6.7 Hz, 1H), 4.93 - 4.86 (m, 1H), 4.85 (ddt, J = 10.0, 2.1, 1.0 Hz, 1H), 3.92 (s, 1H), 
2.17 - 2.10 (m, 1H), 2.09 (dd, J = 11.3, 2.8 Hz, 1H), 1.41 (s, 9H, 1.25 (s, 6H), 1.24 (s, 6H). 13C 
NMR (151 MHz, CDCl3) d 174.3, 141.3, 138.4, 128.4, 127.9, 127.1, 125.9, 114.8, 83.6, 82.5, 80.1, 
30.2, 27.8, 24.9, 24.8. HRMS (ESI+) [M+Na]+ calcd for C22H33BO5Na+ 411.2319, found 










yl)pentanoate (1.54). Following General Procedure C, the crude mixture was purified by silica 
gel (80:20 regular:deactivated, layered) chromatography (benzene, gravity) to yield β-
hydroxyboronate 1.54 as a colorless oil in 33% isolated yield (14.8 mg). 1H NMR (600 MHz, 
CDCl3) d 7.48 - 7.42 (m, 2H), 7.30 - 7.25 (m, 2H), 7.24 - 7.20 (m, 1H), 7.18 (d, J = 7.6 Hz, 2H), 
7.14 - 7.09 (m, 1H), 7.04 - 6.99 (m, 2H), 3.93 (s, 1H), 2.72 (ddd, J = 13.6, 10.6, 4.6 Hz, 1H), 2.37 
(ddd, J = 13.7, 10.2, 7.0 Hz, 1H), 2.03 (dd, J = 11.1, 3.4 Hz, 1H), 1.71 (dtd, J = 13.2, 10.6, 4.6 Hz, 
1H), 1.39 (s, 9H), 1.34 (ddt, J = 13.7, 6.6, 3.4 Hz, 1H), 1.29 (s, 6H), 1.28 (s, 6H). 13C NMR (151 
MHz, CDCl3) d 174.5, 142.7, 141.4, 128.5, 128.4, 128.1, 127.8, 127.0, 125.8, 125.5, 83.5, 82.4, 
80.5, 35.4, 27.7, 27.2, 25.0, 24.8. HRMS (ESI+) [M+Na]+ calcd for C27H37BO5Na+ 475.2632, 
found 475.2627. IR (u/cm-1): 3524 (m, br), 2979 (s), 2931 (s), 1722 (s), 1369 (m). [a]22D = +11.1° 
(c = 0.44, CH2Cl2, l = 100 mm). 
 
 
Tert-butyl (2S,3R)-2,3-dihydroxy-2-phenylbutanoate (OH-1.46). Following General Procedure 
B and Supplementary Procedure A, the crude oxidation mixture was purified by silica gel (regular) 
chromatography (4:1 hexanes:ethyl acetate, gravity) to yield diol OH-1.46 as a white solid in 40% 










2H), 7.34 (dd, J = 8.3, 6.7 Hz, 2H), 7.30 - 7.26 (m, 1H), 4.48 (q, J = 6.4 Hz, 1H), 4.03 (s, 1H), 
1.48 (s, 9H), 0.95 (d, J = 6.5 Hz, 3H). 13C NMR (151 MHz, CDCl3) d 173.6, 139.1, 128.2, 127.7, 
125.6, 83.8, 81.2, 72.3, 27.8, 17.0. HRMS (ESI+) [2M+Na]+ calcd for C28H40O8Na+ 527.2621, 
found 527.2609. IR (u/cm-1): 3460 (m, br), 2925 (s), 1716 (s), 1449 (m), 1278 (s). [a]22D = -37.2° 
(c = 0.51, CH2Cl2, l = 100 mm). 





Major: 13.3 min; Minor: 19.9 min; 98:2 e.r. 
 
 
Tert-butyl (2S,3R)-5-((tert-butyldimethylsilyl)oxy)-2,3-dihydroxy-2-phenylpentanoate  (OH-






mixture was purified by silica gel (regular) chromatography (15:1 hexanes:ethyl acetate, gravity) 
to yield diol OH-1.47 as a colorless oil in 91% isolated yield (15.2 mg). 1H NMR (600 MHz, 
CDCl3) d 7.63 (dd, J = 7.9, 1.4 Hz, 2H), 7.37 - 7.30 (m, 2H), 7.30 - 7.26 (m, 1H), 4.55 (ddd, J = 
9.6, 7.0, 1.9 Hz, 1H), 4.00 (s, 1H), 3.78 (ddd, J = 10.2, 7.2, 4.4 Hz, 1H), 3.68 (ddd, J = 10.6, 6.7, 
4.8 Hz, 1H), 2.95 (d, J = 7.0 Hz, 1H), 1.47 (s, 9H), 0.88 (s, 9H), 0.02 (d, J = 14.9 Hz, 6H). 13C 
NMR (151 MHz, CDCl3) d 173.4, 138.8, 128.1, 127.6, 125.8, 83.4, 81.1, 75.0, 61.2, 32.6, 27.8, 
25.9, 18.2, -5.5, -5.5. HRMS (ESI+) [2M+Na]+ calcd for C42H72O10Si2Na+ 815.4562, found 
815.4546. IR (u/cm-1): 3482 (m, br), 2955 (s), 2857 (m), 1723 (s), 1370 (m). [a]22D = -16.7° (c = 
1.03, CH2Cl2, l = 100 mm). 









Di-tert-butyl (2S,3R)-2,3-dihydroxy-2-phenylpentanedioate (OH-1.48). Following General 
Procedure C and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (regular) chromatography (4:1 hexanes:ethyl acetate, gravity) to yield diol OH-1.48 as a 
colorless oil in 21% isolated yield (7.5 mg) over two steps. 1H NMR (600 MHz, CDCl3) d 7.68 - 
7.62 (m, 2H), 7.39 - 7.32 (m, 2H), 7.32 - 7.27 (m, 1H), 4.73 (dd, J = 10.0, 2.7 Hz, 1H), 4.05 - 3.93 
(m, 1H), 2.35 (dd, J = 16.5, 10.0 Hz, 1H), 2.02 (dd, J = 16.6, 2.7 Hz, 1H), 1.48 (s, 9H), 1.41 (s, 
9H). 13C NMR (151 MHz, CDCl3) d 172.7, 172.2, 138.2, 128.3, 128.0, 125.8, 83.9, 81.2, 80.6, 
73.0, 36.4, 28.1, 27.8. HRMS (ESI+) [2M+Na]+ calcd for C38H66O12Na+ 727.3669, found 
727.3658. IR (u/cm-1): 3486 (m, br), 2978 (s), 2927 (m), 1727 (s), 1154 (s). [a]22D = -23.74° (c = 
0.38, CH2Cl2, l = 100 mm). 














Major: 10.4 min; Minor: 15.8 min; 94:6 e.r. 
 
 
Tert-butyl (2S,3R)-2,3-dihydroxy-2-phenylhexanoate (OH-1.51). Following General Procedure 
C and Supplementary Procedure A, the crude oxidation mixture was purified by silica gel (regular) 
chromatography (4:1 hexanes:ethyl acetate, gravity) to yield diol OH-1.51 as a white solid. 1H 
NMR (600 MHz, CDCl3) δ 7.61 (dd, J = 5.3, 3.4 Hz, 2H), 7.38 – 7.32 (m, 2H), 7.31 – 7.27 (m, 
1H), 4.29 – 4.22 (m, 1H), 4.05 (s, 1H), 1.91 (d, J = 11.1 Hz, 1H), 1.56 – 1.49 (m, 1H), 1.48 (s, 
9H), 1.31 – 1.22 (m, 2H), 1.09 – 1.03 (m, 1H), 0.81 (t, J = 7.2 Hz, 3H). 13C NMR (151 MHz, 
CDCl3) δ 173.7, 139.0, 128.2, 127.7, 125.6, 83.9, 81.4, 75.9, 32.7, 27.8, 19.1, 13.9. HRMS (ESI+) 
[2M+Na]+ calcd for C44H70B2O10Na+ 803.5063, found 803.5065. IR (u/cm-1): 3481 (m, br), 2960 
(m), 1869 (s), 1716 (m), 1541 (m), 1507 (m), 1457 (s), 1395 (s), 1371 (s), 1278 (s), 1141 (s), 1069 
(s).  [a]16D = -5.1° (c = 0.19, CH2Cl2, l = 100 mm). 












Major: 11.8 min; Minor: 23.9 min; 98:2 e.r. 
 
 
Tert-butyl (2S,3R)-2,3-dihydroxy-6-methyl-2-phenylhept-5-enoate (OH-1.52). Following 
General Procedure C and Supplementary Procedure A, the crude oxidation mixture was purified 
by silica gel (regular) chromatography (15:1 hexanes:ethyl acetate, gravity) to yield diol OH-1.52 
as a colorless oil in 39% isolated yield (11.8 mg) over two steps. 1H NMR (600 MHz, CDCl3) d  
7.67 - 7.61 (m, 2H), 7.38 - 7.32 (m, 2H), 7.32 - 7.26 (m, 1H), 5.14 (dddd, J = 8.1, 6.8, 2.9, 1.4 Hz, 
1H), 4.28 (dd, J = 10.2, 2.8 Hz, 1H), 4.06 (s, 1H), 2.09 - 2.01 (m, 1H), 1.86 - 1.79 (m, 1H), 1.66 







127.7, 125.7, 120.5, 83.8, 81.1, 76.4, 29.6, 27.8, 25.9, 17.8. HRMS (ESI+) [2M+Na]+ calcd for 
C36H52O8Na+ 635.3560, found 635.3554. IR (u/cm-1): 3475 (m, br), 2977 (s), 2927 (s), 1721 (s), 
1159 (s). [a]22D = -3.9° (c = 0.65, CH2Cl2, l = 100 mm). 





Major: 8.8 min; Minor: 21.4 min; 99:1 e.r 
 
 
Tert-butyl (2S,3R)-2,3-dihydroxy-2-phenylhex-5-enoate (OH-1.53). Following General 
Procedure C and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (regular) chromatography (8:1 hexanes:ethyl acetate, pressure) to yield diol OH-1.53 as a 





7.61 (m, 2H), 7.39 - 7.33 (m, 2H), 7.32 - 7.28 (m, 1H), 5.79 (dddd, J = 16.9, 10.2, 7.6, 6.5 Hz, 
1H), 5.06 - 5.03 (m, 1H), 5.03 - 4.99 (m, 1H), 4.36 - 4.30 (m, 1H), 4.06 (d, J = 0.7 Hz, 1H), 2.11 - 
2.02 (m, 2H), 1.92 (dddd, J = 13.3, 6.6, 2.8, 1.4 Hz, 1H), 1.48 (s, 9H). 13C NMR (151 MHz, 
CDCl3) d 173.3, 138.6, 135.0, 128.3, 127.9, 125.7, 117.6, 83.9, 81.0, 75.4, 35.4, 27.8. HRMS 
(ESI+) [2M+Na]+ calcd for C32H44O8Na+ 579.2934, found 579.2928. IR (u/cm-1):  3485 (m, br), 
2926 (s), 1721 (s), 1278 (s). [a]22D = -20.7° (c = 0.44, CH2Cl2, l = 100 mm). 










Tert-butyl (2S,3R)-2,3-dihydroxy-2,5-diphenylpentanoate (OH-1.54). Following General 
Procedure C and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (regular) chromatography (8:1 hexanes:ethyl acetate) to yield diol OH-1.54 as a colorless oil 
in 22% isolated yield (7.5 mg) over two steps. 1H NMR (600 MHz, CDCl3) d 7.55 - 7.51 (m, 2H), 
7.34 - 7.29 (m, 2H), 7.29 - 7.26 (m, 1H), 7.21 (t, J = 7.5 Hz, 2H), 7.16 - 7.12 (m, 1H), 7.08 - 7.03 
(m, 2H), 4.28 (td, J = 10.7, 1.9 Hz, 1H), 4.07 (d, J = 0.7 Hz, 1H), 2.86 (ddd, J = 14.6, 10.4, 4.8 
Hz, 1H), 2.53 (ddd, J = 13.9, 10.1, 6.9 Hz, 1H), 2.06 (d, J = 11.2 Hz, 1H), 1.67 - 1.58 (m, 1H), 
1.47 (s, 9H), 1.44 (ddt, J = 10.4, 3.4, 1.7 Hz, 1H). 13C NMR (151 MHz, CDCl3) d 173.5, 141.9, 
138.7, 128.4, 128.2, 128.2, 127.8, 125.7, 125.6, 83.9, 81.3, 75.5, 32.4, 32.2, 27.8. HRMS (ESI+) 
[2M+Na]+ calcd for C42H52O8Na+ 707.3560, found 707.3558. IR (u/cm-1): 3460 (m, br), 2926 (m), 
1721 (s), 1278 (s). [a]22D = +11.6° (c = 0.14, CH2Cl2, l = 100 mm). 
















Following General Procedure B, the crude material (42% NMR conversion) was purified by silica 
gel (regular) chromatography (20:1 hexanes:diethyl ether) to yield β-hydroxyboronate 1.57 which 
was taken directly on to oxidation (see below). 1H NMR (600 MHz, CDCl3) δ 7.57 (dd, J = 8.4, 
1.1 Hz, 2H), 7.46 (dd, J = 8.4, 1.1 Hz, 2H), 7.28 – 7.23 (m, 6H), 7.13 (ddd, J = 11.9, 6.0, 2.9 Hz, 
2H), 3.61 (s, 1H), 2.40 (q, J = 7.4 Hz, 1H), 1.08 (s, 6H), 0.95 (s, 6H), 0.92 (d, J = 7.4 Hz, 3H). 13C 














(R)-(+)-1,1-Diphenyl-1,2-propanediol (OH-1.57). Following General Procedure B and 
Supplementary Procedure A, the crude oxidation mixture was purified by silica gel (regular) 
chromatography (4:1 hexanes:ethyl acetate, gravity) to yield diol OH-1.57 as a white solid in 12% 
isolated yield (2.7 mg) over two steps. Spectral data aligns with previously reported results.10 
[a]22D = +9.7° (c = 0.14, MeOH, l = 100 mm). 




















((trimethylsilyl)oxy)hept-5-enoate (TMS-1.52).  Following General Procedure C and 
Supplementary Procedure C, the crude material was purified by silica gel chromatography (50:1 
pentane:diethyl ether) to yield TMS-1.52 as a colorless oil in 60% yield (8.8 mg). 1H NMR (600 
MHz, CDCl3) d  7.45 (dd, J = 8.5, 1.3 Hz, 2H), 7.28 (t, J = 7.4 Hz, 2H), 7.22 - 7.18 (m, 1H), 5.04 
(ddd, J = 8.2, 4.0, 2.4 Hz, 1H), 2.11 - 1.94 (m, 1H), 1.83 - 1.71 (m, 2H), 1.56 (s, 3H), 1.47 (s, 9H) 
1.40 (s 3H), 1.19 (s, 6H), 1.18 (s, 6H), 0.17 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.9, 143.9, 
130.9, 127.6, 126.9, 126.0, 124.8, 84.2, 82.9, 82.1, 28.1, 25.9, 25.1, 24.9, 24.8, 17.7, 2.9. HRMS 
(ESI+) [M+Na]+ calcd for C27H45BO5SiNa+ 511.3027, found 511.3013. IR (u/cm-1): 2979 (m), 




yl)methyl)-2-((trimethylsilyl)oxy)hept-5-enoate (1.58). Following a literature procedure68, 
protected hydroxyboronate TMS-1.52 (23.9 mg, 0.05 mmol) was added to an oven dried 8 mL 
vial containing a stir bar. The vial was purged with nitrogen for 3 minutes. A solution of 





















the vial via syringe. The vial was cooled to -78 °C (dry ice/acetone bath). A solution of nBuLi 
(0.066 mL, 0.11 mmol, 1.67M) in hexanes was added dropwise via syringe. The reaction was 
allowed to stir at -78 °C for 20 minutes and then allowed to warm to room temperature and stirred 
for an additional two hours. The reaction was quenched with a saturated solution of ammonium 
chloride (1.5 mL), extracted with diethyl ether (3x), dried over MgSO4 and concentrated. The 
crude material was purified via silica gel (regular) chromatography (100:1 pentane:ether, gravity) 
to yield the desired homologated product 1.58 in 50% yield (12.5 mg). 1H NMR (400 MHz, 
CDCl3) d   7.63 - 7.55 (m, 2H), 7.29 (dd, J = 8.4, 6.7 Hz, 2H), 7.25 - 7.16 (m, 1H), 4.99 - 4.88 (m, 
1H), 2.64 (td, J = 9.7, 4.2 Hz, 1H), 1.77 - 1.59 (m, 2H), 1.56 (s, 3H), 1.48 (s, 9H), 1.41 (s, 3H), 
1.24 (s, 12H), 0.21 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.8, 142.7, 131.8, 127.8, 127.0, 
126.2, 123.6, 87.3, 82.9, 81.8, 43.9, 29.9, 28.0, 26.3, 25.1, 17.8, 3.0. LRMS (ESI+) [M+Na]+ calcd 
for C28H47BO5SiNa+ 525.3184, found 525.26. IR (u/cm-1): 2978 (m), 1734 (s), 1457 (m), 1369 




5-enoate (1.61). An 8 mL vial containing a magnetic stir bar was charged with allyl 



















4.4 µL). The vial was sealed, evacuated, and placed under an inert atmosphere of N2 gas. To a 
separate, oven-dried 8 mL vial, (1,3-Bis-(2,4,6-trimethylphenyl)-2-
imidazolidinylidene)dichloro(o-isopropoxyphenylmethylene)ruthenium (1.60 1.7 mg, 0.0027 
mmol) was added. The vial was sealed, evacuated and purged with N2. The vial containing the 
catalyst was then charged with dry THF (200 µL) and purged with N2 gas. The catalyst solution 
was cannula transferred to the reaction vial containing hydroxyboronate and alkene at room 
temperature. The green reaction mixture was warmed to 40 °C and allowed to stir for 6 hours. 
After, the reaction was diluted with wet diethyl ether and concentrated in vacuo. Analysis of the 
crude mixture revealed formation of desired product in a 6.5:1 E/Z ratio. The resulting brown oil 
was purified by silica gel chromatography (4:1 hexanes:ethyl acetate) to afford 1.61 (7.1 mg, 0.017 
mmol, 63% yield) as a white solid in 94:6 E/Z ratio. 1H NMR (600 MHz, CDCl3) δ 7.60 – 7.55 
(m, 2H), 7.34 (t, J = 7.7 Hz, 2H), 7.28 – 7.24 (m, 1H), 5.61 (dt, J = 15.0, 6.8 Hz, 1H), 5.52 – 5.46 
(m, 1H), 3.98 (d, J = 1.9 Hz, 2H), 3.95 (d, J = 5.1 Hz, 1H), 2.19 – 2.08 (m, 2H), 1.87 – 1.81 (m, 
1H), 1.43 (s, 9H), 1.27 (s, 12H), 1.09 (t, J = 5.7 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 174.27, 
141.38, 133.12, 129.18, 127.90, 127.09, 125.93, 83.63, 82.65, 80.06, 63.82, 28.47, 27.76, 24.97, 
24.74. LRMS (ESI+) [M+Na]+ calcd for C23H35BO6Na+ 441.24, found 441.36. IR (u/cm-1): 3482 








dioxaborolan-2-yl)tetrahydro-2H-pyran-2-carboxylate (1.62). Following a modified literature 
procedure59, prenyl-substituted hydroxyboronate 1.52 (16.8 mg, 0.040 mmol) was added to an 8 
mL amber vial containing a stir bar. The vial was placed under vacuum for ten minutes, then back-
filled with nitrogen. The vial was charged with dry acetonitrile (0.4 mL) and cooled to 0 °C in an 
ice water bath. Sodium bicarbonate (10.1 mg, 0.121 mmol) was added to the vial, the vial was 
capped, and the resulting suspension was allowed to stir at 0 °C for 15 minutes. The reaction was 
then transferred to a -35 °C bath, where it was allowed to cool for ten minutes. Iodine (30.7 mg, 
0.121 mmol) was added to the vial, and the reaction was kept at -35 °C for 1.5 hours. The reaction 
mixture was diluted with water and extracted with ethyl acetate (4x). The combined organics were 
washed with saturated sodium thiosulfate solution, dried over MgSO4, filtered and concentrated in 
vacuo. The crude material was purified via silica gel (regular) chromatography (20:1 
hexanes:diethyl ether) to yield the desired cyclized product 1.62 in 45% yield (9.5 mg). 1H NMR 
(600 MHz, CDCl3) δ 7.41 (dd, J = 5.3, 3.4 Hz, 2H), 7.27 (d, J = 7.7 Hz, 2H), 7.25 – 7.21 (m, 1H), 
4.37 (dd, J = 13.2, 3.8 Hz, 1H), 2.70 (dd, J = 27.5, 13.4 Hz, 1H), 2.43 (dt, J = 14.4, 3.9 Hz, 1H), 
1.60 (s, 3H), 1.57 (s, 3H), 1.53 (s, 9H), 1.18 (s, 6H), 1.17 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 
173.7, 143.2, 127.3, 127.1, 126.7, 84.0, 82.8, 82.8, 39.8, 34.0, 31.8, 31.6, 27.8, 25.3, 24.2, 22.7, 
22.2, 14.2. LRMS (ESI+) [M+Na]+ calcd for C24H36BIO5Na+ 565.16, found 565.18. IR (u/cm-1): 

















































































































































































































































































































































































































































































































































NOE between Hd and Ha supports assignment of major diastereomer 
Hd Hc Hb 























13C NMR (151 MHz, CDCl3)
	 136 
n Crystal Structure Data for 1.46 
 
Identification Code: jcg_ii_300a 
Empirical Formula: C40H58B2O10 
Formula Weight: 720.43 
Measurement Temperature: 100(2) K 
Radiation Type: CuK\a 
Wavelength: 1.54178 
Crystal System: triclinic 
Space Group: P-1 
Unit Cell Dimensions: a = 6.2365(3) Å;  
α = 101.486(3)° 
              b = 9.4178(4) Å;  
β = 93.584(3)° 
              c = 18.1506(9) Å;  
γ = 100.833(3)° 
Volume: 1020.55(8) Å3 
Z: 2 
Density (calculated): 1.172 g/cm3 
Absorption Correction Coefficient: 0.622 
(mm-1)  
F(000): 388 
Crystal size: 0.035 mm x 0.053 mm x 0.202 mm 
Theta Max: 66.61° 
Index Ranges: hmax = 7; kmax = 11; lmax = 21 
Reflections Collected: 6875 
Independent Reflections: 5753 
Completeness of Theta: 98 
Min:Max Transmission Ratio: 0.8977 
Refinement Method: XL 
Goodness-of-fit on F2 0: 0.822 
R Indicies:  R1 = 0.0415; wR2 = 0.0564 
 
n Table 2: Bond Lengths for 1.46 (Å) 
 
Number Atom1 Atom2 Length 
1 O1 C17 1.469(3) 
2 O1 B1 1.363(3) 
3 O2 C16 1.473(3) 
4 O2 B1 1.369(3) 
5 O5 C9 1.330(3) 
6 O5 C22 1.495(3) 
7 O3 C7 1.420(3) 
8 O3 H3 0.88(4) 
9 O4 C9 1.212(3) 
10 C17 C19 1.513(4) 
Figure 1: X-Ray Crystal Structure of 1.46 
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11 C17 C16 1.552(3) 
12 C17 C20 1.530(4) 
13 C7 C9 1.535(4) 
14 C7 C1 1.542(4) 
15 C7 C12 1.543(3) 
16 C19 H19A 0.98 
17 C19 H19B 0.979 
18 C19 H19C 0.98 
19 C16 C21 1.513(4) 
20 C16 C18 1.518(4) 
21 C1 C2 1.387(4) 
22 C1 C6 1.399(4) 
23 C12 H12 1 
24 C12 C26 1.539(4) 
25 C12 B1 1.581(4) 
26 C21 H21A 0.98 
27 C21 H21B 0.98 
28 C21 H21C 0.98 
29 C22 C23 1.520(4) 
30 C22 C25 1.510(4) 
31 C22 C24 1.513(4) 
32 C2 H2 0.95 
33 C2 C3 1.393(4) 
34 C23 H23A 0.981 
35 C23 H23B 0.98 
36 C23 H23C 0.979 
37 C4 H4 0.95 
38 C4 C5 1.380(5) 
39 C4 C3 1.377(4) 
40 C20 H20A 0.979 
41 C20 H20B 0.98 
42 C20 H20C 0.98 
43 C6 H6A 0.95 
44 C6 C5 1.383(4) 
45 C25 H25A 0.98 
46 C25 H25B 0.981 
47 C25 H25C 0.98 
48 C5 H5 0.949 
49 C26 H26A 0.98 
50 C26 H26B 0.98 
51 C26 H26C 0.98 
52 C3 H3A 0.95 
53 C18 H18A 0.98 
54 C18 H18B 0.979 
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55 C18 H18C 0.98 
56 C24 H24A 0.98 
57 C24 H24B 0.98 
58 C24 H24C 0.98 
59 C34 H34 0.95 
60 C34 C37 1.400(4) 
61 C34 C41 1.374(4) 
62 C38 H38 0.95 
63 C38 C37 1.388(4) 
64 C38 C39 1.394(4) 
65 C37 C42 1.543(4) 
66 C40 H40 0.949 
67 C40 C41 1.396(4) 
68 C40 C39 1.377(5) 
69 C41 H41 0.95 
70 C39 H39 0.951 
71 O6 C42 1.422(3) 
72 O6 H6 0.95(4) 
73 O7 C50 1.207(3) 
74 O8 C49 1.491(3) 
75 O8 C50 1.326(3) 
76 C49 C54 1.521(4) 
77 C49 C53 1.509(4) 
78 C49 C52 1.520(4) 
79 C43 H43 1 
80 C43 C42 1.546(4) 
81 C43 C55 1.540(4) 
82 C43 B2 1.579(4) 
83 C50 C42 1.539(4) 
84 C55 H55A 0.981 
85 C55 H55B 0.98 
86 C55 H55C 0.98 
87 C54 H54A 0.98 
88 C54 H54B 0.979 
89 C54 H54C 0.98 
90 C53 H53A 0.98 
91 C53 H53B 0.98 
92 C53 H53C 0.98 
93 C52 H52A 0.98 
94 C52 H52B 0.98 
95 C52 H52C 0.98 
96 O9 B2 1.370(3) 
97 O9 C58 1.457(4) 
98 O10 B2 1.374(5) 
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99 O10 C59 1.461(4) 
100 C58 C59 1.548(5) 
101 C58 C61 1.512(6) 
102 C58 C63 1.518(5) 
103 C59 C64 1.534(7) 
104 C59 C62 1.502(8) 
105 C61 H61A 0.98 
106 C61 H61B 0.981 
107 C61 H61C 0.98 
108 C63 H63A 0.98 
109 C63 H63B 0.98 
110 C63 H63C 0.98 
111 C64 H64A 0.98 
112 C64 H64B 0.981 
113 C64 H64C 0.98 
114 C62 H62A 0.98 
115 C62 H62B 0.981 
116 C62 H62C 0.98 
 
 
n Table 3: Bond Angles for 1.46 (°) 
 
Number Atom1 Atom2 Atom3 Angle 
1 C17 O1 B1 106.4(2) 
2 C16 O2 B1 106.5(2) 
3 C9 O5 C22 121.3(2) 
4 C7 O3 H3 110(2) 
5 O1 C17 C19 109.5(2) 
6 O1 C17 C16 101.9(2) 
7 O1 C17 C20 107.0(2) 
8 C19 C17 C16 115.1(2) 
9 C19 C17 C20 109.9(2) 
10 C16 C17 C20 112.8(2) 
11 O3 C7 C9 108.4(2) 
12 O3 C7 C1 110.0(2) 
13 O3 C7 C12 107.6(2) 
14 C9 C7 C1 103.8(2) 
15 C9 C7 C12 113.9(2) 
16 C1 C7 C12 113.0(2) 
17 C17 C19 H19A 109.5 
18 C17 C19 H19B 109.5 
19 C17 C19 H19C 109.5 
20 H19A C19 H19B 109.4 
21 H19A C19 H19C 109.5 
	 140 
22 H19B C19 H19C 109.5 
23 O2 C16 C17 101.8(2) 
24 O2 C16 C21 108.7(2) 
25 O2 C16 C18 106.5(2) 
26 C17 C16 C21 115.1(2) 
27 C17 C16 C18 113.0(2) 
28 C21 C16 C18 110.9(2) 
29 O5 C9 O4 126.2(2) 
30 O5 C9 C7 112.0(2) 
31 O4 C9 C7 121.7(2) 
32 C7 C1 C2 120.2(2) 
33 C7 C1 C6 121.7(2) 
34 C2 C1 C6 118.0(3) 
35 C7 C12 H12 106.6 
36 C7 C12 C26 110.6(2) 
37 C7 C12 B1 114.1(2) 
38 H12 C12 C26 106.5 
39 H12 C12 B1 106.6 
40 C26 C12 B1 111.9(2) 
41 C16 C21 H21A 109.5 
42 C16 C21 H21B 109.5 
43 C16 C21 H21C 109.5 
44 H21A C21 H21B 109.4 
45 H21A C21 H21C 109.5 
46 H21B C21 H21C 109.5 
47 O5 C22 C23 111.3(2) 
48 O5 C22 C25 108.0(2) 
49 O5 C22 C24 101.5(2) 
50 C23 C22 C25 112.9(2) 
51 C23 C22 C24 110.9(2) 
52 C25 C22 C24 111.6(2) 
53 C1 C2 H2 119.6 
54 C1 C2 C3 120.9(3) 
55 H2 C2 C3 119.5 
56 C22 C23 H23A 109.5 
57 C22 C23 H23B 109.5 
58 C22 C23 H23C 109.4 
59 H23A C23 H23B 109.4 
60 H23A C23 H23C 109.5 
61 H23B C23 H23C 109.5 
62 H4 C4 C5 120.4 
63 H4 C4 C3 120.4 
64 C5 C4 C3 119.2(3) 
65 C17 C20 H20A 109.5 
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66 C17 C20 H20B 109.4 
67 C17 C20 H20C 109.4 
68 H20A C20 H20B 109.6 
69 H20A C20 H20C 109.5 
70 H20B C20 H20C 109.4 
71 C1 C6 H6A 119.7 
72 C1 C6 C5 120.7(3) 
73 H6A C6 C5 119.6 
74 C22 C25 H25A 109.4 
75 C22 C25 H25B 109.5 
76 C22 C25 H25C 109.5 
77 H25A C25 H25B 109.4 
78 H25A C25 H25C 109.5 
79 H25B C25 H25C 109.5 
80 C4 C5 C6 120.8(3) 
81 C4 C5 H5 119.6 
82 C6 C5 H5 119.6 
83 C12 C26 H26A 109.4 
84 C12 C26 H26B 109.5 
85 C12 C26 H26C 109.4 
86 H26A C26 H26B 109.6 
87 H26A C26 H26C 109.5 
88 H26B C26 H26C 109.4 
89 C2 C3 C4 120.5(3) 
90 C2 C3 H3A 119.8 
91 C4 C3 H3A 119.7 
92 C16 C18 H18A 109.5 
93 C16 C18 H18B 109.5 
94 C16 C18 H18C 109.5 
95 H18A C18 H18B 109.5 
96 H18A C18 H18C 109.5 
97 H18B C18 H18C 109.5 
98 C22 C24 H24A 109.5 
99 C22 C24 H24B 109.5 
100 C22 C24 H24C 109.5 
101 H24A C24 H24B 109.5 
102 H24A C24 H24C 109.4 
103 H24B C24 H24C 109.5 
104 O1 B1 O2 113.6(2) 
105 O1 B1 C12 126.4(2) 
106 O2 B1 C12 119.9(2) 
107 H34 C34 C37 119.8 
108 H34 C34 C41 119.9 
109 C37 C34 C41 120.4(2) 
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110 H38 C38 C37 119.7 
111 H38 C38 C39 119.8 
112 C37 C38 C39 120.5(3) 
113 C34 C37 C38 118.7(2) 
114 C34 C37 C42 120.5(2) 
115 C38 C37 C42 120.8(2) 
116 H40 C40 C41 120.5 
117 H40 C40 C39 120.5 
118 C41 C40 C39 119.1(3) 
119 C34 C41 C40 120.8(3) 
120 C34 C41 H41 119.6 
121 C40 C41 H41 119.6 
122 C38 C39 C40 120.5(3) 
123 C38 C39 H39 119.7 
124 C40 C39 H39 119.7 
125 C42 O6 H6 107(2) 
126 C49 O8 C50 121.8(2) 
127 O8 C49 C54 109.8(2) 
128 O8 C49 C53 109.4(2) 
129 O8 C49 C52 101.7(2) 
130 C54 C49 C53 112.6(2) 
131 C54 C49 C52 111.1(2) 
132 C53 C49 C52 111.6(2) 
133 H43 C43 C42 107.7 
134 H43 C43 C55 107.7 
135 H43 C43 B2 107.6 
136 C42 C43 C55 111.2(2) 
137 C42 C43 B2 109.8(2) 
138 C55 C43 B2 112.6(2) 
139 O7 C50 O8 126.3(2) 
140 O7 C50 C42 121.9(2) 
141 O8 C50 C42 111.8(2) 
142 C37 C42 O6 110.9(2) 
143 C37 C42 C43 111.6(2) 
144 C37 C42 C50 107.4(2) 
145 O6 C42 C43 106.8(2) 
146 O6 C42 C50 107.5(2) 
147 C43 C42 C50 112.6(2) 
148 C43 C55 H55A 109.5 
149 C43 C55 H55B 109.5 
150 C43 C55 H55C 109.5 
151 H55A C55 H55B 109.5 
152 H55A C55 H55C 109.5 
153 H55B C55 H55C 109.4 
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154 C49 C54 H54A 109.4 
155 C49 C54 H54B 109.4 
156 C49 C54 H54C 109.5 
157 H54A C54 H54B 109.5 
158 H54A C54 H54C 109.5 
159 H54B C54 H54C 109.5 
160 C49 C53 H53A 109.5 
161 C49 C53 H53B 109.5 
162 C49 C53 H53C 109.4 
163 H53A C53 H53B 109.5 
164 H53A C53 H53C 109.5 
165 H53B C53 H53C 109.5 
166 C49 C52 H52A 109.5 
167 C49 C52 H52B 109.4 
168 C49 C52 H52C 109.5 
169 H52A C52 H52B 109.5 
170 H52A C52 H52C 109.5 
171 H52B C52 H52C 109.5 
172 B2 O9 C58 108.0(2) 
173 B2 O10 C59 107.7(3) 
174 C43 B2 O9 122.3(2) 
175 C43 B2 O10 125.5(3) 
176 O9 B2 O10 112.1(3) 
177 O9 C58 C59 102.4(3) 
178 O9 C58 C61 106.2(3) 
179 O9 C58 C63 109.3(3) 
180 C59 C58 C61 113.6(3) 
181 C59 C58 C63 114.6(3) 
182 C61 C58 C63 110.0(3) 
183 O10 C59 C58 102.9(3) 
184 O10 C59 C64 105.8(3) 
185 O10 C59 C62 110.4(3) 
186 C58 C59 C64 112.9(3) 
187 C58 C59 C62 115.4(3) 
188 C64 C59 C62 109.0(4) 
189 C58 C61 H61A 109.5 
190 C58 C61 H61B 109.5 
191 C58 C61 H61C 109.5 
192 H61A C61 H61B 109.5 
193 H61A C61 H61C 109.4 
194 H61B C61 H61C 109.5 
195 C58 C63 H63A 109.4 
196 C58 C63 H63B 109.4 
197 C58 C63 H63C 109.5 
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198 H63A C63 H63B 109.5 
199 H63A C63 H63C 109.5 
200 H63B C63 H63C 109.5 
201 C59 C64 H64A 109.5 
202 C59 C64 H64B 109.5 
203 C59 C64 H64C 109.5 
204 H64A C64 H64B 109.4 
205 H64A C64 H64C 109.5 
206 H64B C64 H64C 109.4 
207 C59 C62 H62A 109.5 
208 C59 C62 H62B 109.4 
209 C59 C62 H62C 109.5 
210 H62A C62 H62B 109.4 
211 H62A C62 H62C 109.5 
212 H62B C62 H62C 109.5 
 
n Table 4: Torsion Angles for 1.46 (°) 
 
Number Atom1 Atom2 Atom3 Atom4 Torsion 
1 B1 O1 C17 C19 148.6(2) 
2 B1 O1 C17 C16 26.2(2) 
3 B1 O1 C17 C20 -92.3(2) 
4 C17 O1 B1 O2 -11.8(3) 
5 C17 O1 B1 C12 164.7(2) 
6 B1 O2 C16 C17 24.6(2) 
7 B1 O2 C16 C21 146.6(2) 
8 B1 O2 C16 C18 -93.9(2) 
9 C16 O2 B1 O1 -9.2(3) 
10 C16 O2 B1 C12 174.1(2) 
11 C22 O5 C9 O4 0.8(4) 
12 C22 O5 C9 C7 
-
175.8(2) 
13 C9 O5 C22 C23 -54.3(3) 
14 C9 O5 C22 C25 70.1(3) 
15 C9 O5 C22 C24 
-
172.4(2) 
16 H3 O3 C7 C9 -8(3) 
17 H3 O3 C7 C1 105(3) 
18 H3 O3 C7 C12 -131(3) 
19 O1 C17 C19 H19A -54.8 
20 O1 C17 C19 H19B -174.8 
21 O1 C17 C19 H19C 65.2 
22 C16 C17 C19 H19A 59.3 
23 C16 C17 C19 H19B -60.7 
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24 C16 C17 C19 H19C 179.3 
25 C20 C17 C19 H19A -172.1 
26 C20 C17 C19 H19B 68 
27 C20 C17 C19 H19C -52.1 
28 O1 C17 C16 O2 -30.5(2) 
29 O1 C17 C16 C21 
-
147.9(2) 
30 O1 C17 C16 C18 83.2(2) 
31 C19 C17 C16 O2 
-
149.0(2) 
32 C19 C17 C16 C21 93.6(3) 
33 C19 C17 C16 C18 -35.2(3) 
34 C20 C17 C16 O2 83.8(2) 
35 C20 C17 C16 C21 -33.6(3) 
36 C20 C17 C16 C18 
-
162.4(2) 
37 O1 C17 C20 H20A -62.9 
38 O1 C17 C20 H20B 177 
39 O1 C17 C20 H20C 57.1 
40 C19 C17 C20 H20A 55.9 
41 C19 C17 C20 H20B -64.2 
42 C19 C17 C20 H20C 175.9 
43 C16 C17 C20 H20A -174.2 
44 C16 C17 C20 H20B 65.7 
45 C16 C17 C20 H20C -54.2 
46 O3 C7 C9 O5 
-
158.0(2) 
47 O3 C7 C9 O4 25.3(3) 
48 C1 C7 C9 O5 85.1(3) 
49 C1 C7 C9 O4 -91.7(3) 
50 C12 C7 C9 O5 -38.2(3) 
51 C12 C7 C9 O4 145.0(3) 
52 O3 C7 C1 C2 -18.7(3) 
53 O3 C7 C1 C6 164.7(2) 
54 C9 C7 C1 C2 97.1(3) 
55 C9 C7 C1 C6 -79.5(3) 
56 C12 C7 C1 C2 
-
139.0(3) 
57 C12 C7 C1 C6 44.4(3) 
58 O3 C7 C12 H12 -174.2 
59 O3 C7 C12 C26 -58.8(3) 
60 O3 C7 C12 B1 68.4(3) 
61 C9 C7 C12 H12 65.6 




63 C9 C7 C12 B1 -51.8(3) 
64 C1 C7 C12 H12 -52.5 
65 C1 C7 C12 C26 62.9(3) 
66 C1 C7 C12 B1 
-
169.9(2) 
67 O2 C16 C21 H21A -50.1 
68 O2 C16 C21 H21B -170 
69 O2 C16 C21 H21C 70 
70 C17 C16 C21 H21A 63.4 
71 C17 C16 C21 H21B -56.6 
72 C17 C16 C21 H21C -176.6 
73 C18 C16 C21 H21A -166.8 
74 C18 C16 C21 H21B 73.3 
75 C18 C16 C21 H21C -46.8 
76 O2 C16 C18 H18A -53.2 
77 O2 C16 C18 H18B -173.2 
78 O2 C16 C18 H18C 66.8 
79 C17 C16 C18 H18A -164.1 
80 C17 C16 C18 H18B 75.9 
81 C17 C16 C18 H18C -44.1 
82 C21 C16 C18 H18A 65 
83 C21 C16 C18 H18B -55 
84 C21 C16 C18 H18C -175 
85 C7 C1 C2 H2 3.5 
86 C7 C1 C2 C3 
-
176.5(2) 
87 C6 C1 C2 H2 -179.7 
88 C6 C1 C2 C3 0.3(4) 
89 C7 C1 C6 H6A -3.5 
90 C7 C1 C6 C5 176.5(3) 
91 C2 C1 C6 H6A 179.8 
92 C2 C1 C6 C5 -0.2(4) 
93 C7 C12 C26 H26A -61.4 
94 C7 C12 C26 H26B 178.5 
95 C7 C12 C26 H26C 58.6 
96 H12 C12 C26 H26A 54 
97 H12 C12 C26 H26B -66.1 
98 H12 C12 C26 H26C 174 
99 B1 C12 C26 H26A 170.2 
100 B1 C12 C26 H26B 50.1 
101 B1 C12 C26 H26C -69.8 
102 C7 C12 B1 O1 22.0(4) 




104 H12 C12 B1 O1 -95.3 
105 H12 C12 B1 O2 81 
106 C26 C12 B1 O1 148.5(3) 
107 C26 C12 B1 O2 -35.1(3) 
108 O5 C22 C23 H23A -38.4 
109 O5 C22 C23 H23B -158.4 
110 O5 C22 C23 H23C 81.5 
111 C25 C22 C23 H23A -160.1 
112 C25 C22 C23 H23B 79.9 
113 C25 C22 C23 H23C -40.1 
114 C24 C22 C23 H23A 73.8 
115 C24 C22 C23 H23B -46.2 
116 C24 C22 C23 H23C -166.2 
117 O5 C22 C25 H25A -64.6 
118 O5 C22 C25 H25B 175.5 
119 O5 C22 C25 H25C 55.4 
120 C23 C22 C25 H25A 58.9 
121 C23 C22 C25 H25B -61.1 
122 C23 C22 C25 H25C 178.9 
123 C24 C22 C25 H25A -175.4 
124 C24 C22 C25 H25B 64.7 
125 C24 C22 C25 H25C -55.3 
126 O5 C22 C24 H24A -55.9 
127 O5 C22 C24 H24B -175.9 
128 O5 C22 C24 H24C 64.1 
129 C23 C22 C24 H24A -174.2 
130 C23 C22 C24 H24B 65.8 
131 C23 C22 C24 H24C -54.2 
132 C25 C22 C24 H24A 59 
133 C25 C22 C24 H24B -61 
134 C25 C22 C24 H24C 179 
135 C1 C2 C3 C4 -0.1(4) 
136 C1 C2 C3 H3A 179.9 
137 H2 C2 C3 C4 179.9 
138 H2 C2 C3 H3A -0.1 
139 H4 C4 C5 C6 -179.8 
140 H4 C4 C5 H5 0.2 
141 C3 C4 C5 C6 0.1(4) 
142 C3 C4 C5 H5 -179.9 
143 H4 C4 C3 C2 179.9 
144 H4 C4 C3 H3A -0.1 
145 C5 C4 C3 C2 -0.1(4) 
146 C5 C4 C3 H3A 179.9 
147 C1 C6 C5 C4 0.1(4) 
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148 C1 C6 C5 H5 -180 
149 H6A C6 C5 C4 180 
150 H6A C6 C5 H5 0 
151 H34 C34 C37 C38 -178.6 
152 H34 C34 C37 C42 2.6 
153 C41 C34 C37 C38 1.5(4) 
154 C41 C34 C37 C42 
-
177.4(2) 
155 H34 C34 C41 C40 179.3 
156 H34 C34 C41 H41 -0.8 
157 C37 C34 C41 C40 -0.7(4) 
158 C37 C34 C41 H41 179.2 
159 H38 C38 C37 C34 178.8 
160 H38 C38 C37 C42 -2.3 
161 C39 C38 C37 C34 -1.2(4) 
162 C39 C38 C37 C42 177.7(3) 
163 H38 C38 C39 C40 -179.8 
164 H38 C38 C39 H39 0.2 
165 C37 C38 C39 C40 0.2(4) 
166 C37 C38 C39 H39 -179.8 
167 C34 C37 C42 O6 175.4(2) 
168 C34 C37 C42 C43 56.4(3) 
169 C34 C37 C42 C50 -67.4(3) 
170 C38 C37 C42 O6 -3.4(3) 
171 C38 C37 C42 C43 
-
122.4(3) 
172 C38 C37 C42 C50 113.7(3) 
173 H40 C40 C41 C34 179.7 
174 H40 C40 C41 H41 -0.2 
175 C39 C40 C41 C34 -0.3(4) 
176 C39 C40 C41 H41 179.8 
177 H40 C40 C39 C38 -179.5 
178 H40 C40 C39 H39 0.6 
179 C41 C40 C39 C38 0.5(4) 
180 C41 C40 C39 H39 -179.4 
181 H6 O6 C42 C37 96(2) 
182 H6 O6 C42 C43 -142(2) 
183 H6 O6 C42 C50 -21(2) 
184 C50 O8 C49 C54 63.5(3) 
185 C50 O8 C49 C53 -60.6(3) 
186 C50 O8 C49 C52 
-
178.7(2) 
187 C49 O8 C50 O7 -2.7(4) 
188 C49 O8 C50 C42 178.9(2) 
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189 O8 C49 C54 H54A -68.1 
190 O8 C49 C54 H54B 172 
191 O8 C49 C54 H54C 51.9 
192 C53 C49 C54 H54A 54.2 
193 C53 C49 C54 H54B -65.8 
194 C53 C49 C54 H54C 174.1 
195 C52 C49 C54 H54A -179.8 
196 C52 C49 C54 H54B 60.3 
197 C52 C49 C54 H54C -59.8 
198 O8 C49 C53 H53A -54.1 
199 O8 C49 C53 H53B -174.2 
200 O8 C49 C53 H53C 65.9 
201 C54 C49 C53 H53A -176.6 
202 C54 C49 C53 H53B 63.4 
203 C54 C49 C53 H53C -56.5 
204 C52 C49 C53 H53A 57.6 
205 C52 C49 C53 H53B -62.4 
206 C52 C49 C53 H53C 177.7 
207 O8 C49 C52 H52A -59.5 
208 O8 C49 C52 H52B -179.4 
209 O8 C49 C52 H52C 60.6 
210 C54 C49 C52 H52A 57.3 
211 C54 C49 C52 H52B -62.6 
212 C54 C49 C52 H52C 177.4 
213 C53 C49 C52 H52A -176 
214 C53 C49 C52 H52B 64 
215 C53 C49 C52 H52C -56 
216 H43 C43 C42 C37 -62.3 
217 H43 C43 C42 O6 176.3 
218 H43 C43 C42 C50 58.6 
219 C55 C43 C42 C37 55.5(3) 
220 C55 C43 C42 O6 -65.9(3) 
221 C55 C43 C42 C50 176.4(2) 
222 B2 C43 C42 C37 
-
179.2(2) 
223 B2 C43 C42 O6 59.4(3) 
224 B2 C43 C42 C50 -58.3(3) 
225 H43 C43 C55 H55A 53.9 
226 H43 C43 C55 H55B -66.1 
227 H43 C43 C55 H55C 173.9 
228 C42 C43 C55 H55A -63.9 
229 C42 C43 C55 H55B 176 
230 C42 C43 C55 H55C 56.1 
231 B2 C43 C55 H55A 172.3 
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232 B2 C43 C55 H55B 52.3 
233 B2 C43 C55 H55C -67.6 
234 H43 C43 B2 O9 -46.8 
235 H43 C43 B2 O10 130.7 
236 C42 C43 B2 O9 70.2(3) 
237 C42 C43 B2 O10 
-
112.3(3) 
238 C55 C43 B2 O9 
-
165.3(3) 
239 C55 C43 B2 O10 12.2(4) 
240 O7 C50 C42 C37 
-
101.7(3) 
241 O7 C50 C42 O6 17.7(3) 
242 O7 C50 C42 C43 135.0(3) 
243 O8 C50 C42 C37 76.8(3) 
244 O8 C50 C42 O6 
-
163.8(2) 
245 O8 C50 C42 C43 -46.5(3) 
246 C58 O9 B2 C43 
-
171.0(3) 
247 C58 O9 B2 O10 11.2(3) 
248 B2 O9 C58 C59 -22.8(3) 
249 B2 O9 C58 C61 96.6(3) 
250 B2 O9 C58 C63 
-
144.8(3) 
251 C59 O10 B2 C43 
-
171.1(3) 
252 C59 O10 B2 O9 6.6(4) 
253 B2 O10 C59 C58 -20.2(3) 
254 B2 O10 C59 C64 98.4(4) 
255 B2 O10 C59 C62 
-
143.8(3) 
256 O9 C58 C59 O10 25.7(3) 
257 O9 C58 C59 C64 -87.8(4) 
258 O9 C58 C59 C62 146.0(3) 
259 C61 C58 C59 O10 -88.3(4) 
260 C61 C58 C59 C64 158.1(4) 
261 C61 C58 C59 C62 31.9(5) 
262 C63 C58 C59 O10 144.0(3) 
263 C63 C58 C59 C64 30.4(5) 
264 C63 C58 C59 C62 -95.8(4) 
265 O9 C58 C61 H61A -61.1 
266 O9 C58 C61 H61B 178.8 
267 O9 C58 C61 H61C 58.8 
268 C59 C58 C61 H61A 50.6 
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269 C59 C58 C61 H61B -69.4 
270 C59 C58 C61 H61C 170.6 
271 C63 C58 C61 H61A -179.3 
272 C63 C58 C61 H61B 60.7 
273 C63 C58 C61 H61C -59.4 
274 O9 C58 C63 H63A -66.6 
275 O9 C58 C63 H63B 173.4 
276 O9 C58 C63 H63C 53.3 
277 C59 C58 C63 H63A 179.1 
278 C59 C58 C63 H63B 59.1 
279 C59 C58 C63 H63C -60.9 
280 C61 C58 C63 H63A 49.6 
281 C61 C58 C63 H63B -70.4 
282 C61 C58 C63 H63C 169.5 
283 O10 C59 C64 H64A -69.3 
284 O10 C59 C64 H64B 170.8 
285 O10 C59 C64 H64C 50.8 
286 C58 C59 C64 H64A 42.5 
287 C58 C59 C64 H64B -77.5 
288 C58 C59 C64 H64C 162.6 
289 C62 C59 C64 H64A 172 
290 C62 C59 C64 H64B 52 
291 C62 C59 C64 H64C -67.9 
292 O10 C59 C62 H62A -67.7 
293 O10 C59 C62 H62B 172.4 
294 O10 C59 C62 H62C 52.4 
295 C58 C59 C62 H62A 176.2 
296 C58 C59 C62 H62B 56.3 
297 C58 C59 C62 H62C -63.7 
298 C64 C59 C62 H62A 48.1 
299 C64 C59 C62 H62B -71.8 
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Chapter 2: Enantio- and Diastereoselective Synthesis of Hydroxy Bis(boronates) via Cu-
Catalyzed Tandem Borylation/1,2-Addition* 
 
2.1 Introduction 
The enantioselective addition of achiral organometallic nucleophiles to prochiral carbonyls 
(e.g. Grignard additions) constitutes one of the foundational pillars of synthetic organic chemistry 
and provides rapid access to biologically relevant secondary and tertiary alcohols (Figure 2.1, 
top).1–5 Incorporating a chiral non-racemic carbon nucleophile into this process creates two vicinal 
stereocenters in addition to a new C–C bond (Figure 2.1, bottom).6–8 Stereoselective generation of 
these highly reactive organometallic species, however, is non-trivial. Enantioenriched variants of 
traditional organometallic nucleophiles (such as organolithiums and Grignard reagents)9–12 present 
many issues, as they are often air- and moisture sensitive and require cryogenic temperatures to 
suppress enantiomerization.13,14 Catalytic in situ generation of these chiral non-racemic 
organometallic nucleophiles presents a possible solution to these problems. 
																																																						
*	A portion of this chapter appeared as a communication in ACS: Catalysis, the reference is as 




Figure 2.1 Advantages of chiral non-racemic alkylmetal nucleophiles 
Current research in the Meek lab focuses on the creation and reactivity of a-boryl 
alkylcopper species, a specific class of organometallic reagent that may participate in a variety of 
C–C bond forming reactions. Previously, we generated these potent enantioenriched nucleophiles 
via enantioselective transmetalation between a chiral copper catalyst and an activated 1,1-
diborylalkane (I) and demonstrated their ability to stereoselectively add into aldehydes15,16 and 
activated ketones17 (see Figure 2.2, right path). While these methods provided excellent means of 
accessing enantioenriched secondary and tertiary alcohols vicinal to a versatile organoboron 
moiety, they were not without their limitations. Particularly limiting was the required use of 
stoichiometric amounts of a harsh alkoxide base to activate the 1,1-diborylalkane, which prevented 
the use of enolizable electrophiles. In order to expand the utility of a-boryl alkylcoppers as chiral 
nucleophiles, an alternative means of generation was needed. 
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A common technique used to produce reactive alkylcopper intermediates involves the 
insertion of Cu–X across an activated olefin (e.g. styrene).18–21 We anticipated that, through the 
utilization of an alkenylboronate such as II, enantioenriched a-boryl alkylcopper species III could 
be generated using this technique (Figure 2.2, left path). No stoichiometric activator is needed, and 
depending on the identity of “X”, other useful functionality could be incorporated into the final 
product if desired. Familiarity with the synthetic utility of alkyl boronic esters drew us towards 
copper-boryl complexes (Cu–B(OR)2), easily created through the reaction between a copper 
alkoxide and bis(pinacolato) diboron.21 Considering that Cu–B(OR)2 complexes readily insert into 
activated olefins regioselectively, we proposed that initial insertion of an in situ generated copper-
boryl species into alkenylboronate ester 2.1 would provide desired bis-boryl alkylcopper 
intermediate 2.2. This method would provide us with alternative means of generating a-boryl 
alkylcopper intermediates without the use of harsh alkoxide activators, expanding the capabilities 
of these valuable organometallic nucleophiles. 
 
Figure 2.3 Tandem borylcupration/1,2-addition reaction between alkenylboronates and 
aldehydes: reaction proposal 
2.2 Background 
Generation of an organocopper through the insertion of a copper-boryl complex across an 
olefin was first reported by Sadighi and co-workers in 2006 (Scheme 2.1).22 Bis(pinacolato) 
diboron (2.4) cleanly reacted with NHC-copper alkoxide complex 2.5 to generate NHC-copper(I) 





















91% yield as a single regioisomer after just twenty minutes. Upon heating, these compounds 
undergo a rapid b-hydride elimination/reinsertion process to generate the more thermodynamically 
stable a-boryl alkylcopper complex 2.8, which was fully characterized by single crystal X-ray 
diffraction studies. To confirm the identity of this product, independently synthesized 
alkenylboronate 2.10 was reacted with an isolated NHC-copper(I) hydride complex 2.923, and a-
boryl alkylcopper 2.8 was isolated as the exclusive product. The creation of 2.8 selectively over 
benzylic alkylcopper 2.7 points to the thermodynamic stability of a-boryl organometallics. 
Scheme 2.1 Isolation and characterization of NHC–Cu(I)–B(pin) complexes: generation of  
a-boryl alkylcopper species via hydrocupration of alkenylboronates 
 
Regioselective hydrocupration of alkenylboronates was further utilized by Yun and co-
workers to develop the enantioselective synthesis of non-symmetric 1,1-diborylalkanes (Scheme 
2.2, top).24 Switching from an achiral NHC ligand to chiral bis-phosphine (R)-dtbm-segphos 
afforded enantioenriched 1,1-diborylalkanes in excellent yields and enantioselectivities. This 



























































fashion to Sadighi and co-workers’ isolated copper-boryl complex, give b-borylated products as 
single regioisomers. This transformation has been extensively applied to metal-catalyzed 
enantioselective hydroboration reactions using both copper25 and rhodium26 catalysis (Scheme 2.2, 
bottom). 
Scheme 2.2 Enantioselective synthesis and reactivity of a-boryl alkylcopper complexes 
 
Many of these reactions proceed through the same general mechanism (Figure 2.4): 
generation of metal-boryl complex II from the reaction between a metal-alkoxide and a boron 
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n Enantioselective Hydroboration via Cu–H Insertion (Yun, 2013)
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boryl alkylmetal intermediate III. Protonolysis of the alkyl-metal bond releases hydroborated 
product IV and regenerates the metal-alkoxide catalyst I. 
 
Figure 2.4 General catalytic cycle for the enantioselective hydroboration of olefins 
In a combination of these previous models, we proposed that the regioselective 
borylcupration of alkenylboronic esters would yield a,b-bisboryl alkylcopper intermediates 2.2 
(See Figure 2.3). Instead of quenching this reactive species through protonolysis, we would 
harness the nucleophilic character of the alkylmetal bond through the 1,2-addition reaction with a 
carbonyl electrophile, a reaction which we possessed extensive precedent for. The resulting 
copper-alkoxide would be turned over through reaction with B2(pin)2, re-entering the catalytic 
cycle and continuing the process. This proposed catalytic system would deliver 1-hydroxy-2,3-
bisboronate products (Figure 2.3, 2.3) which contain two new stereogenic centers and multiple 



























2.3 Copper-Catalyzed Enantioselective Tandem Borylation/1,2-Addition of 
Alkenylboronates to Carbonyl Electrophiles 
 
2.3.1 Reaction Discovery and Optimization 
Initially, our efforts focused on the development of a diastereoselective borylcupration 
reaction, as we believed enantioselectivity could be controlled through simple ligand 
modifications. Thorough examination of the diastereoselectivity of quenching a,b-bisboryl 
alkylcopper intermediate with benzaldehyde (2.17) was undertaken. To our delight, copper(I) 
alkoxide/rac-BINAP catalyst, generated in situ, efficiently produced 1-hydroxy-2,3-bisboronate 
2.19 in >98% conversion and 9:1 d.r. from the multicomponent reaction between alkenylboronate 
2.18, 2.4, and benzaldehyde (Scheme 2.3). Purification of the bisboronate products provided an 
interesting result: the less-stable syn diastereomer underwent boron-Wittig type elimination upon 
exposure to silica gel27, while the anti diastereomer remained untouched. Due to this phenomenon, 
isolation of 1-hydroxy-2,3-bisboronate products via silica gel chromatography resulted in 
enrichment of the anti diastereomer. Compound 2.19 was isolated in 77% yield as a single 
diastereomer. These conditions proved tolerable for a selection of aryl (2.20 and 2.21), alkenyl 










Scheme 2.3 Diastereoselective tandem borylation/1,2-addition of aldehydes using 2.18 
 
With an efficient racemic reaction developed, we turned our attention to rendering this 
transformation enantioselective through the employment of a chiral copper catalyst (Table 2.1). 
The direct switch from rac-BINAP to (R)-BINAP gave appreciable conversion to product in both 
THF and toluene, but suffered from lower levels of enantioselectivity (Entries 1 and 2). A wide 
selection of mono- and bidentate phosphines (2.24 to 2.30, Entries 3-8) were unable to deliver high 
conversion and selectivity. Application of biphenyl phosphine (R)-Cl-MeO-BIPHEP (2.31), 
however, produced desired 1-hydroxy-2,3-bisboronate 2.19 in quantitative conversion as a 3.2:1 
mixture of diastereomers and 95:5 e.r. for the major diastereomer (Entry 9). Reproducibility issues 
persisted when using an in situ generated copper alkoxide, so independently synthesized copper(I) 
tert-butoxide28 was employed as a pre-generated replacement (Entry 10). Although this saw a 
slight decrease in conversion, selectivity levels remained unchanged, and a simple switch to 













>98% conv, 9:1 dr
2.4 (1.1 equiv)
THF, 22 °C, 48 h








































2.24: Ar = Ph






















2.29: Ar = Ph









































toluene 88 1:1 95:5
Cu(MeCN)4PF6
2.24
toluene <2 - -
Cu(MeCN)4PF6
2.24
toluene <2 - -
Cu(MeCN)4PF6
ligand Cu source
toluene 12 11.5:1 -
2.30 Cu(MeCN)4PF6 toluene <2 - -
























aReactions performed under N2 atmosphere; see Experimental Section for details.
bDetermined by 1H NMR crude spectra analysis using hexamethyldisiloxane as
an internal standard. cDetermined by chiral HPLC analysis. dThe e.r. of the
syn diastereomer is not reported due to its propensity to undergo elimination.
e[0.167M] in benzene with 2.0 equivalents of 2.18.
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2.3.2 Substrate Scope – Intermolecular Additions to Aldehydes 
With optimized conditions in hand, we set out to explore the scope of the tandem 
borylation/1,2-addition reaction of alkenylboronate 2.18 to various aryl aldehydes (Scheme 2.4). 
It should be noted that crude diastereoselectivities for all substrates varied widely, but all products 
were enriched after purification via silica gel chromatography. This decomposition process could 
be prevented through the simple silyl protection of crude product mixtures before purification (vide 
infra). Various derivatives of parent substrate benzaldehyde, including ortho-, meta-, and para-
substitution, were well-tolerated under these reaction conditions, delivering 1-hydroxy-2,3-
bisboronates in up to 83% isolated yield, up to >20:1 d.r., and up to 96:4 e.r. (2.20, 2.32-2.37, 2.39) 
Heterocyclic aldehydes also participated readily; N-Boc indole substrate 2.21 was produced in 
63% yield, 3:1 d.r., and 94:6 e.r., while furyl-substituted bisboronate 2.38 was isolated in 52% 
yield as a single diastereomer and excellent enantioselectivity (97:3 e.r.). Unfortunately, Lewis-
basic functionality presents a limitation, as 3-pyridinecarboxaldehyde reacts sluggishly under 











Scheme 2.4 Tandem borylation/1,2-addition of 2.18: aryl aldehyde scope 
 
Both alkenyl and alkyl aldehydes were also able to participate in the copper-catalyzed 
tandem borylation/1,2 addition reaction (Scheme 2.5). Cinnamaldehyde-derived products 2.41 and 
2.42 were synthesized in 55% and 63% yield, respectively, while giving respectable diastereo- and 
enantioselectivities (9:1 d.r. and 93:7 e.r. for both substrates). Long-chain alkenyl aldehyde 
Geranial reacted smoothly to give hydroxybisboronate 2.22 in 78% yield, >20:1 d.r. and 93:7 e.r. 
Due to the lack of stoichiometric activator, the first alkyl substituted products were able to be 






































































>20:1 d.r., 96:4 e.r.
2.32
70% yield
>20:1 d.r., 96:4 e.r.
2.33
68% yield
5.7:1 d.r., 95:5 e.r.
2.34
70% yield
>20:1 d.r., 95:5 e.r.
2.20
75% yield
>20:1 d.r., 95:5 e.r.
2.35
81% yield
>20:1 d.r., 96:4 e.r.
2.36
83% yield
>20:1 d.r., 96:4 e.r.
2.37
44% yield
>20:1 d.r., 94:6 e.r.
2.21
63% yield
3:1 d.r., 94:6 e.r.
2.38
52% yield
>20:1 d.r., 97:3 e.r.
2.39
71% yield




under optimized reaction conditions, although enantioselectivities were slightly lower than aryl 
and alkenyl counterparts. 
Scheme 2.5 Tandem borylation/1,2-addition of 2.18: alkenyl and alkyl aldehyde scope 
 
2.3.3 Substrate Scope – Intramolecular Additions to Aldehydes and Ketones 
Substituted alkenylboronates bearing a pendant aldehyde or ketone were viable substrates 
in the intramolecular enantio- and diastereoselective tandem borylation/1,2-addition protocol. 
These substrates could be easily synthesized through a ruthenium-catalyzed cross-metathesis 
between parent alkenylboronate 2.18 and the corresponding terminal olefin.29 Aryl aldehyde 2.45 
produced hydroxybisboronate anti,syn-2.46 in 49% yield, >20:1 d.r., and 98.5:1.5 e.r. 
Surprisingly, acetophenone derivative 2.47 gave tertiary alcohol anti,anti-2.48, which was isolated 



























9:1 d.r., 93:7 e.r.
2.42
63% yield
9:1 d.r., 93:7 e.r.
2.22
78% yield
>20:1 d.r., 93:7 e.r.
2.23
63% yield
>20:1 d.r., 92:8 e.r.
2.43
48% yield
>20:1 d.r., 75:25 e.r.
2.44
70% yield
























Scheme 2.6 Borylation/intramolecular 1,2-addition to aryl aldehydes and ketones 
 
This unexpected change in selectivity can be rationalized by invoking a change in the mode 
of 1,2-addition between the two electrophiles (Figure 2.5). Sterically unencumbered aryl aldehyde 
2.45 directly engages the pendant copper-alkyl in a stereoretentive pathway. On the other hand, 
the additional methyl group on aryl ketone 2.47 causes a shift to a stereoinvertive backside addition 
of the copper-alkyl in order to alleviate steric strain.30 This invertive pathway is consistent across 
a number of aryl and alkyl ketone substrates (Scheme 2.6, bottom). Fluorinated aryl triol 2.49 is 
produced in 73% yield, >20:1 d.r. and 95.5:4.5 e.r. over two steps. Linear alkyl chains and amines 












>20:1 dr, 99:1 er
2.51
58% yield
>20:1 dr, 97:3 er
2.50
59% yield








































>20:1 dr, 94:6 er
OHMe
NaOH(aq), H2O2
THF, 0 °C to 22 °C
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yields and enantioselectivities (59% yield, >20:1 d.r., 88:12 e.r. for 2.50, 58% yield, >20:1 d.r., 
97:3 e.r. for 2.51). 
 
Figure 2.5 Proposed stereochemical model detailing the differing modes of addition for 
aldehydes and ketones 
Based on these data, we proposed a catalytic cycle for the tandem borylation/1,2-addition 
reaction between 2.4, alkenylboronates and various carbonyl electrophiles (Figure 2.6). Initial 
copper-B(pin) complex formation occurs through the reaction between copper (I) alkoxide I and 
B2(pin)2. Copper-boryl complex II then reacts with alkenylboronate 2.1 to generate 
enantioenriched a,b-bisboryl alkylcopper III. Diastereoselective 1,2-addition with the 
corresponding carbonyl electrophile (IV) occurs next to give copper alkoxide intermediate V. This 
alkoxide may react with another equivalent of B2(pin)2 to release borylated product VI and 
regenerate the required copper-boryl complex II, obviating the need for any exogenous activator. 



















Figure 2.6 Proposed catalytic cycle for the copper-catalyzed tandem borylation/1,2-addtion 
reaction between alkenylboronates and aldehydes/ketones 
2.3.4 Product Functionalizations 
Both the primary and secondary boronic ester groups present in the isolated 1-hydroxy-
2,3-bisboronate products were amenable to a variety of functionalizations (Scheme 2.7). Global 
oxidation of both organoboron groups in product 2.22 with NaOH/H2O2 in THF yielded triol 2.52 
in 93% isolated yield. Silyl protection of secondary alcohol 2.19 proceeded in 62% yield (over two 
steps) as an 84:16 mixture of diastereomers. Attempts to cross couple vinyl bromide 2.53 under 
Suzuki-Miyaura conditions were successful, delivering vinylated product 2.54 in 59% yield as a 
single diastereomer. Under these conditions, the more reactive primary boronic ester is exclusively 
coupled, while the secondary organoboron group remains intact. Exposure of isolated 
















































conditions led to the generation of densely functionalized secondary alcohols bearing a variety of 
synthetically significant functional handles. Selective sequential activation of each individual 
boronic ester on isolated 1-hydroxy-2,3-bisboronates showcases these products’ tremendous 
synthetic versatility. 
Scheme 2.7 Functionalization of isolated 1-hydroxy-2,3-bisboronate products 
 
Cyclized products arising from the intramolecular reaction between a ketone and a pendant 
alkenylboron group were also able to participate in functionalization reactions (Scheme 2.8). 
Crude cyclic tertiary alcohol 2.50 could be silyl protected with 2.57 in 43% yield over two steps. 
Subsequent exposure of this silyl ether to Matteson homologation conditions resulted in the 






















THF, -78 °C, 1 h
NBS, -78 °C, 1 h
Na2S2O3
1) H2N–OMe, n-BuLi
THF, -78 °C to rt, 20 h
2) Boc2O




































Scheme 2.8 Matteson-type bis-homologation of cyclic 1-hydroxy-2,3-bisboronate 2.50 
 
2.4 Conclusions 
In conclusion, we have developed an enantio- and diastereoselective tandem 
borylation/1,2-addition protocol for the reaction between alkenylboronates, B2(pin)2, and carbonyl 
electrophiles. The reaction utilizes an in situ generated copper (I) alkoxide catalyst bearing (R)-
Cl-OMe-BIPHEP as a chiral bis-phosphine ligand. Intramolecular reactions between vinyl boronic 
acid pinacol ester (2.18) and a number of aryl, alkenyl, and alkyl aldehydes proceed smoothly in 
up to 83% isolated yield, up to >20:1 isolated d.r., and up to 97:3 e.r. Intramolecular additions to 
aldehydes and ketones bearing a pendant alkenylboron moiety create cyclized products in up to 
95% yield, up to >20:1 d.r. and up to 98.5:1.5 e.r. Reactions with ketones result in the generation 
of the anti-,anti diastereomer due to a switch to stereoinvertive backside addition to the more 
sterically hindered ketone face. Both primary and secondary organoboron groups may partake in 
common C–B bond functionalizations, including oxidation, amination, and cross-coupling. Under 
selective conditions, the primary boronic ester may be activated preferentially over the hindered 





































n General: All reactions were carried out in oven-dried (150 ̊ C) or flame-dried glassware under 
an inert atmosphere of dried N2 unless otherwise noted. Analytical thin-layer chromatography was 
performed on glass plates coated with 0.25 mm of 60 Å mesh silica gel. Plates were visualized by 
exposure to UV light (254 nm) and/or immersion into KMnO4 or Seebach Stain followed by 
heating. Column chromatography was performed using silica gel P60 (mesh 230-400) supplied by 
Silicycle. Deactivated silica gel was prepared by stirring a slurry of the aforementioned silica gel 
in a 4.5% NaOAc aqueous solution for 15 minutes. The deactivated silica gel was collected by 
filtration and then dried in a 150 ˚C oven for 3 days. All solvents were sparged with argon and 
then purified under a positive pressure of argon through a SG Water, USA Solvent Purification 
System. Tetrahydrofuran, toluene, and benzene (OmniSolv) were passed successively through two 
columns of neutral alumina. The ambient temperature in the laboratory was approximately 22 ˚C.		
	
n Instrumentation: All 1H NMR spectra were recorded on Bruker Spectrometers (AVANCE-
600, AVANCE-500 and AVANCE-400). Chemical shifts are reported in ppm from 
tetramethylsilane and referenced to the residual protio solvent peak (CDCl3: δ 7.26, C6D6: δ 7.16). 
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, qu = 
quartet, quint = quintet, br = broad, m = multiplet, app = apparent), integration, and coupling 
constants are given in Hz. 13C NMR spectra were recorded on Bruker Spectrometers (AVANCE-
600 and AVANCE-400) with carbon and proton decoupling. Chemical shifts are reported in ppm 
from tetramethylsilane and referenced to the residual protio solvent peak (CDCl3: δ 77.16, C6D6: 
δ 128.06). All IR spectra were recorded on a Jasco 260 Plus Fourier transform infrared 
spectrometer. Optical rotations were determined using a Jasco P1010 polarimeter and 
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concentrations are reported in g/100mL. Enantiomeric ratios were determined on an Agilent 
Technologies 1220 Infinity LC using the following columns: Diacel CHIRALPAK IA (4.6 mm x 
250 mm x 5 µm), Diacel CHIRALPAK IB (4.6 mm x 250 mm x 5 µm), and Diacel CHIRALPAK 
IC (4.6 mm x 250 mm x 5 µm). Chiral supercritical fluid chromatography analysis was performed 
on a Waters Acquity UPC2 instrument at 22°C with Phenomenex chiral columns (15 cm) using the 
conditions detailed for each substrate. Mass Spectrometry samples were analyzed with a hybrid 
LTQ FT (ICR 7T) (ThermoFisher, Bremen, Germany) mass spectrometer. Samples were 
introduced via a micro-electrospray source at a flow rate of 10 µL/min (solvent composition 10:1 
MeOH:H2O or pure acetonitrile for copper complexes). Xcalibur (ThermoFisher, Breman, 
Germany) was used to analyze the data. Molecular formula assignments were determined with 
Molecular Formula Calculator (v 1.2.3). Low-resolution mass spectrometry (linear ion trap) 
provided independent verification of molecular weight distributions. All observed species were 
singly charged, as verified by unit m/z separation between mass spectral peaks corresponding to 
the 12C and 13C12Cc-1 isotope for each elemental composition. 
	
n Reagents: All liquid aldehydes were distilled from CaH2 or CaSO4 under reduced pressure 
and then sparged with dry N2. Solid aldehydes were purified via recrystallization, followed by 
azeotropic drying with benzene. Tetrakis(acetonitrile)copper hexafluorophosphate was purchased 
from Sigma Aldrich and kept in an N2-filled glove box. All chiral phosphine ligands used were 
purchased from Strem Chemicals Inc. and used as received.  
 
1-(2-allyl-4-fluorophenyl)ethan-1-one was prepared according to a literature procedure31 
2’-Allylacetophenone was prepared according to a literature procedure31 
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2-Allylbenzaldehyde was prepared according to a literature procedure31 
4-Anisaldehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under reduced 
pressure, and then sparged with dry N2 
Bis(pinacolato)diboron was purchased from Frontier Scientific, recrystallized from boiling 
hexanes, azeotropically dried with benzene three times, and kept in an N2-filled glovebox 
Benzaldehyde was purchased from Alfa-Aesar, vacuum distilled from CaH2, and then sparged 
with dry N2 
Benzene-d6 was purchased from Cambridge Isotope Laboratories and distilled over 
Na/benzophenone, sparged with dry N2, and kept in an N2-filled glove box over 4 Å molecular 
sieves 
Benzoic Anhydride was purchased from Acros and used as received. 
Benzylchlorodimethylsilane was purchased from TCI and used as received 
1-Bromo-2-methyl-1-propene was purchased from Matrix Scientific and used as recieved 
2-Bromobenzaldehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under reduced 
pressure, and then sparged with dry N2 
2-Bromo-4-chlorobenzaldehyde was purchased from Alfa-Aesar, recrystallized from methanol, 
azeotropically dried with benzene three times, and then stored in an N2-filled glovebox 
4-Bromobenzaldehyde was purchased from Alfa-Aesar, recrystallized from methanol, 
azeotropically dried with benzene three times, and then stored in an N2-filled glovebox 
Calcium hydride was purchased from Acros and used without further purification 
CDCl3 was purchased from Cambridge Isotope Laboratories and used without further purification 
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Cyclohexanecarboxyaldehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under 
reduced pressure, and then sparged with dry N2 
Dibromomethane was purchased from Aldrich and used as received 
Dihydrocinnamaldehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under 
reduced pressure, sparged with dry N2, and stored at -20 °C 
4-Dimethylaminopyridine was purchased from Sigma Aldrich and used as received. 
4-Fluorobenzaldehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under reduced 
pressure, and then sparged with dry N2 
Furan was purchased from Alfa Aesar, dried over CaH2, distilled under reduced pressure, kept 
over 4Å molecular sieves and sparged with dry N2 
2-Furylaldehyde was purchased from Acros Organics, dried over CaH2, distilled under reduced 
pressure, and then sparged with dry N2 
Geranial was synthesized according to a published literature procedure32 
Grubb’s 1st Generation Catalyst was purchased from Aldrich and used as received 
5-Hexen-2-one was purchased from Alfa Aesar and used as received 
Hydrogen Peroxide was purchased as a 30% solution in water and stored at -20 °C 
Isovaleraldehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under reduced 
pressure, sparged with dry N2, and stored at -20 °C. 
Methoxyamine was prepared according to a literature procedure33 
n-Butyllithium was purchased from Strem and titrated with phenanthroline/sec-butanol 
N-Boc-3-indolecarboxaldehyde was synthesized according to a published literature procedure34 
N-Bromosuccinimide was purchased from Aldrich and recrystallized from water before use 
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Nicotinaldehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under reduced 
pressure, and then sparged with dry N2 
Palladium(II) Acetate was purchased from Strem Chemicals and used as received 
Potassium tert-butoxide were purchased from Strem and used as received 
RuPhos was purchased from Sigma Aldrich and used as received 
Sodium Hydroxide was purchased from Fisher Scientific and used as received 
tert-Butyl allyl(2-oxopropyl)carbamate was prepared according to a modified literature 
procedure35 
tert-Butyldimethylsilyl chloride was purchased from Sigma-Aldrich and used as received 
2-Tolualdehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under reduced 
pressure, and then sparged with dry N2 
3-Tolualdehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under reduced 
pressure, and then sparged with dry N2 
Triethylamine was purchased from Sigma Aldrich, dried over CaH2, and distilled under N2. 
2,4,6-Trimethylbenzaldehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under 
reduced pressure, and then sparged with dry N2 
trans-Cinnamaldehyde was purchased from Alfa-Aesar, dried over CaH2, distilled under reduced 
pressure, and then sparged with dry N2 
trans-α-Methylcinnamaldehyde was purchased from Alfa-Aesar, dried over CaH2, distilled 
under reduced pressure, and then sparged with dry N2 
Vinyl boronic acid pinacol ester was purchased from Sigma Aldrich, dried over CaH2, distilled 
under reduced pressure, sparged with dry N2, and stored at -20 °C in an N2-filled glovebox 
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n Synthesis of Copper tert-butoxide 
	
Procedure: Copper tert-butoxide was prepared according to a literature procedure.28 In an N2-
filled glovebox, a -20 °C solution of KOt-Bu (295.6 mg, 2.625 mmol) in THF (3.35 mL) was added 
to a -20 °C suspension of CuI (500.0 mg, 2.625 mmol) in THF (3.35 mL) in a 20 mL scintillation 
vial. The vial was agitated and allowed to stand at -20 °C for 30 minutes. The reaction was then 
allowed to stir at ambient temperature for 18 hours. The heterogeneous reaction was allowed to 
settle and the supernatant was removed and filtered over Celite®. The filtrate was concentrated to 
afford CuOt-Bu as a tan/yellow powder in 75% yield (269 mg). 1H NMR (600 MHz, C6D6): δ 1.31 
(s, 9H). 13C NMR (151 MHz, C6D6): δ 72.3, 35.5.  
	
n General Procedure (I) for the Diastereoselective Multicomponent Borylation/1,2-
Addition Reaction 
	
Procedure: In an N2-filled glovebox, an 8-mL vial equipped with a magnetic stir bar was charged 
with Cu(MeCN)4PF6 (1.9 mg, 0.0050 mmol) and rac-binap (3.7 mg, 0.0060 mmol) and dissolved 
in 400 µL of THF. The reaction was allowed to stir at ambient temperature for 60 minutes, after 
which time the solution was transferred to an 8-mL vial containing KOtBu (0.6 mg, 0.0050 mmol). 
The original vial was washed with 200 µL of THF and the reaction mixture allowed to stir at 
ambient temperature for 30 minutes. Bis(pinacolato)diboron (27.9 mg, 0.110 mmol) was added to 
Cu–I + KOt-Bu
THF




















the vial as a solution in THF (200 µL). Vinyl boronic acid pinacol ester (18.7 µL, 0.110 mmol) 
and the aldehyde (0.1 mmol) were added sequentially via syringe. The reaction was capped with a 
Teflon-lined lid, sealed with electrical tape, removed from the glovebox, and allowed to stir at 
ambient temperature for 48 hours. The reaction was quenched with 2 mL of a saturated aqueous 
solution of NH4Cl and allowed to stir vigorously at 22 °C for 30 minutes. The aqueous layer was 
extracted three times with diethyl ether, and the combined organic extracts were dried over MgSO4, 
filtered, and concentrated in vacuo. Conversions and diastereomeric ratios were determined by 1H 
NMR, using hexamethyldisiloxane as an internal standard.   
 
n General Procedure (II) for the Enantio- and Diastereoselective Multicomponent 
Borylation/1,2-Addition Reaction 
	
Procedure: In an N2-filled glovebox, an 8-mL vial equipped with a magnetic stir bar was charged 
with CuOt-Bu (1.4 mg, 0.010 mmol) and (R)-Cl-OMe-biphep (7.2 mg, 0.011 mmol) and dissolved 
in 400 µL of benzene. The reaction was allowed to stir at ambient temperature for 60 minutes. 
Bis(pinacolato)diboron (27.9 mg, 0.110 mmol) was added to the vial as a solution in benzene (200 
µL), followed by vinyl boronic acid pinacol ester (18.7 µL, 0.110 mmol), and the aldehyde (0.1 
mmol) neat via syringe. The reaction was capped with a Teflon-lined lid, sealed with electrical 
tape, removed from the glovebox, and allowed to stir at ambient temperature for 48 hours. The 
reaction was quenched with 2 mL of a saturated aqueous solution of NH4Cl and allowed to stir 





O CuOt-Bu (5 mol%)(R)-Cl-OMe-BIPHEP (6 mol%)
B2(pin)2 (1.1 equiv)









and the combined organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. 
Conversions and diastereomeric ratios were determined by 1H NMR, using hexamethyldisiloxane 
as an internal standard.   
 
For determination of the enantioselectivity of alkyl aldehyde addition products without a UV 
absorbing group (aryl ring, alkene, etc.), the 1-hydroxy-2,3-bisboroantes were oxidized to the triol 
and subsequently benzoylated to afford the 1,2,3-tris-benzoate products, which were assayed via 
HPLC.  
	
n General Procedure (III) for the TBS-Protection of 1-Hydroxy-2,3-bisboronate Products	
	
A crude reaction mixture of 1-hydroxy-2,3-bisboronate was charged with imidazole (4.0 
equivalents) and a magnetic stir bar and dried under vacuum for 20 minutes. TBSCl (3.0 
equivalents) was then added to the vial and purged with N2 for 5 minutes. Anhydrous dmf (0.15M) 
was then added via syringe under N2 and the reaction was purged for an additional 5 minutes and 
then allowed to stir at ambient temperature for 18 hours. The reaction was quenched by addition 
of 1 mL of a saturated aqueous solution of NH4Cl. The mixture was extracted 3X with diethyl 
ether and the combined organic extracts were washed with a saturated aqueous solution of 
NaHCO3, followed by brine. The washed organic extracts were dried over MgSO4, filtered, and 
concentrated in vacuo. The crude reaction mixture was purified via silica gel chromatography 
(20:1 hexanes:Et2O, Seebach Stain visualization) to yield the TBS-protected products. 
TBS—Cl (3.0 equiv)
imidazole (4.0 equiv)



















n Supplementary Procedure A: Oxidation/Benzoylation of Alkyl Aldehyde Addition 
Products	
	
A vial containing 2.46 (7.9 mg, 0.2 mmol) was charged with THF (800 µL) and allowed to cool to 
0 °C (ice/water bath). The reaction was charged with 3M NaOH (400 µL, 1.2 mmol) and then 30% 
H2O2 (400 µL, 4.0 mmol) dropwise. The reaction was allowed to slowly warm up to ambient 
temperature over 2 hours, followed by 4 hours of additional stirring at that temperature. The 
reaction was allowed to cool to 0 °C and quenched by dropwise addition of 1M Na2S2O3. The 
reaction was diluted with water and then extracted 6X with EtOAc. The combined organic extracts 
were dried over Na2SO4, filtered, and then concentrated in vacuo. The crude oxidation mixture 
was taken up in 1:1 hexanes:EtOAc and passed through a column of silica gel (to remove pinacol) 
and then flushed thoroughly with pure EtOAc to isolate the product. The purified triol (9.4 mg, 
0.054 mmol), benzoic anhydride (48.8 mg, 0.216 mmol), and 4-dimethylaminopyridine (1.3 mg, 
0.0108 mmol) were added to an 8 mL vial equipped with a stir bar and then dried in vacuo for 10 
minutes. The vial was purged with N2 for 10 minutes and then charged with CH2Cl2 (500 µL) 
followed by NEt3 (30.1 µL, 0.216 mmol). The reaction was allowed to stir at ambient temperature 
for 2 hours and then quenched with a saturated aqueous solution of NH4Cl. The biphasic mixture 
was extracted 3X with diethyl ether, dried over MgSO4, filtered, and then concentrated in vacuo. 
The product was purified via silica gel chromatography (5:1 pentane:Et2O) to afford the product.  
	
1) NaOH(aq), 30% H2O2
THF, 0 to 22 °C, 6 h
2) (Bz)2O (4 equiv)
NEt3 (4 equiv)
DMAP (20 mol%)












1-phenyl-2,3-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-ol (2.19). Following 
General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 74% yield (28.7 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 7.39 – 7.35 (m, 2H), 
7.32 (t, J = 7.6 Hz, 2H), 7.26 – 7.22 (m, 1H), 4.72 (dd, J = 7.6, 3.7 Hz, 1H), 3.11 (d, J = 4.7 Hz, 
1H), 1.66 (ddd, J = 8.9, 7.5, 5.7 Hz, 1H), 1.25 (d, J = 2.2 Hz, 24H), 0.88 – 0.74 (m, 2H). 13C NMR 
(151 MHz, CDCl3) δ 144.3, 128.1, 127.1, 126.4, 83.5, 83.1, 28.4, 24.9, 24.8, 24.8, 24.8, 9.6. IR 
(υ/cm-1): 3481 (s, br), 3080 (w), 2976 (s), 2941 (m), 2875 (m), 1489 (w), 1465 (m), 1330 (m), 1249 
(w), 1230 (w), 1113 (w), 1111 (w). HRMS (ESI+) calcd for C21H34B2O5Na+ 411.2490, found: 
[M+Na+] 411.2485. [α]D22 = —20.6 (c = 5.45, CH2Cl2, l = 100 mm). 
The absolute stereochemistry and diastereoselectivity of the product was determined by [α]D 
analysis of the oxidized product (1,2,3-triol) which has been previously characterized (found [α]D22 
= —71.67 (c = 2.95, CH2Cl2, l = 100 mm), lit: [α]D21 = —89.73 (c = 0.66, CHCl3).6 
For all 1-hydroxy-2,3-bisboronate products, the 13C NMR signals for the carbons bound to each 
boronate ester are highly broadened and sometimes absent, likely due to quadrupolar relaxation of 
the 10/11B nucleus coupled to 13C nucleus.  















yl)propoxy)silane (TBS-2.19). Following General Procedure III, the crude reaction mixture was 













the TBS-protected product in 62% yield (over two steps) in 84:16 d.r. (155.6 mg). Anti 
diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.34 – 7.30 (m, 2H), 7.25 (dd, J = 8.3, 6.8 Hz, 2H), 
7.20 – 7.16 (m, 1H), 4.78 (d, J = 6.5 Hz, 1H), 1.63 – 1.58 (m, 1H), 1.25 (s, 6H), 1.23 (s, 6H), 1.21 
(s, 6H), 1.21 (s, 6H), 0.88 (s, 9H), 0.78 – 0.74 (m, 2H), 0.03 (s, 3H), -0.27 (s, 3H). Syn 
diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.34 – 7.31 (m, 2H), 7.25 (t, J = 7.6 Hz, 2H), 7.20 
– 7.16 (m, 1H), 4.62 (d, J = 8.7 Hz, 1H), 1.54 (ddd, J = 12.4, 8.7, 3.6 Hz, 1H), 1.25 (s, 6H), 1.23 
(s, 6H), 1.21 (s, 6H), 1.21 (s, 6H), 0.84 (s, 9H), 0.78 – 0.74 (m, 2H), 0.02 (s, 3H), -0.27 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 145.5, 145.1, 127.6, 127.5, 127.2, 127.0, 126.8, 126.6, 82.9, 82.9, 
82.8, 82.8, 78.0, 77.9, 30.1, 26.0, 25.9, 25.2, 25.0, 25.0, 25.0, 24.9, 24.8, 24.8, 24.7, 18.2, 8.9, -
4.5, -4.7. IR (ν/cm-1): 2985 (m), 2945 (m), 2879 (m), 2843 (m), 1416 (m), 1402 (w), 1379 (m), 
1371 (m). HRMS (ESI+): calcd for C27H48B2O5SiNa+ 525.3355, found [M+Na+] 525.3350. [α]D22 




Following General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 70% yield (28.4 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 7.36 – 7.31 (m, 2H), 
7.00 (t, J = 8.7 Hz, 2H), 4.70 (dd, J = 7.7, 2.9 Hz, 1H), 3.18 (d, J = 4.6 Hz, 1H), 1.65 – 1.57 (m, 










162.4 (d, J = 244.2 Hz), 140.1 (d, J = 3.1 Hz), 128.0 (d, J = 8.0 Hz), 114.8 (d, J = 21.2 Hz), 83.6, 
83.2, 76.6, 28.5, 24.9, 24.8, 24.8, 24.8, 9.5. IR (υ/cm-1): 3506 (s, br), 3080 (w), 2890 (m), 1510 
(w), 1499 (m), 1340 (m), 1199 (w). HRMS (ESI+) calcd for C21H33O5B2FNa+ 429.2396, found: 
[M+Na] 429.2391. [α]D22 = —39.4 (c = 5.40, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 
Diacel CHIRALPAK IC Column; 98.8:1.2 hexanes:iPrOH; 0.3 mL/min; 210 nm 
Racemic Material 
Enantioenriched Material 





Following General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 68% yield (31.8 
mg) and a 5.7:1 anti:syn diastereomeric ratio. 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.40 (m, 2H), 
7.26 – 7.22 (m, 2H), 4.68 (d, J = 7.3 Hz, 1H), 3.22 (s, 1H), 1.63 – 1.56 (m, 1H), 1.25 (s, 24H), 
0.80 (ddd, J = 14.9, 7.5, 5.7 Hz, 2H). 13C NMR (151 MHz, CDCl3) δ 143.4, 131.1, 128.2, 120.8, 
83.6, 83.2, 76.7, 28.3, 24.9, 24.8, 24.8, 24.8, 9.6. IR (υ/cm-1): 3400 (s, br), 2988 (w), 2850 (m), 
1599 (w), 1511 (m), 1329 (m). HRMS (ESI+) calcd for C21H33O5B2BrNa+ 489.1595, found: 
[M+Na] 489.1593. [α]D22 = —19.3 (c = 6.05, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 
















Following General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 










mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 7.31 – 7.26 (m, 2H), 
6.88 – 6.84 (m, 2H), 4.66 (dd, J = 7.9, 2.7 Hz, 1H), 3.80 (s, 3H), 3.04 (d, J = 4.3 Hz, 1H), 1.62 
(ddd, J = 9.0, 7.9, 5.7 Hz, 1H), 1.26 (s, 12H), 1.23 (s, 12H), 0.81 – 0.70 (m, 2H). 13C NMR (151 
MHz, CDCl3) δ 158.7, 136.5, 127.6, 113.4, 83.5, 83.1, 76.9, 55.3, 28.4, 24.9, 24.9, 24.8, 24.8, 9.6. 
IR (υ/cm-1): 3489 (s, br), 2921 (m), 1567 (m), 1482 (w), 1289 (m). HRMS (ESI+) calcd for 
C22H36O6B2Na+ 441.2596, found: [M+Na] 441.2590. [α]D22 = —27.8 (c = 5.56, CH2Cl2, l = 100 
mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 






Anti diastereomer: (1R,2R) enantiomer: 7.9 min; (1S,2S) enantiomer: 10.1 min: 94:6 e.r. 
 
 
2,3-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(3-tolyl)propan-1-ol (2.20). Following 
General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 75% yield (30.2 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 7.22 – 7.18 (m, 3H), 
7.16 – 7.13 (m, 1H), 7.05 (dd, J = 7.9, 1.1 Hz, 1H), 4.68 (d, J = 7.5 Hz, 1H), 3.09 (s, 1H), 2.34 (s, 
3H), 1.67 – 1.61 (m, 1H), 1.25 (d, J = 5.3 Hz, 24H), 0.87 – 0.74 (m, 2H). 13C NMR (151 MHz, 
CDCl3) δ 144.3, 137.5, 127.9, 127.8, 127.1, 123.6, 83.5, 83.1, 77.3, 28.4, 24.9, 24.9, 24.8, 24.8, 










(ESI+) calcd for C22H36O5B2Na+ 425.2647, found: [M+Na] 425.2642. [α]D22 = —30.2 (c = 5.73, 
CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 
Diacel CHIRALPAK IC Column; 98:2 hexanes:iPrOH; 0.3 mL/min; 210 nm 
Racemic Material 
Enantioenriched Material 





butyl)dimethylsilane (TBS-2.20). Following General Procedure III, the crude reaction mixture 
was purified via silica gel chromatography (25:1 pentane:Et2O, Seebach Stain visualization) to 
yield the TBS-protected product in 77% yield (over two steps) in 3.6:1 d.r. (39.5 mg). Anti 
diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.14 – 7.07 (m, 4H), 4.74 (d, J = 6.4 Hz, 1H), 2.29 
(s, 3H), 1.57 (ddd, J = 11.2, 6.2, 4.8 Hz, 1H), 1.22 (s, 6H), 1.20 (s, 6H), 1.19 (s, 6H), 1.18 (s, 6H), 
0.85 (s, 9H), 0.00 (s, 3H), -0.28 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 145.0, 136.7, 127.7, 127.3, 
127.2, 124.1, 82.9, 82.8, 77.9, 26.0, 25.2, 25.0, 25.0, 24.7, 21.5, 18.2, -4.5, -4.7. Syn diastereomer: 
1H NMR (600 MHz, CDCl3) 6.96 (m, 4H), 4.57 (d, J = 8.6 Hz, 1H), 2.29 (s, 3H), 1.49 (ddd, J = 
12.4, 8.6, 3.6 Hz, 1H), 1.22 (s, 6H), 1.21 (s, 6H), 1.12 (s, 6H), 0.99 (s, 6H), 0.82 (s, 9H), -0.01 (s, 
3H), -0.29 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 145.4, 136.7, 127.8, 127.5, 127.4, 124.2, 82.8, 
82.8, 77.9, 26.0, 24.9, 24.8, 24.8, 24.7, 21.5, 18.2, -4.4, -4.8. IR (ν/cm-1): 2977.55 (s), 2928.38 
(m), 2856.06 (m), 1471.42 (s), 1371.14 (m), 1316.18 (m), 1144.55 (s). HRMS (ESI+): calcd for 

















2,3-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-tolyl)propan-1-ol (2.35). Following 
General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 81% yield (32.6 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 7.48 (dd, J = 7.7, 
1.4 Hz, 1H), 7.20 (td, J = 7.4, 1.6 Hz, 1H), 7.16 – 7.08 (m, 2H), 4.91 (d, J = 6.8 Hz, 1H), 3.21 (s, 
1H), 2.37 (s, 3H), 1.67 (dt, J = 8.7, 6.5 Hz, 1H), 1.26 (m, 12H), 1.25 (s, 12H), 0.92 – 0.81 (m, 2H). 
13C NMR (151 MHz, CDCl3) δ 142.7, 135.3, 130.1, 126.8, 125.9, 125.6, 83.5, 83.1, 74.0, 24.9, 
24.9, 24.8, 19.5, 10.2. IR (υ/cm-1): 3892 (s, br), 2899 (m), 2657 (m), 1455 (w), 1515 (w) 1301 (m). 
HRMS (ESI+) calcd for C22H36O5B2Na+ 425.2647, found: [M+Na] 425.2643. [α]D22 = —39.2 (c 
= 6.19, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 












Anti diastereomer: (1R,2R) enantiomer: 39.4 min; (1S,2S) enantiomer: 55.2 min: 96:4 e.r.  
The peak at 42 min is the major enantiomer of the minor diastereomer, which was not present in 














chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 83% yield (38.8 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 7.58 (dd, J = 7.8, 
1.7 Hz, 1H), 7.50 (dd, J = 8.0, 1.2 Hz, 1H), 7.33 – 7.29 (m, 1H), 7.09 (ddd, J = 7.9, 7.3, 1.7 Hz, 
1H), 5.03 (dd, J = 6.5, 3.2 Hz, 1H), 3.65 (d, J = 4.8 Hz, 1H), 1.76 (dt, J = 9.4, 5.4 Hz, 1H), 1.27 
(d, J = 3.9 Hz, 24), 1.05 (dd, J = 15.9, 9.2 Hz, 1H), 0.90 (dd, J = 16.0, 5.0 Hz, 1H). 13C NMR (151 
MHz, CDCl3) δ 143.6, 132.4, 128.4, 127.9, 127.2, 123.0, 83.5, 83.2, 76.6, 27.5, 25.0, 24.9, 24.9, 
24.8, 10.7. IR (υ/cm-1): 3545 (s, br), 2923 (m), 1525 (m), 1359 (m), 1189 (w). HRMS (ESI+) calcd 
for C21H33O5B2BrNa+ 489.1595, found: [M+Na] 489.1590. [α]D22 = —41.1 (c = 7.38, CH2Cl2, l = 
100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 




Anti diastereomer: (1R,2R) enantiomer: 28.8 min; (1S,2S) enantiomer: 44.4 min: 96:4 e.r. 
The peak at 36 min is the major enantiomer of the minor diastereomer, which was not present in 




1-mesityl-2,3-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-ol (2.37).  Following 
General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 44% yield (18.9 
mg) and >99:1 anti:syn diastereomeric ratio.  1H NMR (600 MHz, CDCl3) δ 6.80 (s, 2H), 5.11 (d, 
J = 11.2 Hz, 1H), 2.65 (s, 1H), 2.44 (s, 6H), 2.25 (s, 3H), 2.00 (td, J = 11.5, 4.3 Hz, 1H), 1.33 (s, 
12H), 1.20 (d, J = 1.8 Hz, 12H), 0.78 – 0.71 (m, 1H), 0.50 (dd, J = 15.8, 4.3 Hz, 1H).  13C NMR 
(151 MHz, CDCl3) δ 137.1, 136.2, 135.8, 83.5, 83.4, 83.0, 73.9, 25.0, 24.9, 24.9, 24.9, 21.1, 20.8.  












C24H40O5B2Na+ 453.2960, found: [M+Na] 453.2955.  [α]D22 = —29.9° (c = 3.59, CH2Cl2, l = 100 
mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material.  Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 










indole-1-carboxylate (2.21). Following General Procedure II, the crude reaction mixture was 
purified via silica gel column chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 
pentane:Et2O, Seebach Stain visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a 
colorless oil in 63% yield (33.2 mg) and a 3:1 anti:syn diastereomeric ratio. Anti diastereomer: 
1H NMR (600 MHz, CDCl3) δ 8.15 (s, 1H), 7.79 (dt, J = 7.9, 1.0 Hz, 1H), 7.52 (s, 1H), 7.34 – 
7.29 (m, 1H), 7.22 (ddd, J = 8.1, 7.2, 1.1 Hz, 1H), 4.99 (t, J = 5.9 Hz, 1H), 3.20 (s, 1H), 1.90 (dt, 
J = 8.3, 6.5 Hz, 1H), 1.66 (s, 9H), 1.27 (d, J = 3.6 Hz, 12H), 1.26 – 1.25 (m, 12H), 1.00 (dd, J = 
16.2, 6.2 Hz, 1H), 0.91 (dd, J = 16.2, 8.3 Hz, 1H). Syn diastereomer: 1H NMR (600 MHz, CDCl3) 
δ 8.15 (s, 1H), 7.79 (dt, J = 7.9, 1.0 Hz, 1H), 7.52 (s, 1H), 7.34 – 7.29 (m, 1H), 7.22 (ddd, J = 8.1, 
7.2, 1.1 Hz, 1H), 5.18 (d, J = 6.5 Hz, 1H), 1.96 – 1.91 (m, 1H) 1.21 (s, 12H), 1.20 (s, 12H). 13C 
NMR (151 MHz, CDCl3) δ 149.7, 129.1, 129.0, 124.2, 124.1, 123.8, 122.7, 122.4, 120.5, 120.0, 
115.1, 83.5, 83.4, 83.3, 83.2, 75.0, 71.2, 69.7, 28.2, 26.7, 25.0, 24.9, 24.9, 24.9, 24.8, 24.8, 24.7, 
24.7, 10.0. IR (ν/cm-1): 3499 (s, br), 2998 (s), 2867 (w), 1732 (s), 1480 (s), 1354 (s), 1319 (m), 
1267 (m). HRMS (ESI+) calcd for C28H43O7NB2Na+ 550.3123, found: [M+Na] 550.3118. [α]D22 
= —9.7 (c = 5.80, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 










Racemic Material (anti) 
Enantioenriched Material (anti) 
Anti diastereomer: (1R,2R) enantiomer: 58.9 min; (1S,2S) enantiomer: 61.1 min: 94:6 e.r. 
 
Racemic Material (syn) 
 
	 199 
Enantioenriched Material (syn) 




Following General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 52% yield (19.7 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 7.35 (dd, J = 1.8, 
0.9 Hz, 1H), 6.30 (dd, J = 3.2, 1.8 Hz, 1H), 6.23 (dt, J = 3.2, 0.8 Hz, 1H), 4.76 (t, J = 6.0 Hz, 1H), 
3.18 (d, J = 6.8 Hz, 1H), 1.81 (dt, J = 8.7, 6.1 Hz, 1H), 1.27 – 1.24 (m, 24H), 0.94 – 0.83 (m, 2H). 
13C NMR (151 MHz, CDCl3) δ 156.8, 141.5, 109.9, 106.1, 83.5, 83.2, 71.1, 25.5, 24.9, 24.8, 24.7, 
9.3. IR (ν/cm-1): 3546 (s, br), 2984 (s), 2916 (m), 1458 (m), 1381 (s), 1312 (m), 1182 (s). HRMS 
(ESI+) calcd for C19H32O6B2Na+ 401.2283, found: [M+Na] 401.2279. [α]D22 = —16.7 (c = 6.04 










Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 
Diacel CHIRALPAK IC Column; 98:2 hexanes:iPrOH; 0.3 mL/min; 210 nm 
Racemic Material 
Enantioenriched Material 





yl)propoxy)dimethylsilane (TBS-2.38). Following General Procedure III, the crude reaction 
mixture was purified via silica gel chromatography (25:1 pentane:Et2O, Seebach Stain 
visualization) to yield the TBS-protected product in 57% yield (over two steps)  in 3.5:1 d.r. (28.2 
mg). Anti diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.26 (s, 1H), 6.24 (dd, J = 3.1, 1.8 Hz, 
1H), 6.14 (d, J = 3.2 Hz, 1H), 4.85 (d, J = 6.3 Hz, 1H), 1.71 – 1.66 (m, 1H), 1.22 (s, 6H), 1.21 (s, 
6H), 1.20 (s, 12H), 0.86 (s, 9H), 0.01 (s, 3H), -0.13 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 157.2, 
140.6, 109.8, 106.5, 83.0, 82.8, 71.7, 25.9, 25.0, 25.0, 24.8, 24.7, 18.2, -4.9, -5.0. Syn 
diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.28 (d, J = 1.0 Hz, 1H), 6.24 (dd, J = 3.1, 1.8 Hz, 
1H), 6.15 (d, J = 3.2 Hz, 1H), 4.67 (d, J = 9.3 Hz, 1H), 1.73 – 1.65 (m, 1H), 1.22 (s, 6H), 1.22 (s, 
6H), 1.12 (s, 6H), 1.09 (s, 6H), 0.82 (s, 9H), 0.01 (s, 3H), -0.18 (s, 3H). 13C NMR (151 MHz, 
CDCl3) δ 157.7, 140.7, 109.8, 106.1, 82.9, 82.9, 70.6, 25.9, 25.0, 24.9, 24.8, 24.7, 18.3, -4.9, -5.0. 
IR (ν/cm-1): 2978.52 (s), 2929.34 (m), 2857.02 (m), 1371.14 (m), 1256.4 (m), 1164.79 (m). HRMS 
(ESI+): calcd for C25H46B2O6SiNa+ 515.3148, found [M+Na+] 515.3163. [α]D22 = + 5.6 (c = 2.67, 

















ol (2.39). Following General Procedure II, the crude reaction mixture was purified via silica gel 
column chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 71% yield (35.5 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 7.57 – 7.49 (m, 2H), 
7.31 – 7.28 (m, 1H), 4.98 (dd, J = 5.7, 2.1 Hz, 1H), 3.81 (d, J = 4.2 Hz, 1H), 1.71 (dt, J = 8.9, 5.2 
Hz, 1H), 1.28 – 1.25 (m, 24H), 1.10 – 0.98 (m, 1H), 0.91 (dd, J = 15.9, 5.2 Hz, 1H). 13C NMR 
(151 MHz, CDCl3) δ 142.3, 133.1, 131.8, 128.9, 127.4, 123.1, 83.6, 83.3, 76.2, 27.7, 24.9, 24.9, 
24.9, 24.81, 11.0. IR (ν/cm-1): 3589 (s, br), 2834 (s), 2865 (w), 1564 (m), 1355 (s), 1314 (s), 1147 
(s). HRMS (ESI+) calcd for C21H32O5B2BrClNa+ 523.1205, found: [M+Na] 523.1203. [α]D22 = 
+10.1 (c = 5.80, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 

















E-1-phenyl-4,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-1-en-3-ol (2.41).  
Following General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 









mg) and 90:10 anti:syn diastereomeric ratio.  1H NMR (600 MHz, CDCl3) δ 7.40 – 7.36 (m, 2H), 
7.33 – 7.29 (m, 2H), 7.25 – 7.20 (m, 1H), 6.61 – 6.54 (m, 1H), 6.25 (dd, J = 15.9, 6.4 Hz, 1H), 
4.34 (d, J = 4.6 Hz, 1H), 2.82 (d, J = 5.3 Hz, 1H), 1.52 (dt, J = 8.8, 6.1 Hz, 1H), 1.27 (s, 6H), 1.26 
(s, 6H), 1.26 (s, 6H), 1.25 (s, 6H), 1.02 – 0.92 (m, 2H).  13C NMR (151 MHz, CDCl3) δ 137.1, 
132.5, 130.1, 128.4, 127.3, 126.5, 126.5, 126.4, 83.5, 83.1, 75.9, 26.8, 24.9, 24.9, 24.9, 24.8, 9.3.  
IR (ν/cm-1): 3430 (s, br), 3019 (w), 2987 (s), 2907 (m), 2845 (w), 1398 (m), 1365 (s), 1286 (m).  
HRMS (ESI+) calcd for C23H36O5B2Na+ 437.2647, found: [M+Na] 437.2642.  [α]D22 =  – 25.4° (c 
= 4.33, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material.  Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 









(2.42).  Following General Procedure II, the crude reaction mixture was purified via silica gel 
column chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 53% yield (27.0 
mg) and 90:10 anti:syn diastereomeric ratio.  1H NMR (600 MHz, CDCl3) δ 7.33 (dd, J = 8.1, 7.1 
Hz, 2H), 7.30 (d, J = 1.6 Hz, 2H), 7.24 – 7.17 (m, 1H), 6.49 (s, 1H), 4.20 (d, J = 8.0 Hz, 1H), 2.96 
(s, 3H), 1.86 (d, J = 1.4 Hz, 3H), 1.59 (ddd, J = 9.2, 8.0, 5.3 Hz, 1H), 1.28 (s, 12H), 1.25 (d, J = 
2.7 Hz, 12H), 0.89 (qd, J = 16.2, 7.3 Hz, 2H).  13C NMR (151 MHz, CDCl3) δ 139.6, 137.9, 129.1, 
128.0, 126.5, 126.2, 83.5, 83.1, 80.9, 24.9, 24.9, 24.9, 23.9, 13.0, 9.8.  IR (ν/cm-1): 3399 (s), 2576 
(m), 2102 (m), 1625 (s), 1201 (m). HRMS (ESI+) calcd for C24H38O5B2Na+ 451.2803, found: 










Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material.  Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 










(2.22). Following General Procedure II, the crude reaction mixture was purified via silica gel 
column chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 78% yield (33.9 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 5.19 (dq, J = 8.9, 
1.3 Hz, 1H), 5.13 – 5.08 (m, 1H), 4.38 (dd, J = 8.9, 7.3 Hz, 1H), 2.54 (s, 1H), 2.10 (td, J = 8.7, 7.9, 
4.7 Hz, 2H), 2.04 – 1.98 (m, 2H), 1.69 (dd, J = 4.5, 1.4 Hz, 6H), 1.61 (d, J = 1.3 Hz, 3H), 1.27 (s, 
12H), 1.25 (s, 12H), 0.91 (dd, J = 16.1, 5.5 Hz, 1H), 0.83 (dd, J = 16.0, 9.5 Hz, 1H). 13C NMR 
(151 MHz, CDCl3) δ 138.1, 131.5, 127.8, 124.2, 83.3, 83.0, 71.6, 39.7, 26.4, 25.7, 25.0, 24.9, 24.9, 
24.8, 17.7, 16.8, 9.0. IR (ν/cm-1): 3600 (s), 2967 (m), 2897 (m), 2092 (m), 1567 (s), 1345 (m), 
1274 (w), 1201 (m). HRMS (ESI+) calcd for C24H44O5B2Na+ 457.3273, found: [M+Na] 457.3268. 
[α]D22 = – 41.6 (c = 6.44, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 













Anti diastereomer: (1R,2R) enantiomer: 34.3 min; (1S,2S) enantiomer: 37.4 min: 93:7 e.r.  
The peak at 34.0 min is the major enantiomer of the minor diastereomer, which was not present in 







4,8-dien-3-yl)oxy)dimethylsilane (TBS-2.22). Following General Procedure III, the crude 
reaction mixture was purified via silica gel chromatography (25:1 pentane:Et2O, Seebach Stain 
visualization) to yield the TBS-protected product in 36% yield (over two steps) in >20:1 d.r. (19.7 
mg). 1H NMR (600 MHz, CDCl3) δ 5.22 (dd, J = 9.2, 1.1 Hz, 1H), 5.10 (ddd, J = 7.0, 5.7, 1.3 Hz, 
1H), 4.38 (dt, J = 10.3, 5.1 Hz, 1H), 2.08 (dd, J = 14.9, 7.4 Hz, 2H), 1.99 – 1.94 (m, 2H), 1.67 (s, 
3H), 1.61 (d, J = 1.1 Hz, 3H), 1.60 (s, 3H), 1.21 (s, 24H), 0.85 (s, 9H), 0.00 (s, 3H), -0.05 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 134.1, 131.3, 129.4, 124.5, 82.8, 82.7, 73.3, 39.7, 26.2, 26.0, 25.7, 
25.1, 25.0, 24.9, 24.8, 18.2, 17.7, 16.8, -3.9, -4.5. IR (ν/cm-1): 2927.41 (s), 2359.48 (m), 1716.34 
(m), 1557.24 (m), 1455.99 (m). HRMS (ESI+): calcd for C30H58B2O5SiNa+ 571.4137, found 




Following General Procedure II, the crude reaction mixture was purified via silica gel column 























visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 63% yield (24.8 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 3.33 (dd, J = 6.3, 
4.8 Hz, 1H), 1.92 (dt, J = 12.7, 1.9 Hz, 1H), 1.80 – 1.70 (m, 3H), 1.68 – 1.61 (m, 3H), 1.49 (d, J = 
4.9 Hz, 6H), 1.28 (s, 6H), 1.27 (s, 6H), 1.25 (s, 6H), 1.14 – 0.96 (m, 4H), 0.96 – 0.93 (m, 2H). 13C 
NMR (151 MHz, CDCl3) δ 83.5, 83.3, 79.8, 42.8, 30.0, 28.0, 26.6, 26.5, 26.3, 25.0, 24.9, 24.9, 
24.8, 24.78. IR (ν/cm-1): 3501 (s, br), 2978 (m), 2967 (s), 1445 (m), 1379 (s), 1344 (m), 1273 (w), 
1199 (w), 1161 (w). HRMS (ESI+): calcd for C21H40O5B2Na 417.2960, found [M+Na+] 417.2955. 
[α]D22 = – 18.5 (c = 5.82, CH2Cl2, l = 100 mm). 
 
Representative Example of tribenzoate: 
 
1-cyclohexylpropane-1,2,3-triyl tribenzoate (OBz-2.23). Following the General 
Oxidation/Benzoylation Procedure, the tribenzoate was purified via silica gel chromatography 
(10:1 to 5:1 pentane:Et2O, KMnO4 visualization) and isolated as a colorless oil in 90% yield (23.6 
mg) in 12:1 d.r. 1H NMR (400 MHz, CDCl3) δ 8.24 – 7.95 (m, 5H), 7.74 – 7.37 (m, 10H), 5.88 
(tq, J = 4.6, 2.1 Hz, 1H), 5.56 (t, J = 6.0 Hz, 1H), 4.89 (dt, J = 12.2, 2.3 Hz, 1H), 4.60 (dd, J = 
12.1, 7.4 Hz, 1H), 2.02 – 1.55 (m, 6H), 1.26 (dt, J = 36.5, 8.4 Hz, 5H). 13C NMR (151 MHz, 
CDCl3) δ 166.4, 165.8, 165.7, 162.4, 134.6, 133.3, 133.2, 133.2, 130.6, 129.8, 129.8, 129.7, 128.9, 
128.8, 128.6, 128.4, 128.4, 76.3, 71.0, 62.9, 39.0, 29.4, 28.2, 26.1, 25.9, 25.7. IR (ν/cm-1): 3350 
(m), 2895 (m), 2870 (m), 1650 (s), 1625 (s), 1546 (m), 1201 (m). HRMS (ESI+): calcd for 






Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 
Diacel CHIRALPAK IC Column; 98:2 hexanes:iPrOH; 1.0 mL/min; 210 nm 
Racemic Material 
Enantioenriched Material 




5-methyl-1,2-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-3-ol (2.43). Following 
General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (NaOAc deactivated silica gel, 5:1 to 2:1 pentane:Et2O, Seebach Stain 
visualization) to yield the 1-hydroxy-2,3-bisboronate ester as a colorless oil in 48% yield (17.7 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 3.70 (ddd, J = 8.9, 
4.8, 3.8 Hz, 1H), 1.82 (dqd, J = 9.0, 6.7, 5.0 Hz, 1H), 1.42 (ddd, J = 14.1, 9.3, 5.0 Hz, 1H), 1.37 – 
1.29 (m, 1H), 1.26 (s, 12H), 1.25 (s, 12H), 0.96 – 0.94 (m, 2H), 0.91 (dd, J = 10.7, 6.7 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 83.3, 83.1, 73.2, 46.2, 24.9, 24.8, 24.8, 24.7, 23.7, 22.0. IR (ν/cm-
1): 3605 (s, br), 3001 (m), 1515 (m), 1410 (s), 1279 (w), 1210 (w). HRMS (ESI+): calcd for 
C19H38O5B2Na+ 391.2803, found [M+Na+] 391.2798. [α]D22 = – 27.6 (c = 3.23, CH2Cl2, l = 100 
mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 













Racemic Material (anti + syn) 
 
Enantioenriched Material (anti + syn) 
Anti diastereomer: (2R,3S) enantiomer: 60.7 min; (2S,3R) enantiomer: 68.4 min: 78:22 e.r. 
Syn diastereomer: Major enantiomer: 65.1 min; Minor enantiomer: 73.3 min: 82:18 e.r. 
 
 
5-phenyl-1,2-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-ol (2.44). Following 










yield. Purification of compound 2.44 (deactivated silica gel, 5:1 pentane:Et2O) gave an inseparable 
mixture of product and ligand. Simple silyl-protection of the crude reaction mixture allowed for 
isolation of clean product (vide infra). Anti diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.32 – 
7.14 (m, 5H), 3.65 (dt, J = 8.8, 4.5 Hz, 1H), 2.86 (ddd, J = 13.6, 9.6, 5.5 Hz, 1H), 2.71 – 2.64 (m, 
1H), 1.81 (dtd, J = 9.8, 8.3, 7.7, 4.7 Hz, 2H), 1.42 – 1.36 (m, 1H), 1.26 (d, J = 0.7 Hz, 12H), 1.24 
(d, J = 2.1 Hz, 14H), 0.95 (dd, J = 7.1, 3.6 Hz, 2H). Syn diastereomer: 1H NMR (600 MHz, 
CDCl3) δ 7.32 – 7.14 (m, 5H), 3.71 (t, J = 6.5 Hz, 1H), 3.02 – 2.90 (m, 1H), 2.79 – 2.72 (m, 1H), 
1.97 – 1.87 (m, 2H), 1.41 – 1.36 (m, 1H), 1.28 (s, 24H), 1.03 (dd, J = 18.9, 7.5 Hz, 1H), 0.88 – 
0.83 (m, 1H). 13C NMR (151 MHz, CDCl3) δ 142.7, 128.5, 128.5, 128.44, 128.4, 128.3, 125.5, 
83.5, 83.4, 83.1, 75.1, 74.7, 38.5, 32.5, 30.3, 29.7, 25.0, 24.9, 24.8, 24.8, 24.8, 24.8, 24.7, 24.7. 
HRMS (ESI+): calcd for C23H38O5B2Na+ 439.2803, found [M+Na+] 439.2802. [α]D22 = –15.6 (c 
=5.66, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.19. 
Diacel CHIRALPAK IA Column; 98:2 hexanes:iPrOH; 1.0 mL/min; 210 nm 
Racemic Material (anti) 
	 215 
Enantioenriched Material (anti) 
Anti diastereomer: (2R,3S) enantiomer: 10.1 min; (2S,3R) enantiomer: 12.9 min: 90:10 e.r. 
 
Racemic Material (syn) 
Enantioenriched Material (syn) 




yl)pentan-3-yl)oxy)silane (TBS-2.44). Following General Procedure III, the crude reaction 
mixture was purified via silica gel chromatography (25:1 pentane:Et2O, Seebach Stain 
visualization) to yield the TBS-protected product in 52% yield (over two steps) in 2.7:1 d.r. (27.8 
mg). Anti diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.28 – 7.24 (m, 2H), 7.20 – 7.17 (m, 3H), 
3.80 – 3.75 (m, 1H), 2.77 (td, J = 12.7, 5.1 Hz, 1H), 2.64 – 2.58 (m, 1H), 1.89 – 1.82 (m, 1H), 1.83 
– 1.76 (m, 1H), 1.52-1.43 (m, 1H), 1.23 (s, 12H), 1.21 (s, 6H), 1.19 (s, 6H), 1.04 – 0.93 (m, 1H), 
0.92 (s, 9H), 0.78 (dd, J = 15.9, 11.4 Hz, 1H), 0.09 (s, 3H), 0.07 (s, 3H). 13C NMR (151 MHz, 
CDCl3) δ 143.6, 128.5, 128.2, 125.4, 82.9, 82.9, 74.7, 38.3, 33.1, 31.0, 26.1, 25.1, 25.0, 24.8, 24.8, 
18.3, -4.1, -4.2. Syn diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.28 – 7.24 (m, 2H), 7.17 – 
7.13 (m, 3H), 3.85 – 3.81 (m, 1H), 2.68 (ddd, J = 13.6, 10.7, 5.5 Hz, 1H), 2.60 – 2.56 (m, 1H), 
1.82 – 1.76 (m, 1H), 1.76 – 1.70 (m, 1H), 1.51-1.43 (m, 2H), 1.24 (s, 6H), 1.23 (s, 6H), 1.23 (s, 
6H), 1.21 (s, 6H), 1.02 – 0.91 (m, 1H), 0.89 (s, 9H), 0.87-0.83 (m, 1H), 0.05 (s, 3H), 0.04 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 143.1, 128.4, 128.2, 125.4, 82.8, 82.7, 75.3, 38.0, 33.1, 26.0, 25.1, 
25.0, 24.7, 24.6, 18.2, -4.3, -4.4. IR (ν/cm-1): 2977.55 (s), 2928.38 (m), 2856.06 (m), 1471.42 (s), 
1371.14 (s), 1315.21 (m), 1144.55 (m). HRMS (ESI+): calcd for C29H52B2O5SiNa+ 553.3668, 















n  General Procedure (IV) for the Synthesis of Intramolecular Alkenylboron Substrates 
 
Metathesis reactions for the 5 intramolecular substrates were performed based on a reported 
procedure.29 To an oven-dried flask equipped with a magnetic stir bar was added Grubb’s 1st 
generation catalyst (5 mol%). A reflux condenser was attached, and the system was evacuated and 
backfilled with N2. The catalyst was dissolved in 15 mL dry dichloromethane (DCM). A solution 
of olefin in 15 mL dry DCM was added, followed by vinyl boronic acid pinacol ester. The 
condenser was washed with dry DCM, and the reaction heated at reflux for 40 hours. The reaction 
was cooled to room temperature and concentrated by rotary evaporation. 
 
 
(E)-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)benzaldehyde (2.45). Following 
General Procedure IV using 2-allylbenzaldeyde (949 mg, 6.49 mmol) and vinyl boronic acid 
pinacol ester (1.10 mL, 6.49 mmol), the crude reaction mixture was purified via silica gel 
chromatography (85:15 hexanes:Et2O, KMnO4 visualization) to yield the desired alkenylboron 
product in 49% yield (860 mg). 1H NMR (600 MHz, CDCl3) δ 10.20 (s, 1H), 7.84 (dd, J = 7.7, 
1.2 Hz, 1H), 7.51 (ddd, J = 15.0, 7.6, 1.5 Hz, 1H), 7.38 (t, J = 7.5 Hz, 1H), 7.25 (d, J = 7.6 Hz, 
1H), 6.80 (dt, J = 17.9, 5.8 Hz, 1H), 5.35 – 5.28 (m, 1H), 3.91 (dd, J = 5.8, 1.6 Hz, 2H), 1.23 (s, 
12H). 13C NMR (151 MHz, CDCl3) δ 192.2, 151.6, 141.3, 134.0, 133.9, 131.6, 131.4, 127.1, 83.2, 





O Grubb’s 1st Gen. (5 mol%)
















Following General Procedure IV using 2’-allylacetophenone (467 mg, 2.914 mmol) and vinyl 
boronic acid pinacol ester (519 µL, 3.06 mmol), the crude reaction mixture was dissolved in 
dimethylsulfoxide (517 µL, 7.285 mmol, 50 equiv relative to Grubb’s catalyst) and 2.5 mL DCM 
and stirred 18 h at room temperature to help complex ruthenium impurities. The DCM was 
removed by rotary evaporation, and the DMSO removed by extraction with water and diethyl 
ether. The aqueous layer was extracted 3xEt2O, and the combined organic layers were dried over 
MgSO4. The solvent was removed by rotary evaporation and the dark residue subjected to silica 
gel flash chromatography (90:10 hexanes:Et2O, KMnO4 visualization) to yield the desired 
alkenylboron product in 35% yield (293 mg). 1H NMR (600 MHz, CDCl3) δ 7.65 (d, J = 7.7 Hz, 
1H), 7.40 (t, J = 7.6 Hz, 1H), 7.28 (t, J = 7.6 Hz, 1H), 7.24 (d, J = 7.7 Hz, 1H), 6.77 (dt, J = 17.9, 
6.0 Hz, 1H), 5.33 (d, J = 17.9 Hz, 1H), 3.77 (d, J = 5.9 Hz, 2H), 2.56 (s, 3H), 1.23 (s, 12H). 13C 
NMR (151 MHz, CDCl3) δ 201.9, 152.5, 138.8, 138.0, 131.8, 131.6, 129.2, 126.3, 83.1, 65.9, 39.8, 
29.8, 29.7, 24.8, 15.3. IR (ν/cm-1): 2978.52 (s), 2929.34 (m), 2362.37 (m), 1716.34 (s), 1684.52 











(S-2.49). Following General Procedure IV using 1-(2-allyl-4-fluorophenyl)ethan-1-one (325 mg, 
1.824 mmol) and vinyl boronic acid pinacol ester (340 µL, 2.01 mmol), the crude reaction mixture 
was dissolved in 324 µL DMSO and diluted with 2 mL DCM . This mixture was stirred for 2 days 
to complex Ru compounds. The DCM was removed by rotary evaporation, and the DMSO was 
removed by extraction (H2O and diethyl ether). The combined organic layers were dried with 
MgSO4, filtered and concentrated by rotary evaporation. The solvent was removed by rotary 
evaporation and the dark residue subjected to silica gel flash chromatography (90:10 hexanes:Et2O 
to 100% Et2O, KMnO4 visualization) to yield 226 mg of a viscous oil. 1H NMR determined the oil 
to be a 9:1 ratio of (E)-1-(4-fluoro-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)allyl)phenyl)ethan-1-one to the homodimer of vinyl boronic acid pinacol ester [(E)-1,2-
Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethene].36 1H NMR (600 MHz, CDCl3) δ 7.71 
(dd, J = 8.4, 5.9 Hz, 1H), 6.99 – 6.92 (m, 2H), 6.73 (dt, J = 17.9, 6.0 Hz, 1H), 5.35 (dd, J = 17.9, 
1.3 Hz, 1H), 3.79 (d, J = 6.0 Hz, 2H), 2.55 (s, 3H), 1.24 (s, 12H). 13C NMR (151 MHz, CDCl3) δ 
200.0, 164.2 (d, J = 253.4 Hz), 151.4, 143.0 (d, J = 8.2 Hz), 133.8 (d, J = 3.0 Hz), 132.0 (d, J = 
9.25 Hz), 118.6 (d, J = 21.31 Hz), 113.1 (d, J = 21.41 Hz), 83.2, 39.9, 29.6, 24.8. IR (ν/cm-1): 
2978.52 (s), 2930.31 (m), 1685.48 (s), 1635.34 (m), 1606.41 (m), 1583.27 (m), 1369.50 (m). 










(E)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hex-5-en-2-one (S-2.50). Following 
General Procedure IV using 5-hexene-2-one (1.18 mL, 10.19 mmol) and vinyl boronic acid pinacol 
ester (1.81 mL, 10.69 mmol), the crude reaction mixture was purified via silica gel 
chromatography (90:10 hexanes:Et2O, KMnO4 visualization) to yield the desired alkenylboron 
product in 44% yield (1.0 g). 1H NMR (600 MHz, CDCl3) δ 6.60 (dt, J = 18.0, 6.1 Hz, 1H), 5.43 
(d, J = 18.0 Hz, 1H), 2.56 (t, J = 7.4 Hz, 2H), 2.42 (q, J = 7.2 Hz, 2H), 2.15 (s, 3H), 1.25 (s, 12H). 
13C NMR (151 MHz, CDCl3) δ 207.9, 152.1, 83.2, 41.9, 30.0, 29.4, 24.8. IR (ν/cm-1): 2978.52 (s), 
2930.31 (m), 2360.44 (m), 2341.16 (m), 1717.30 (s), 1639.20 (m), 1363.43, (m), 1322.93 (m). 




(S-2.51). Following General Procedure IV using tert-butyl allyl(2-oxopropyl)carbamate (421 mg, 
2.0 mmol) and vinyl boronic acid pinacol ester (351 µL, 2.1 mmol) the crude reaction mixture was 
purified via silica gel chromatography (10:1 to 5:1 hexanes:Et2O, KMnO4 visualization) to yield 
the desired alkenylboron product in 28% yield (201.2 mg). NOTE: Purified material contained an 
inseparable amount of (E)-1,2-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethene (8%).8 1H 
NMR (600 MHz, CDCl3) δ 6.48 (ddt, J = 22.9, 18.0, 4.9 Hz, 1H), 5.49 (dd, J = 17.8, 16.5 Hz, 1H), 














3H), 1.45 – 1.40 (m, 9H), 1.27 (s, 6H), 1.26 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 204.5, 155.6, 
155.0, 148.0, 83.4, 83.4, 80.5, 65.9, 56.5, 55.9, 51.8, 51.4, 30.3, 28.3, 28.2, 27.0, 26.8, 24.9, 24.8, 
15.3. IR (ν/cm-1): 2978.52 (s), 2931.27 (m), 2360.44 (m), 2341.16 (m), 1736.58 (s), 1698.02 (s), 
1643.05 (m), 1366.32 (m), 1331.61 (m), 1162.87 (m). HRMS (ESI+): calcd for C17H30BNO5Na+ 




(2.46). In an N2-filled glovebox, an 8-mL vial equipped with a magnetic stir bar was charged with 
CuOtBu (1.4 mg, 0.010 mmol, 10 mol%) and (R)-Cl-OMe-biphep (7.8 mg, 0.012 mmol, 12 mol%), 
followed by 400 µL toluene. The reaction was capped with a Teflon-lined septum cap and allowed 
to stir at ambient temperature for 30 minutes, after which time a solution of B2(pin)2 (27.9 mg, 
0.11 mmol, 1.1 equiv) in 200 µL toluene was added. After stirring for 10 minutes, the vial was 
sealed with electrical tape and removed from the glovebox. In a separate 8 mL vial, a solution of 
2.45 (32.6 mg, 0.12 mmol) in 240 µL toluene was prepared in the glovebox. This solution was 
sealed with electrical tape and a Teflon-lined septum cap and removed from the glovebox. Both 
vials were then cooled to 4 °C in a cryobath, and a 200 µL aliquot of the substrate solution was 
added to the reaction vial. The reaction was allowed to stir at 4 °C for 48 hours. The reaction was 
quenched with 2 mL of saturated aqueous NH4Cl at 4 °C, and allowed to stir vigorously at 22 °C 










organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. The crude reaction 
mixture was purified via silica gel column chromatography to yield 1-hydroxy-2,3-bisboronate 
2.46 as a colorless oil in 49% yield (19.6 mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR 
(600 MHz, CDCl3) δ 7.44 – 7.39 (m, 1H), 7.16 – 7.10 (m, 2H), 7.10 – 7.06 (m, 1H), 4.98 (d, J = 
6.0 Hz, 1H), 2.96 – 2.87 (m, 2H), 2.43 (s, 1H), 1.85 (td, J = 7.0, 3.5 Hz, 1H), 1.70 (dd, J = 6.0, 3.4 
Hz, 1H), 1.20 (s, 6H), 1.18 (s, 6H), 1.17 (s, 6H), 1.14 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 
138.5, 137.6, 128.9, 128.8, 127.1, 125.7, 83.4, 83.2, 69.2, 30.1, 24.9, 24.7, 24.7, 24.7. IR (υ/cm-
1): 3430.74 (br), 2977.55 (s), 2930.31 (m), 1643.05 (m), 1379.82 (m), 1313.29 (m), 1143.58 (m). 
HRMS (ESI+): calcd for C44H68O10B4Na+ 823.5082, found [2M+Na+] 823.5097. [α]D22 = + 6.1 (c 
= 0.39, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Relative stereochemistry was established via oxidation of 2.46 to the corresponding triol 
(see Supplementary Procedure B) and comparison to literature spectra.37 Absolute stereochemistry 
was assigned by independent analysis of Cu-B(pin) insertion component through copper-catalyzed 
enantioselective hydroboration.38 
 
In an N2-filled glovebox, an 8-mL vial equipped with a magnetic stir bar was charged with CuOt-
Bu (1.4 mg, 0.010 mmol) and (R)-BINAP (7.5 mg, 0.012 mmol), followed by 400 µL 1,4-dioxane. 
The reaction was capped with a Teflon-lined septum cap and allowed to stir at ambient temperature 
for 30 minutes, after which time a solution of B2(pin)2 (27.9 mg, 0.11 mmol) in 200 µL dioxane 
was added. After stirring for 10 minutes, a solution of (E)-4,4,5,5-tetramethyl-2-(3-phenylprop-1-
















sealed with electrical tape and removed from the glovebox. Dry, freshly-sparged methanol (40.5 
µL, 1.0 mmol) was then added by syringe. The reaction was allowed to stir 18 hours at 22 °C. The 
reaction was quenched with 2 mL of saturated aqueous NH4Cl and allowed to stir vigorously at 22 
°C for 30 minutes. The aqueous layer was extracted three times with diethyl ether, and the 
combined organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. 
The oxidation was performed according to Supplementary Procedure B. Silica gel flash 
chromatography (1:1 hexanes:EtOAc → 100% EtOAc; Rf=0.35 in 100% EtOAc) afforded 9.8 mg 
(0.064 mmol, 64%) of (R)-3-phenylpropane-1,2-diol.  
1H NMR (400 MHz, CDCl3): δ 7.33-7.29 (2H, m); 7.23-7.21 (3H, m); 3.94 (1H, m); 3.67 (1H, d); 
3.50 (1H, m); 2.76 (2H, m); 2.42 (2H, m). 1H NMR in accordance with literature values.38 
HPLC Traces: 3-phenylpropane-1,2-diol 




Minor enantiomer: 10.4 min; Major enantiomer: 11.4 min: 94.5:5.5 e.r. 
Literature value of [α]D22 + 33.2 (c = 1.00, EtOH), 97.5:2.5 e.r is assigned to the (R) enantiomer.39 








Anti-,Syn diastereomer: (1S,2R,3R) enantiomer: 10.8 min; (1R,2S,3S) enantiomer: 12.9 min: 99:1 
e.r. 
 
n  General Procedure (V) for the Enantio- and Diastereoselective Intramolecular 
Borylation/1,2-Addition to Ketones 
 
In an N2-filled glovebox, an 8-mL vial equipped with a magnetic stir bar was charged with CuOtBu 
(1.4 mg, 0.010 mmol, 10 mol%) and (R)-BINAP (7.5 mg, 0.012 mmol, 12 mol%), followed by 
400 µL 1,4-dioxane. The reaction was capped with a Teflon-lined septum cap and allowed to stir 
at ambient temperature for 30 minutes, after which time a solution of B2(pin)2 (27.9 mg, 0.11 
mmol, 1.1 equiv) in 200 µL dioxane was added. After stirring for 10 minutes, a solution of ketone 
substrate (0.10 mmol, 1.0 equiv) in 200 µL dioxane was added. The vial was sealed with electrical 


















was then added by syringe. The reaction was allowed to stir 18 hours at 22 °C. The reaction was 
quenched with 2 mL of saturated aqueous NH4Cl and allowed to stir vigorously at 22 °C for 30 
minutes. The aqueous layer was extracted three times with diethyl ether, and the combined organic 
extracts were dried over MgSO4, filtered, and concentrated in vacuo. 
 
n  Supplementary Procedure B: NaOH/H2O2 Oxidation of Hydroxy(bis)boronate Products 
 
In an 8 mL vial, the crude bisboronate was dissolved in 500 µL THF and cooled to 0 °C. A 0 °C 
solution of 2M NaOH (300 µL, 0.6 mmol, 6 equiv) was added dropwise over 30 seconds. 
Immediately after, a 0 °C solution of 30% (w/w) H2O2 (204 µL, 2.0 mmol, 20 equiv) was added 
dropwise over 30 seconds. The reaction was allowed to stir open to the atmosphere for 1 hour at 0 
°C after which point the reaction was allowed to stir for 4 hours at 22 °C. 500 µL of a saturated 
aqueous solution of NH4Cl was added, followed by Na2SO3, and solid NaCl. 2 mL EtOAc was 
then added, and the aqueous layer was extracted three times with EtOAc. The combined organic 
extracts were dried over MgSO4, filtered, and concentrated in vacuo. 
 
 
1-methyl-1,2,3,4-tetrahydronaphthalene-1,2,3-triol (OH-2.48). Following General Procedure 
V and Supplementary Procedure B, the crude reaction mixture was purified via silica gel column 
NaOH(aq) (2M), H2O2 (30%)















chromatography to yield 1,2,3-triol OH-2.48 as a colorless oil in 95% yield over two steps (18.4 
mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 7.52 (d, J = 7.5 Hz, 
1H), 7.20 (t, J = 7.1 Hz, 1H), 7.15 (t, J = 7.1 Hz, 1H), 6.98 (d, J = 7.2 Hz, 1H), 4.52 (s, 1H), 4.08 
(s, 1H), 3.91 (dd, J = 15.5, 8.3 Hz, 1H), 3.80 (d, J = 10.1 Hz, 1H), 3.67 (s, 1H), 3.12 (dd, J = 16.3, 
5.5 Hz, 1H), 2.74 (dd, J = 15.8, 10.6 Hz, 1H), 1.34 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 141.8, 
131.4, 128.4, 127.7, 126.8, 126.1, 80.0, 75.5, 68.4, 36.8, 25.7. IR (υ/cm-1): 3361.32 (br), 2926.45 
(s), 2360.44 (m), 2342.12 (m), 1443.46 (m), 1369.21, (m), 1102.12 (m). HRMS (ESI+): calcd for 
C11H14O3Na+ 217.0841, found [M+Na+] 217.0836. [α]D22 = —51.4 (c = 0.66, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Relative stereochemistry was determined through selective 1D 1H NMR experiments. 
 
HA and HB assignments were made by gCOSY analysis (vide infra). The doublet of doublets at 
2.74 ppm consists of 15.8 Hz and 10.6 Hz coupling constants, consistent with an anti relationship 
with HB. The doublet of doublet at 3.12 ppm has coupling constants of 16.5 Hz and 5.5 Hz, 
consistent with a gauche relationship with HB. The coupling constants confirm the assignments of 
which proton is axial and which is equatorial. 
 
 Absolute stereochemistry was inferred from the stereochemistry obtained for compound 2.46. 
Diacel CHIRALPAK IC Column; 90:10 hexanes:iPrOH; 1.0 mL/min; 210 nm 








6-fluoro-1-methyl-1,2,3,4-tetrahydronaphthalene-1,2,3-triol (OH-2.49). Following General 
Procedure V and Supplementary Procedure B, the crude reaction mixture was purified via silica 







steps (16.2 mg) and a >20:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CD3CN) δ 7.53 
(dd, J = 8.7, 6.0 Hz, 1H), 6.95 (td, J = 8.7, 2.5 Hz, 1H), 6.81 (dd, J = 9.9, 2.4 Hz, 1H), 3.84 (qd, J 
= 9.3, 2.9 Hz, 1H), 3.60 – 3.56 (m, 1H), 3.55 (s, 1H), 3.41 (s, 1H), 3.40 (s, 1H), 3.15 (dd, J = 16.8, 
6.2 Hz, 1H), 2.72 (dd, J = 16.8, 9.5 Hz, 1H), 1.29 (s, 3H). 13C NMR (151 MHz, CD3CN) δ 161.7 
(d, J = 242.8 Hz), 139.2 (d, J = 2.8 Hz), 134.8 (d, J = 7.8 Hz), 128.6 (d, J = 8.5 Hz), 114.0 (d, J = 
21.0 Hz), 113.3 (d, J = 21.5 Hz), 79.0, 73.9, 67.9, 36.4, 36.4, 25.4. IR (υ/cm-1): 3358.43 (br), 
2981.41 (m), 2933.20 (m), 1615.09 (m), 1497.45 (m), 1240.97 (m). HRMS (ESI+): calcd for 
C11H13O3FNa+ 235.0746, found [M+Na+] 235.0742. [α]D22 = —65.8 (c = 0.38, CH2Cl2, l = 100 
mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Relative stereochemistry was inferred from the stereochemistry obtained for compound 
OH-2.48. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.46. 









Following General Procedure V, the crude reaction mixture was purified via silica gel column 
chromatography to yield 1-hydroxy-2,3-bisboronate 2.50 as a colorless oil in 59% yield (20.6 mg) 
and a 5:1 anti:syn diastereomeric ratio. 1H NMR (600 MHz, CDCl3) δ 1.83 – 1.75 (m, 1H), 1.74 
– 1.67 (m, 3H), 1.47 – 1.38 (m, 2H), 1.28 (s, 3H), 1.22 (s, 6H), 1.21 (s, 12H), 1.20 (s, 6H). 13C 
NMR (151 MHz, CDCl3) δ 83.1, 83.1, 82.2, 42.4, 26.1, 25.4, 25.0, 24.7, 24.7. IR (υ/cm-1): 3463.53 
(br), 2977.55 (s), 2932.33 (m), 2870.52 (m), 1371.44 (m), 1314.25 (s), 1142.62 (m). HRMS 
(ESI+): calcd for C36H68O10B4Na+ 727.5082, found [2M+Na+] 727.5073. [α]D22 = —4.1 (c = 0.71, 











Enantiomeric excess was determined through silylation of the hydroxyl(bis)boronate product with 
benzylchlorodimethylsilane (vide infra), followed by oxidation to provide the mono-protected 
triol. This compound was analyzed by SFC and compared to the authentic racemic material. 
Relative stereochemistry was established through oxidation of the crude hydroxy(bis)boronate to 
the corresponding triol (see Supplementary Procedure B) and comparison to known literature 
spectra.40 










yl)piperidine-1-carboxylate (2.51). Following General Procedure V, the crude reaction mixture 
was purified via silica gel column chromatography to yield 1-hydroxy-2,3-bisboronate 2.51 as a 
colorless oil in 58% yield (27.1 mg) and a >20:1 anti:syn diastereomeric ratio. At room 
temperature, the product exists as a 1.3:1 mixture of chair conformations, which were resolved 
through variable temperature 1H NMR experiments (vide infra). Peaks corresponding to the minor 
conformation are starred. 1H NMR (600 MHz, CDCl3) δ 4.01 (dd, J = 62.8, 18.1 Hz, 2H), *3.86 
(s, J = 9.7 Hz, 2H), *3.37 (d, J = 8.0 Hz, 2H), 3.32 (dd, J = 14.2, 9.3 Hz, 1H), 3.24 (dd, J = 14.1, 
6.7 Hz, 1H), 2.10 (s, 3H), *2.09 (s, 3H), 1.45 (s, 9H), *1.38 (s, 9H), 1.22 (s, 24H), *1.22 (s, 12H), 
*1.21 (s, 12H), 0.90 – 0.75 (m, 2H). 13C NMR (151 MHz, CDCl3) δ 205.6, 205.2, 156.3, 155.3, 
83.2, 83.14, 83.0, 83.0, 80.0, 79.8, 65.9, 57.2, 56.8, 51.3, 50.9, 28.4, 28.3, 27.0, 26.7, 24.9, 24.9, 
24.8, 15.3. IR (υ/cm-1): 3552.24 (br), 2977.55 (m), 2930.31 (m), 2360.44 (m), 2342.12 (m), 
1736.58 (s), 1697.05 (m), 1369.21 (m), 1146.47 (m). HRMS (ESI+): calcd for C23H43O7B2NNa+ 
490.3123, found [M+Na+] 490.3118. [α]D22 = —3.7 (c = 0.73, CH2Cl2, l = 100 mm). 
Enantiomeric excess was determined by HPLC analysis compared to the authentic racemic 
material. Relative stereochemistry was inferred from the stereochemistry obtained for compound 
2.50. Absolute stereochemistry was inferred from the stereochemistry obtained for compound 
2.46. 

















E-5,9-dimethyldeca-4,8-diene-1,2,3-triol (2.52). A vial containing 2.22 (17.3 mg, 0.0398 mmol) 
was charged with THF (159 µL) and allowed to cool to 0 °C (ice/water bath). The reaction was 








The reaction was allowed to slowly warm up to ambient temperature over 2 hours, followed by 4 
hours of additional stirring at that temperature. The reaction was allowed to cool to 0 °C and 
quenched by dropwise addition of 1M Na2S2O3. The reaction was diluted with water and then 
extracted 6X with EtOAc. The combined organic extracts were dried over Na2SO4, filtered, and 
then dried in vacuo. The crude reaction mixture was purified via silica gel chromatography (1:1 
EtOAc:hexanes to pure EtOAc) to yield the triol in 93% yield (7.9 mg) as a colorless oil. 1H NMR 
(600 MHz, CDCl3) δ 5.22 (dq, J = 9.0, 1.3 Hz, 1H), 5.08 (tq, J = 5.5, 1.4 Hz, 1H), 4.42 – 4.36 (m, 
1H), 3.76 – 3.68 (m, 1H), 3.60 – 3.53 (m, 2H), 3.13 (s, 1H), 2.33 (s, 2H), 2.12 (q, J = 7.4 Hz, 2H), 
2.09 – 2.03 (m, 2H), 1.73 (d, J = 1.4 Hz, 3H), 1.70 (d, J = 1.4 Hz, 3H),, 1.62 (d, J = 1.3 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 142.1, 132.0, 123.7, 123.1, 75.0, 69.5, 65.9, 39.7, 26.3, 25.7, 24.9, 
17.7, 16.9. IR (ν/cm-1): 3745 (s), 2968 (m), 2888 (m), 1314 (w), 1225 (m). HRMS (ESI+): calcd 





4-en-1-yl)oxy)silane (2.54). Following a modified literature procedure41, TBS-2.19 (20.0 mg, 
0.0398 mmol) was charged with a THF solution (362 µL) of Pd(OAc)2 (0.4 mg, 0.00199 mmol) 
and RuPhos (0.9 mg, 0.00119 mmol) that was allowed to stir at ambient temperature for 10 minutes 












of KOH (6.7 mg, 0.12 mmol) in H2O (35.8 µL) that had been sparged with N2 for 2.5 hours. The 
reaction was sealed and allowed to stir at 70 °C for 12 hours. The reaction was allowed to cool to 
ambient temperature, then quenched by addition of methylene chloride and water. The layers were 
separated and the aqueous layer was extracted 3X with methylene chloride. The combined organic 
layers were dried over Na2SO4, filtered, and concentrated in vacuo. The crude reaction was purified 
via silica gel chromatography (25:1 pentane:Et2O, Seebach Stain visualization) to afford the 
product in 51% yield (8.8 mg) as a single diastereomer. 1H NMR (600 MHz, CDCl3) δ 7.34 – 7.26 
(m, 4H), 7.25 – 7.17 (m, 1H), 5.05 (ddq, J = 7.6, 6.1, 1.4 Hz, 1H), 4.71 (d, J = 8.2 Hz, 1H), 1.99 
(ddd, J = 14.1, 10.8, 8.2 Hz, 1H), 1.78 – 1.70 (m, 1H), 1.63 (d, J = 1.5 Hz, 3H), 1.50 (s, 4H), 1.25 
(s, 6H), 1.25 (s, 6H), 0.87 (s, 9H), 0.02 (s, 3H), -0.34 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 
145.4, 131.4, 127.7, 126.9, 126.8, 123.9, 83.0, 26.9, 25.9, 25.7, 25.3, 25.0, 18.1, 17.8, -4.3, -4.7. 
IR (ν/cm-1): 2935 (m), 2921 (s), 2838 (m), 1328 (m), 1427 (w), 1338 (m), 1376 (m). HRMS (ESI+): 
calcd for C25H43O3BSiNa+ 453.2972, found: [M+Na+] 453.2968. [α]D22 =  – 22.8 (c = 4.12, CH2Cl2, 




TBS-protected alcohol 2.55 was prepared following a modified literature procedure.42 A 
flame--dried 8-mL vial was charged with furan (6.2 µL, 0.0859 mmol) and anhydrous THF (0.290 











butyllithium (54.7 µL, 0.0859 mmol, 1.57 M solution in hexanes). The cooling bath was removed 
and the reaction was allowed to stir at ambient temperature for 1 hour. The mixture was allowed 
to cool back down to -78 ˚C (dry ice/acetone) and then charged with 2.54 (3.7:1 d.r.) as a 0.4 M 
solution in THF (30.8 mg, 0.0715 mmol) and allowed to stir at that temperature for 1.5 hour. NBS 
(15.3 mg, 0.0859 mmol) was then added to the reaction as a 0.3 M solution in THF. After allowing 
the reaction to stir for 1.5 hours, 1 mL of a saturated aqueous solution of Na2S2O3 was added to 
the reaction and allowed to stir at ambient temperature for 30 minutes. The layers were separated 
and extracted three times with diethyl ether. The combined organic extracts were dried over 
MgSO4, filtered, and concentrated in vacuo. The crude reaction mixture was purified by silica gel 
chromatography (pure hexanes to 50:1 hexanes:Et2O, KMnO4 stain visualization) to give the 
product 2.55 as a colorless oil in 52% yield (13.9 mg) and 3.8:1 anti:syn diastereomeric ratio. Anti 
diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.34 – 7.32 (m, 1H), 7.28 – 7.25 (m, 2H), 7.22 – 
7.17 (m, 1H), 7.17 – 7.13 (m, 2H), 6.29 (dd, J = 3.1, 1.8 Hz, 1H), 5.99 (d, J = 3.1 Hz, 1H), 4.95 
(ddd, J = 7.0, 5.7, 1.3 Hz, 1H), 4.83 (d, J = 6.6 Hz, 1H), 2.98 (ddd, J = 10.9, 6.6, 4.7 Hz, 1H), 2.21 
– 2.07 (m, 2H), 1.59 (s, 3H), 1.45 (s, 3H), 0.81 (s, 9H), -0.08 (s, 3H), -0.24 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 155.8, 143.2, 140.5, 132.5, 127.7, 126.8, 122.1, 110.1, 107.2, 48.8, 27.9, 25.7, 
18.1, 17.6, -4.9, -5.4. Syn diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.25 – 7.22 (m, 6H), 6.20 
(dd, J = 3.1, 1.8 Hz, 1H), 5.82 (d, J = 3.1 Hz, 1H), 4.98 (dd, J = 11.5, 4.2 Hz, 1H), 4.88 (d, J = 6.2 
Hz, 1H), 2.92 – 2.87 (m, 1H), 2.61 – 2.54 (m, 1H), 2.41 – 2.33 (m, 1H), 1.60 (s, 3H), 1.51 (s, 3H), 
0.90 (s, 9H), -0.08 (s, 3H), -0.25 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 155.6, 143.8, 140.6, 
132.4, 127.6, 127.1, 126.8, 126.3, 110.0, 107.0, 65.9, 49.3, 26.7, 25.8, 25.7, 18.2, 15.3, -4.8, -5.4. 
IR (ν/cm-1): 2956.34 (s), 2927.41 (m), 2856.06 (m), 1250.61 (m), 1090.55 (m). HRMS (ESI+): 
	 237 
calcd for C23H34O2SiNa+ 393.2231, found: [M+Na+] 393.2226. [α]D22 = + 7.0 (c = 0.70, CH2Cl2, l 




yl)carbamate (2.56). Carbamate 2.56 was prepared from compound 2.54 according to literature 
procedure.33 A flame-dried 8-mL vial equipped with a magnetic stir bar was flushed with N2 and 
charged with 2.54 (21.6 mg, 0.0502 mmol) and 414 µL of anhydrous THF. A 0.837 M solution of 
O-methylhydroxylamine (180 µL, 0.151 mmol) was added to a separate N2-flushed, flame-dried 
8-mL vial and then diluted with 328 µL of anhydrous THF. Both vials were cooled to -78 °C in a 
dry ice/acetone bath. A 1.69 M solution of n-butyllithium in hexanes (89 µL, 0.151 mmol) was 
added dropwise to the O-methylhydroxylamine solution and this was allowed to stir at -78 °C for 
30 minutes. After this time, the in situ generated solution of lithium O-methylhydroxylamide was 
cannula transferred to the cooled solution of 2.54. The resulting solution was allowed to warm to 
room temperature and was then heated to 60 °C with stirring for 20 h. After this time, the solution 
was allowed to cool to 22 °C and di-tert-butyl dicarbonate (36.8 µL, 0.161 mmol) was added via 
syringe. The solution was allowed to stir for 2 hours at 22 °C. The reaction was quenched with 3 
mL of deionized water, and the aqueous layer was extracted four times with ethyl acetate. The 
combined organic layers were then dried over Na2SO4, filtered, and concentrated in vacuo. The 
crude residue was purified by silica gel column chromatography (10:1 pentane:diethyl ether), 











(6.3 mg). 1H NMR (3:1 mixture of rotamers, asterisks denote minor rotamer peaks, 600 MHz, 
CDCl3) δ 7.31 – 7.27 (m, 3H), 7.24 – 7.20 (m, 2H), 5.13 (tt, J = 7.1, 1.4 Hz, 1H), 4.74 (d, J = 3.2 
Hz, 1H), *4.69 (bs, 1H), 4.57 (d, J = 9.5 Hz, 1H), *4.42 (d, J = 9.8 Hz, 1H), 3.68 (d, J = 8.2 Hz, 
1H), *3.55 (bs, 1H), 2.31-2.27 (m, 1H), 2.14 – 1.97 (m, 1H), 1.70 (s, 3H), 1.59 (s, 3H), 1.35 (bs, 
9H), 0.91 (s, 9H), 0.05 (s, 3H), -0.17 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 155.5, 142.1, 133.9, 
127.8, 127.2, 126.5, 120.5, 57.1, 30.3, 28.4, 28.1, 27.4, 25.9, 25.8, 18.2, 18.1, 14.1, -4.5, -5.1. IR 
(ν/cm-1): 2929 (s), 2857 (m), 1716 (s), 1496 (m), 1456 (m), 1364 (m), 1253 (m). HRMS (ESI+): 
calcd for C48H82N2O6Si2Na+ 861.5610, found: [2M+Na+] 861.5601. [α]D22 = + 13.9 (c = 0.09, 




yl)cyclopentyl)oxy)silane (2.58). A crude reaction mixture of 1-hydroxy-2,3-bisboronate 2.50 
(0.2 mmol scale) was charged with imidazole (54.5 mg, 0.8 mmol) and a magnetic stir bar and 
dried under vacuum for 20 minutes. Anhydrous DMF (1.3 mL) was then added via syringe under 
N2, followed by benzylchlorodimethylsilane (109 µL, 0.6 mmol). The reaction was allowed to stir 
at ambient temperature for 18 hours. The reaction was quenched by addition of 1 mL of a saturated 
aqueous solution of NH4Cl. The mixture was extracted 3X with diethyl ether and the combined 
organic extracts were washed with a saturated aqueous solution of NaHCO3, followed by brine. 














crude reaction mixture was purified via silica gel chromatography (20:1 hexanes:Et2O, Seebach 
Stain visualization) to yield the silyl-proteced 1-hydroxy-2,3-bisboronate 2.58 as a colorless oil in 
43% yield (43.0 mg, over two steps) and in 4.8:1 d.r. Anti-, Anti diastereomer: 1H NMR (600 
MHz, CDCl3) δ 7.19 (dd, J = 10.5, 4.7 Hz, 2H), 7.08 (d, J = 7.3 Hz, 2H), 7.05 (t, J = 7.2 Hz, 1H), 
2.16 (s, 2H), 1.76 – 1.65 (m, 2H), 1.61 – 1.55 (m, 1H), 1.52 (d, J = 12.6 Hz, 1H), 1.39 – 1.32 (m, 
2H), 1.27 (s, 3H), 1.25 (s, 6H), 1.24 (s, 6H), 1.22 (s, 6H), 1.22 (s, 6H), 0.07 (s, 3H), 0.06 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 140.2, 128.5, 128.0, 123.8, 85.1, 82.8, 82.8, 44.1, 28.8, 27.2, 25.8, 
25.0, 24.8, 24.8, 0.4, 0.4. IR (ν/cm-1): 2976.59 (s), 2932.23 (m), 2360.44 (m), 2341.16 (m), 
1600.63 (s), 1371.14 (m), 1316.18 (m), 1144.55 (m). HRMS (ESI+): calcd for C27H46O5B2SiNa+ 




yl)methyl)cyclopentyl)oxy)silane (2.59). Bis-homologated 1-hydroxy-2,3-bisboronate 2.59 was 
prepared according to a modified literature procedure.43 Protected hydroxybisboronate 2.58 (35.6 
mg, 0.0711 mmol) was added to an oven-dried 8 mL vial containing a stir bar. The vial was purged 
with nitrogen for 3 minutes. A solution of dibromomethane in THF was made (0.178 mmol, 
0.25M) and an aliquot (0.711 mL) was added to the vial via syringe. The vial was cooled to -78 
°C (dry ice/acetone bath). A solution of n-BuLi (0.100 mL, 0.157 mmol, 1.57M) in hexanes was 














allowed to warm to room temperature and stirred for an additional two hours. The reaction was 
quenched with a saturated solution of ammonium chloride (1.5 mL), extracted with diethyl ether 
(3x), dried over MgSO4 and concentrated. The crude material was purified via silica gel 
chromatography (20:1 to 10:1 hexanes:Et2O, Seebach’s stain visualization) to yield the desired 
bis-homologated product 2.59 in 78% yield (29.3 mg) as a viscous, colorless oil. 1H NMR (600 
MHz, CDCl3) δ 7.19 (t, J = 7.7 Hz, 2H), 7.05 (d, J = 7.1 Hz, 3H), 2.13 (d, J = 2.7 Hz, 2H), 1.79 – 
1.72 (m, 2H), 1.71 – 1.67 (m, 2H), 1.57 – 1.49 (m, 2H), 1.25 (s, 12H), 1.23 (s, 6H), 1.22 (s, 6H), 
1.10 (dd, J = 15.6, 3.7 Hz, 1H), 1.06 (s, 3H), 0.88 – 0.83 (m, 1H), 0.69 (dd, J = 15.4, 11.0 Hz, 1H), 
0.57 (dd, J = 15.4, 8.6 Hz, 1H), 0.06 (s, 3H), 0.05 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 140.1, 
128.5, 128.0, 123.8, 83.6, 82.9, 82.8, 54.8, 40.3, 39.9, 29.8, 28.8, 25.1, 25.0, 24.9, 24.7, 24.2, 0.6, 
0.5. IR (ν/cm-1): 2976.34 (m), 2929.34 (m), 1371.14 (m), 1316.18 (m), 1145.51 (m). HRMS 
(ESI+): calcd for C29H52O5B2SiNa+ 551.3511, found: [M+Na+] 551.3518.  [α]D22 = – 3.0 (c = 0.44, 





























































































































































































































































































































































































































































































































































































































































































































































































































































































JMZ I pg 249 triol column DMSO mar 9.001.esp




























































JMZ I pg 249 triol column DMSO mar 9 13C.001.esp










































characterization sample F CD3CN nOe methyl irradiated.003.esp
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Chapter 3: Regio- and Stereoselective Nucleophilic Allylation of Aldimines Utilizing Highly 
Substituted Allylic gem-Diboronate Esters 
 
3.1 Introduction 
Due to their abundance in bioactive natural products and pharmaceuticals, as well as their 
ability to function as versatile synthetic intermediates en route to a variety of complex molecules, 
chiral homoallylic amines constitute a privileged functional group in organic synthesis.1–5 The 
enantioselective allylation of prochiral imines represents a direct route to the generation of these 
useful functional handles (Figure 3.1).6–8 Simple allyl fragment addition to imines has been 
reported numerous times, with many methods relying on enantioenriched allylation reagents or 
metal catalysts as chiral non-racemic allyl nucleophiles. Employment of allylation reagents 
bearing functionality at the terminus of the olefin results in the generation of secondary 
homoallylic amines vicinal to an additional stereocenter. Despite the clear advantages of this 
strategy from a retrosynthetic sense, few methods have achieved this type of reactivity selectively. 
 


































Research in the Meek lab focuses on the design of new chemical methods that use a-boryl 
alkylcopper intermediates, which function as powerful chiral non-racemic carbon nucleophiles. 
Previously, we developed catalytic methods that generated these species in two different ways, the 
first being enantioselective transmetalation of a substituted 1,1-diborylalkane9 (see Chapter 1), and 
the second involving the regioselective addition of an in situ generated chiral copper-boryl 
complex across alkenylboronates10 (see Chapter 2). Both of these transformations showcased the 
ability of a-boryl alkylcoppers to add to activated ketones and aldehydes, respectively, with high 
levels of selectivity (Figure 3.2, top panel). 
To this point, only 1,1-diborylalkanes bearing an unsubstituted methylene in the b-position 
had been isolated in our lab.11,12 The ability to access multiple hybridization states at this position 
(e.g. sp2) would open up these versatile reagents to the rich chemistry of allyl boronic esters (Figure 
3.2, bottom). We proposed that, through the application of our copper/phosphoramidite catalyst 
system to a new class of 1,1-organodiboron reagents, namely bis-allylic 1,1-diboronate esters, an 
array of novel, synthetically relevant small molecules bearing multiple stereogenic centers could 
be accessed with ease. In addition, nucleophilic g-allylation of C=N electrophiles with 
disubstituted, non-symmetric bis-allyl 1,1-diboron reagents held the potential to create 
enantioenriched all-carbon quaternary centers vicinal to a stereodefined amine, both of which are 
ubiquitous in bioactive molecules.8,13–24 
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Figure 3.2 Previous catalytic protocol involving 1,1-diborylalkanes; Proposed reactivity model 
for bis-allylic 1,1-diboronate esters  
3.2 Background 
3.2.1 Catalytic Enantioselective Allylation of Imines 
Catalytic enantioselective allylation of C=N electrophiles (aldimines and ketimines) has 
been developed and refined over the past few decades into one of the most effective systems at 
installing chiral non-racemic homoallylic amines into molecules.25–27 A wide range of allyl 






















































halides28–30, allylic silanes31–35, allylic stannanes36–39, and allylic alcohols.40 One of the most 
widely employed allylation reagents, however, are allylic boranes. These adaptable reagents, under 
favorable conditions, may react directly with imine electrophiles via a highly ordered six-
membered Zimmerman-Traxler type transition state to give g-allylation products. Although yields 
for these direct transformations are often quite high, enantioselective variants require the 
installation of a complex chiral diol backbone onto the allylic borane.41–43 Alternatively, 
transmetalation of the allylic borane to a metal catalyst bearing chiral ligands imparts the same g-
allylation with high enantioselectivity and without the need to generate an enantioenriched 
allylation reagent.39,44–52 
The simple addition of an allyl fragment to an imine via addition of an allylic borane has 
been thoroughly developed using multiple metals and a breadth of allylation reagents. Far less 
common, however, are methods that invoke nucleophilic g-allylation to imines using terminally 
substituted allylic boranes, which generates multiple contiguous stereocenters in a single chemical 
step. The first example of enantioselective “crotylboration” of aldimines was reported by 
Ramachandran and Burghardt in 2005, in which they synthesize and apply a number of 
allylboranes derived from a-pinene to set two contiguous stereocenters via g-crotylation of N-
trimethylsilyl imines.41 Schaus and co-workers later improved on these results through the 
implementation of a catalytic amount of a chiral BINOL derivative (Scheme 3.1).42 Upon exposure 
to allyldiisopropoxyborane (3.2), chiral diol (S)-3.3 displaces a single isopropoxy group and serves 
as a chiral auxiliary for the subsequent inner sphere allylation reaction involving N-benzoyl imine 
3.1. Interestingly, the stereochemical outcome of the reaction was independent of the starting 
olefin isomer, as both (E)- and (Z)-3.2 gave the anti-product in high diastereo- and 
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enantioselectivity. Schaus and co-workers attributed this to the adoption of chair- and boat-like 
transition states for each isomer (see lower part of Scheme 3.2). 
Scheme 3.1 Asymmetric allylation of N-benzoyl imines catalyzed by a chiral diol (Schaus, 2007)  
 
More recently, Hoveyda and co-workers reported the enantioselective allylation of N-
phosphinoyl imines using allyl B(pin) and a catalytic amount of amino alcohol 3.7 (Scheme 3.2, 
top).23 Included in this study are three examples of homoallylic amines bearing multiple 
stereocenters, including an all-carbon quaternary center (3.8). However, due to the nature of the 
mechanism of the transformation, the allylation reagent must possess an enantioenriched a-
stereocenter prior to addition (3.6). In a similar vein, Aggarwal and co-workers disclosed the 
generation of contiguous quaternary stereogenic centers through the diastereoselective allylation 
of N-silylated imines with allylboronic esters bearing an a-stereocenter (Scheme 3.2, bottom).21 
Incredible stereocontrol is exhibited, and all four possible stereoisomers may be accessed through 




















>99:1 d.r., >99:1 e.r.
(Z)-3.2: 68% yield






























Scheme 3.2 Enantio- and diastereoselective synthesis of vicinal secondary amines and all-carbon 
quaternary centers  
 
Metal-catalyzed enantioselective allylations of imines using allylboron reagents have also 
received attention in the literature. Most prevalent in this field is the Kobayashi group, who have 
developed multiple catalytic protocols for the diastereo- and enantioselective allylation of 
hydrazones using zinc and indium catalysts (Scheme 3.3).49,52 Both of these systems utilize 
racemic a-substituted allylboronic esters (such as rac-3.13) as precursors to nucleophilic 
allylmetal species. Because transmetalation occurs in SN2’ fashion, the final allylation product 
constitutes a formal “direct addition” product bearing an a-stereocenter (3.15). In reality, both 
processes undergo a double g-allylation sequence, proceeding through allylmetal intermediates 
such as (Z)-3.16 before generating final products in high diastereoselectivities and good 
enantioselectivities. Unfortunately, the scope of a-substitution of the resulting homoallylic amine 
was limited to chlorine, a benzylic ether, and a few alkyl groups. 
3.8
70% yield





Et B(pin) 1) n-BuLi, -78 °C2) TFAA, 30 min
3) 3.9, MeOH
THF, -78 °C to rt, 16 h
4) Ac2O (R,R)-3.11
81% yield





































Scheme 3.3 Enantio- and diastereoselective crotylation of hydrazones via allylzinc intermediates 
 
Enhancement of this type of metal-catalyzed transformation was reported by Lam and co-
workers. Using an isolated rhodium (I)/chiral diene catalyst and potassium allyltrifluoroborate 
salts, Lam and co-workers were able to successfully allylate cyclic sulfonyl imines (3.17) with 
high levels of stereocontrol.47 Employment of either the (E)- or (Z)-isomer of potassium 
crotyltrifluoroborate led to the generation of both diastereomers of allylated product with complete 
diastereocontrol. Longer alkyl chains were also compatible under these catalytic conditions, as 
well as gem-disubstituted olefins, as “reverse prenylation” product 3.20 was isolated in 75% yield 
and 95% ee (Scheme 3.4). This represented the first ever catalytic enantioselective reverse 
prenylation of an imine, although it was limited to a single example. 





























































For their rhodium-catalyzed enantioselective g-allylation of imines, Lam and co-workers 
proposed the following catalytic cycle (Figure 3.3). Isolated rhodium (I) complex bearing chiral 
diene ligand 3.19 reacts with activated allyltrifluoroborate II to form allylrhodium intermediate 
III. After substrate coordination to give intermediate IV, g-allylation proceeds smoothly to 
generate aminorhodium species V. Protonation of the Rh–N bond in V results in simultaneous 
product release and catalyst regeneration.47 We drew inspiration from this mechanism, as it 
represents one of the few enantio- and diastereoselective metal-catalyzed g-crotylation and reverse 
prenylation of imines in existence. Through the use of bis-allyl 1,1-organodiboron reagents and a 
chiral copper catalyst, we hoped to expand upon this initial proof of concept and create a general 





Figure 3.3 Proposed catalytic cycle for the rhodium-catalyzed enantioselective g-allylation of 
cyclic sulfonyl imines 
3.2.2 Bis-Allyl 1,1-Diboronate Esters: Synthesis and Reactivity 
Recently, bis-allyl 1,1-organodiboron compounds have emerged as useful reagents in 
allylation reactions of carbonyls and imines. The first evidence of an allylic gem-diboronate ester 
was reported by Murakami and co-workers in which they disclosed the highly enantio- and 
diastereoselective crotylation of aryl, alkenyl, and alkyl aldehydes (Scheme 3.5).53 In this account, 
bis-allylic 1,1-diboronate esters are generated in situ via the palladium-catalyzed isomerization of 
allyl-substituted 1,1-diborylalkane 3.21. Selective generation of the (E)-olefin isomer is controlled 
through steric interactions of the gem-diboron group and the terminal methyl group (3.22). 
















































enantioselectivity is governed by a catalytic amount of chiral phosphoric acid (R)-TRIP. Final 
isomerization of the kinetically generated (Z)-alkenylboron to the more thermodynamically stable 
(E)-isomer gives the resulting anti-homoallylic alcohol bearing a pendant alkenylboronic ester 
(3.23) in good yields and high selectivity. Worth noting is the single example of exo-olefinic 
boronate 3.24, which constitutes a formal reverse prenylation of benzaldehyde. Product 3.25 is 


















Scheme 3.5 Stereoselective crotylation of aldehydes using in situ generated bis-allyl 1,1-
diboronate esters: reaction and stereochemical model  
 
In order to access the less stable (Z)-isomer of their products, Murakami and co-workers 
utilized cationic ruthenium complex 3.26 to facilitate their initial isomerization process, as detailed 
in Scheme 3.6.54 Unlike their previous report, this ruthenium catalyst left the (Z)-olefin in the final 
product untouched, leading to the isolation of unique cyclized 1,2-oxaborinan-3-ene products 



























(Ar = 2,4,6-i-Pr Ph)
3.23
82% yield






























































well as longer alkyl chains on the allylic gem-diboronate ester precursor, although lengthy alkyl 
chains led to significant decreases in enantioselectivity. As with the palladium-catalyzed 
isomerization system, reverse prenylation under these new conditions was unable to be rendered 
selective, giving racemic product in 67% yield. 
Scheme 3.6 Synthesis of 1,2-oxaborinan-3-enes using dual ruthenium/phosphoric acid catalysis 
 
Cho and co-workers reported the diastereoselective addition of allylic gem-diboronate 
esters to aldehydes and cyclic imines.55 This new report cut out the need for a metal catalyst, as 
bis-allyl 1,1-diboronate ester (E)-3.22 was isolated via recrystallization in 91% yield on multi-
gram scale. The utility of this reagent was highlighted through a series of allylation reactions 
involving aldehydes and imines. Similar to previous methods, cyclic sulfonyl imines were required 
for appreciable amounts of product to be generated. A variety of aryl sulfonyl imines were 
tolerated, delivering various homoallylic amines bearing an alkenyl boron group in good yields 
and diastereoselectivities, yet only a single allylic gem-diboronate ester was showcased in this 
process. These previous reports provided the foundation for our proposed transformation, in which 
a bis-allyl 1,1-organodiboronate ester would undergo enantioselective transmetalation with a 














20 °C, 3 h3.21
2.0 equiv. 3.2794% yield














Scheme 3.7 Diastereoselective crotylation of cyclic sulfonyl imines utilizing (E)-3.22  
 
3.3 Enantio- and Diastereoselective Nucleophilic Allylation of Aryl Imines Using Novel 
Allylic gem-Diboronate Esters 
 
3.3.1 Synthesis and Isolation of Allylic gem-Diboronate Esters 
Purification and isolation of (E)-3.22 by Cho and co-workers served to highlight the 
stability of bis-allyl 1,1-diboronate esters.55 In spite of this, current methods utilizing other variants 
of these reagents rely solely on in situ generation via metal-catalyzed isomerization.53,54 Interested 
in harnessing allylic gem-diboronate esters in new catalytic transformations, we sought to develop 
a general method for their synthesis. 
Alkylation of parent organodiboron 3.29 is easily achieved through lithiation with bulky 
amide base LTMP, followed by quenching with the corresponding primary alkyl halide (Figure 
3.4, left pathway). Due to the ease with which lithiated organodiboron Li-3.29 could be created56, 
we envisioned a similar strategy could succeed in generating a variety of bis-allyl 1,1-diboron 
reagents (Figure 3.4, right pathway). Instead of direct SN2 substitution, Li-3.29 would instead 
undergo a metal-catalyzed cross-coupling reaction with vinyl halides, which would efficiently 











90 °C, 16 h
3.21
















Figure 3.4 Proposed synthetic route to allylic gem-diboronate esters via metal-catalyzed cross-
coupling of Li-3.29 with alkyl halides 
Precedent for a cross-coupling reaction involving organolithium species came from 
Feringa and co-workers, who disclosed the palladium-catalyzed coupling reaction between aryl 
lithiums and aryl halides.57 Using slightly modified conditions, Li-3.29 was able to be coupled 
with a variety of trisubstituted vinyl halides (Scheme 3.8). Isocrotyl bromide participated readily 
under these conditions, yielding dimethyl-substituted (E)-3.30 in 55% yield. Non-symmetric 
alkenyl iodides were also compatible with these conditions; butyl-containing (E)-3.31 could be 
synthesized in 74% isolated yield on multi-gram scale, while products bearing pendant 
functionality, such as silyl-protected alcohol (E)-3.32 and phenyl-subsituted (E)-3.33, were 
generated in 50% and 25% yield, respectively. Iodides containing a-branched alkyl groups were 
also tolerated; cyclohexyl-substituted (E)-3.34 was produced in 45% yield, while 
cyclopropylacetylene-derived alkenyl iodide delivered (E)-3.35 in 29% yield. Ethyl-substituted 


































Scheme 3.8 Scope of the palladium-catalyzed cross coupling of Li-3.29 and alkenyl halides 
 
3.3.2 Catalyst and Reaction Optimization 
With a library of bis-allyl 1,1-organodiborons in hand, we set out to incorporate these 
versatile reagents in the copper-catalyzed allylation of imines. Due to the success of our copper 
(I)/phosphoramidite catalyst system in 1,2-addition reactions9,11, our initial reactivity screen relied 
on a pre-generated solution of copper (I) tert-butoxide and (R)-H8-Monophos (see Experimental 
section for details). Attempting first to develop the enantioselective reverse prenylation of 
aldimines, we combined phenyl N-phosphinoyl imine 3.5 and prenyl substituted 1,1-diboronate 
3.38. In the presence of our copper/phosphoramidite catalyst and an equivalent of methanol (to 
facilitate catalyst turnover) we were encouraged to observe desired g-allylation product 3.39 in 
























































a-allylation product was observed. The resulting homoallylic amine was easily purified via silica 
gel chromatography and was stable to both air and moisture. Heartened by this initial result, we 
tested a wide array of both mono- and bidentate phosphine ligands of varying classes and structures 
(Scheme 3.9). Unfortunately, while most ligands gave appreciable conversions to the desired 
homoallylic amine as a single olefin isomer, enantioselectivities were unable to be improved 
through ligand modification. 
Scheme 3.9 Enantioselective reverse-prenylation of aryl imines: initial hit and ligand screen 
 
Efforts at developing a diastereo- and enantioselective manifold through the use of non-
symmetric bis-allyl 1,1-diboron reagents yielded interesting results (Table 3.1). Under identical 























3.40 (R = n-Bu):
3.41 (R = n-Hex): 
3.42 (R = Piperidine): 




3.44 (G = Ph):
3.45 (G = Br):
3.46 (G = p-Tol): 








49% NMR yield, 64:36 e.r.
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delivered secondary amine 3.48 in 66% NMR yield, 77:23 d.r., and an enantiomeric ration of 78:21 
for the major diastereoisomer (70:30 e.r. for the minor). Modifications to the phosphoramidite 
ligand, particularly arylation of the 3 and 3’ positions of the H8-BINOL backbone, led to significant 
increases to the enantioselectivity of the reaction, but at the expense of diastereoselectivity (Table 
3.1, entries 3-6). In the most extreme case, xylyl-substituted phosphoramidite 3.49 (Entry 5) gave 
an even 1:1 mixture of diastereomers, but both isomers displayed excellent levels of 
enantioselectivity (97:3 e.r. and 96:4 e.r.). Further examination of the data revealed a surprising 
trend: ligand alterations brought to light the seemingly inverse relationship between 
















Table 3.1 Diastereo- and enantioselective nucleophilic allylation of aryl imines: ligand screen 
 
Closer mechanistic analysis allowed us to develop a working hypothesis for this interesting 
trend, which is further detailed in Figure 3.5. In our proposed mechanism, transmetalation to the 
copper (I)-phosphoramidite catalyst is enantiodetermining, while the diastereoselectivity is 
governed by facial selectivity of the imine. In this particular case, diastereoselectivity was low, but 



































78:21 (maj), 70:30 (min)
82:18 (maj), 80:20 (min)
90:10 (maj), 91:9 (min)
92:8 (maj), 91:9 (min)
97:3 (maj), 96:4 (min)






3.49 (G = 3,5-Xylyl)








aReaction performed under an N2 atmosphere; see Experimental Section for details.
bDetermined using 1H NMR spectroscopy with hexamethyldisiloxane as an internal
standard. cDetermined using 1H NMR spectroscopy. dDetermined using chiral 




















transmetalation of our copper/phosphoramidite catalyst is indeed enantioselective, and that the 
subsequent g-allylation step is unable to discriminate between faces of the imine electrophile. 
 
Figure 3.5 Proposed mechanism of the reverse prenylation of phosphinoyl imines with (E)-3.31 
A possible explanation for this phenomenon was that addition to the imine was occurring 
in an outer sphere type of mechanism, instead of a highly ordered inner sphere six-membered 
transition state (Figure 3.6).6 We predicted that promoting a more ordered inner sphere transition 
state through substrate modification, while keeping the highly selective catalyst system constant, 
would help remedy this lack of diastereoselectivity. 
 
































































Previous examples of imine allylation using allylboron reagents often required the use of 
specific protecting groups in order for reactivity to occur.47,51,55 Based on these data, we posited 
that the identity of the protecting group present on the aldimine held the key to unlocking a 
selective allylation process. A small screen proved that the identity of imine protecting group was 
indeed critical, as benzyl-protected phenyl aldimine produced alkenylboronate 3.52 in 72% 
conversion as a single diastereoisomer and in high enantioselectivity (98:2 e.r.) (Scheme 3.10, 
top). These conditions proved optimal for the reverse prenylation reaction as well, delivering gem-
dimethyl substituted alkenylboronate 3.53 in 46% conversion and 97:3 e.r. (Scheme 3.10, bottom). 
Scheme 3.10 Allylation of N-benzyl amine 3.51 
 
The presence of an alkenylboron moiety, sensitive to hydrogenation, in the final product 
prompted a reevaluation of protecting groups with similar steric environments to benzyl. Electron-
rich para-methoxybenzyl (PMB) protected 3.54 was chosen as an alternative, since it could be 
removed under mild oxidative conditions.58 Unfortunately, this exchange resulted in a sharp 
decrease in conversion for the reverse prenylation reaction, coupled with a rise in side products 


















72% 1H NMR yield





























Scheme 3.11). To remedy this issue, we took inspiration from Buchwald and co-workers and 
switched from methanol to methanol-d4 (CH3OH vs. CD3OD).59 Decomposition of the allylcopper 
intermediate via protonolysis would be significantly slowed due to a deuterium isotope effect, 
allowing the reactive organometallic species more time to undergo productive allylation. Because 
proton exchange between heteroatoms occurs rapidly, the switch to methanol-d4 would have little 
influence on the rate of catalyst turnover. Incorporation of one equivalent of CD3OD, under 
otherwise standard reaction conditions, completely suppressed any adverse protonation reactions 
previously observed and delivered desired homoallylic amine 3.55 in 65% conversion and 95:5 
e.r. 
Table 3.2 Suppression of protodeboration via application of methanol-d4  
 
3.3.3 Enantioselective Reverse Prenylation of Aryl Imines 
With optimal conditions in hand, the substrate scope of the reverse prenylation reaction 
between dimethyl substituted bis-allyl 1,1-diboron reagent 3.30 and aryl imines was evaluated. 








































aReaction performed under an N2 atmosphere; see 
Experimental Section for details. bDetermined using 1H
NMR spectroscopy with hexamethyldisiloxane as an 
internal standard. cDetermined using chiral HPLC
analysis
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99:1 e.r. Substitution in the para position on the aryl imine was well-tolerated; p-Br, p-OMe, and 
p-CF3 substituted products (3.58, 3.59, and 3.60) were isolated in good yields (73%, 61%, and 
68%, respectively) and excellent enantioselectivities (>99:1 e.r., 98:2 e.r., and >99:1 e.r., 
respectively). The reaction was also amenable to substitution in the meta position; m-CO2Me 
product 3.61 was delivered in 61% yield and 99:1 e.r., while m-CF3 homoallylic amine 3.62 was 
generated in 65% yield as a single enantiomer. Naphthyl-substituted imine reacted smoothly to 
give product 3.63 in 67% yield (>99:1 e.r.). Even ortho-substitution on the aryl imine was 
acceptable, as o-F aryl imine provided fluorinated product 3.64 in 65% yield and 98:2 e.r. 
Dihalogenated homoallylic amine 3.65 was generated in 55% yield as a single enantiomer. Certain 
heterocyclic imines did not inhibit reactivity, as both furyl and thiophene-substituted products 3.66 
and 3.67 were isolated in excellent yields (78% and 73%, respectively) and high 
enantioselectivities (98:2 e.r. and 99:1 e.r., respectively). Pyridyl-substituted imines were also able 












Scheme 3.11 Scope of the reverse prenylation of aryl N-PMB imines using allylic gem-
diboronate 3.30 
 
3.3.4 Enantio- and Diastereoselective g-Allylation of Aryl Imines Using Non-Symmetric 
Allylic gem-Diboronate Esters 
 
These optimized conditions were completely transferable to the reaction of non-symmetric 
















































































































bearing a vicinal all-carbon quaternary center and a pendant alkenylboron group. Longer alkyl 
chains (3.69, 72% yield, >20:1 d.r., >99:1 e.r.), silyl ethers (3.70, 78% yield, >20:1 d.r., >99:1 
e.r.), and distant phenyl groups (3.71, 76% yield, 13:1 d.r., 95:5 e.r.) were all tolerated under the 
reaction conditions. Stereoselective synthesis of bis-allyl 1,1-diboronate esters bearing an ethyl 
group instead of a methyl group allowed for the synthesis of ethyl-substituted variants (see Section 
3.3.1): 3.72 and 3.73 were isolated in 82% and 72% yield, respectively, as single diastereomers 
and single enantiomers. a-Branched alkyl groups were able to participate under these reaction 
conditions, although with mixed results. Cyclohexyl-substituted organodiboron reagent 3.34 
delivered product 3.74 in good yield (64%) and d.r. (>20:1) but suffered from low 
enantioselectivity (92:8 e.r.). Incorporating a smaller carbocycle (e.g. 3.35) results in a return of 
high selectivity (3.75, produced in 74% yield, >20:1 d.r., and 98:2 e.r.). 











































































3.3.5 Product Functionalizations 
The isolated alkenylboronates were amenable to a range of subsequent functionalizations 
(Scheme 3.13). Exposure of furyl-substituted product 3.71 to standard Suzuki-Miyaura cross 
coupling conditions provided coupled product 3.77 as a single olefin isomer in 66% isolated yield. 
Allylboronic ester 3.79 was successfully synthesized in 72% isolated yield via the one carbon 
homologation of 3.73. Additionally, protodeborylation of alkenylboronate 3.55 proceeded 
smoothly in the presence of a superstoichiometric amount of silver(I) fluoride, providing terminal 
olefin 3.80 in 67% yield. This two-step process represents the first example of a formal 







































1) NaBO3•4H2O (3 equiv)
THF:H2O (1:1), rt, 2 h
2) NaBH3CN (1.5 equiv)
AcOH (10% in MeOH)
0 °C to rt, 3 h
3.82 (R = Me)
47% yield 
3.83 (R = n-Bu)
57% yield
>20:1 d.r.
















n Suzuki Cross Coupling







B(pin) n-BuLi (1.2 equiv)















B(pin) AgF (2 equiv)
THF:MeOH:H2O (0.1 M)














Oxidation of alkenylboronates 3.58, 3.69, and 3.70 to the corresponding aldehyde gave 
complete conversion to the cyclized hemiaminal product as a mixture of diastereomers 
(intermediate 3.81). The resulting hemiaminal could be selectively reduced through the use of 
NaBH3CN, affording functionalized pyrrolidines 3.82, 3.83 and 3.84 in 47%, 57%, and 49% yield 
(over two steps), respectively (Scheme 3.13, bottom). Dimethyl-substituted pyrrolidine 3.82 was 
recrystallizaed and subjected to X-Ray crystallographic analysis, which revealed that the 
stereochemical orientation of the secondary amine to be (R) (Figure 3.7). 
 
Figure 3.7 X-Ray crystal structure of 3.82 
Analysis of products 3.83 and 3.84 by 1D-NOESY revealed a cis-relationship between 
benzylic proton Ha and the adjacent methyl group. This came as a surprise, as six-membered 
transition state models for the allylation of aldehydes and aldimines traditionally position the large 
substituent in the pseudoequatorial position (TS-1, Figure 3.8). Placing the bulkier aryl group in 
the pseudo-axial position of the six-membered transition state provides the correct stereochemical 
relationship between Ha and the methyl group (TS-2, Figure 3.8). Although the identity of the 
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protecting group on the imine is crucial to achieve high selectivity, it is not due to facile (E) to (Z) 
isomerization of the imine, as other groups have observed.60  
 
Figure 3.8 Explanation of observed relative stereochemistry through transition state models 
3.3.6 Mechanistic Studies 
Based on these results, we propose the following catalytic cycle for the enantioselective g-
allylation of aryl imines with bis-allyl 1,1-diboronate esters (Figure 3.9). In situ generated copper 
(I) alkoxide catalyst I reacts with bis-allyl 1,1-diboron II to generate chiral non-racemic 
allylcopper species III. Use of deuterated methanol suppresses protodeboration, preventing the 
creation of decomposition products V and VI. Coordination of (E)-imine (E)-3.54 facilitates inner 
sphere g-allylation in a highly diastereoselective manner. Methanol-d4 then reacts with 
aminocopper intermediate VII, simultaneously releasing desired homoallylic amine product VIII 

























Figure 3.9 Proposed catalytic cycle for the copper-catalyzed enantio- and diastereoselective g-
allylation of aryl imines with allylic gem-diboronate esters 
According to this mechanistic model, the diastereoselectivity of this reaction is controlled 
by the geometry of the incoming trisubstituted olefin. If this aspect were true, altering the 
geometric orientation of the bis-allyl 1,1-diboron reagent would allow both possible 
diastereoisomers of products to be accessed with ease. In order to confirm this, we independently 
synthesized both (E)-3.85 and (Z)-3.85 and exposed them to identical reaction conditions. As 
detailed in Scheme 3.14, incorporation of (E)-3.85 provided (R,S)-3.86 as a single diastereomer 
in 97.5:2.5 e.r., while (R,R)-3.86 was generated in >20:1 d.r. and 99:1 e.r. when (Z)-3.85 was used 
instead. Based on these data, our initial hypothesis was proven correct, and the geometry of the 

















































Scheme 3.14 Generation of both possible diastereoisomers through the stereoselective synthesis 
of each olefin isomer of the allylic gem-diboronate ester 
 
3.4 Conclusions 
We have developed the first enantio- and diastereoselective g-allylation of aryl imines 
using novel bis-allyl 1,1-diboronate esters as allylation reagents. The system takes advantage of 
the ability of a copper (I)/phosphoramidite catalyst to undergo enantioselective transmetalation 
with these activated boron reagents, generating a highly reactive a-boryl allylcopper intermediate. 
This species reacts rapidly with a variety of substituted aryl imines to generate enantioenriched 
homoallylic amines in high yields and selectivities. Dimethyl substituted allylic gem-diboronate 
ester 3.30 reacts cleanly with a variety of aryl imines to give reverse prenylation products in up to 
78% yield and up to >99:1 e.r. Utilization of non-symmetric bis-allyl 1,1-diboronates in this 
catalytic protocol produces homoallylic amines bearing a vicinal all-carbon quaternary center in 
up to 82% yield, up to >20:1 d.r. and up to >99:1 e.r. The utility of the isolated alkenylboron 
products is highlighted through a selection of functionalizations, including a cross coupling and a 
telescoped oxidation/reduction sequence. Access to two different diastereoisomers is possible 





















THF, -78 to -40 °C
18 h(R,R)-3.86
52% yield













THF, -78 to -40 °C
18 h Ar = 2-Naphthyl
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3.5 Experimental 
n General: All reactions were carried out in oven-dried (150 ̊ C) or flame-dried glassware under 
an inert atmosphere of dried N2 unless otherwise noted. Analytical thin-layer chromatography was 
performed on glass plates coated with 0.25 mm of 60 Å mesh silica gel. Plates were visualized by 
exposure to UV light (254 nm) and/or immersion into KMnO4 or Curcumin stain61 followed by 
heating. Column chromatography was performed using silica gel P60 (mesh 230-400) supplied by 
Silicycle. All solvents were sparged with argon and then purified under a positive pressure of argon 
through a SG Water, USA Solvent Purification System. Tetrahydrofuran, toluene, and 
dichloromethane (OmniSolv) were passed successively through two columns of neutral alumina. 
The ambient temperature in the laboratory was approximately 22 ˚C.  
	
n Instrumentation: All 1H NMR spectra were recorded on Bruker Spectrometers (AVANCE-
600 and AVANCE-500). Chemical shifts are reported in ppm from tetramethylsilane and 
referenced to the residual protio solvent peak (CDCl3: δ 7.26). Data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, qu = quartet, quint = quintet, br = 
broad, m = multiplet, app = apparent, bs = broad singlet), integration, and coupling constants are 
given in Hz. 13C NMR spectra were recorded on Bruker Spectrometers (AVANCE-600 and 
AVANCE-500) with carbon and proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane and referenced to the residual protio solvent peak (CDCl3: δ 77.16). All IR 
spectra were recorded on a Jasco 260 Plus Fourier transform infrared spectrometer. Optical 
rotations were determined using a Jasco P1010 polarimeter and concentrations are reported in 
g/100mL. Enantiomeric ratios were determined on an Agilent Technologies 1220 Infinity LC or a 
Waters Acquity UPC2 SFC using the following columns: Diacel CHIRALPAK IA (4.6 mm x 250 
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mm x 5 µm), Diacel CHIRALPAK IB (4.6 mm x 250 mm x 5 µm), Diacel CHIRALPAK IC (4.6 
mm x 250 mm x 5 µm), Diacel CHIRALPAK IF (4.6 mm x 250 mm x 5 µm), Phenomenex 
Amylose-1 (4.6 mm x 150 mm x 5 µm), Phenomenex Cellulose-1 (4.6 mm x 150 mm x 5 µm), 
and Phenomenex Cellulose-3 (4.6 mm x 150 mm x 5 µm). Chiral supercritical fluid 
chromatography analysis was performed on a Waters Acquity UPC2 instrument at 35°C with 
Phenomenex chiral columns (15 cm) using the conditions detailed for each substrate. Mass 
Spectrometry samples were analyzed with a Q Exactive HF-X (Waters, Acquity-H class) mass 
spectrometer. Samples were introduced via a micro-electrospray source at a flow rate of 10 µL/min 
in MeOH. Xcalibur (ThermoFisher, Breman, Germany) was used to analyze the data. Molecular 
formula assignments were determined with Molecular Formula Calculator (v 1.2.3). Low-
resolution mass spectrometry (linear ion trap) provided independent verification of molecular 
weight distributions. All observed species were singly charged, as verified by unit m/z separation 
between mass spectral peaks corresponding to the 12C and 13C12Cc-1 isotope for each elemental 
composition. 
	
n Reagents: Copper (I) tert-butoxide was synthesized according to a previous literature 
procedure.10 All chiral bidentate phosphine ligands were purchased from Strem Chemicals Inc. 
and used as received. Phosphoramidites 3.40, 3.41, 3.42, and 3.43 were synthesized according to 
a published literature procedure.62 Phosphoramidites 3.44, 3.45, 3.46, 3.47 and 3.50 were 
synthesized according to the same protocol as 3.49 (vide infra).	
	
Ammonium Chloride was purchased from Alfa Aesar and used as received 
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4-Anisaldehyde was purchased from Alfa Aesar, dried over CaH2, distilled under reduced 
pressure, and then sparged with dry N2 
Bis(pinacolato)diboron was purchased from Frontier Scientific, recrystallized from boiling 
hexanes, azeotropically dried with benzene three times, and kept in an N2-filled glovebox 
Benzaldehyde was purchased from Alfa Aesar and used as received 
Benzylamine was purchased from Sigma Aldrich and used as received 
(E)-N-benzylidene-P,P-diphenylphosphinic amide was prepared according to a published 
literature procedure63 
[1,1-Bis(diphenylphosphino)ferrocene]palladium(II) dichloride was purchased from Alfa 
Aesar and used as received 
1-Bromo-2-methyl-1-propene was purchased from Matrix Scientific and sparged with N2 before 
use 
2-Bromo-4-chlorobenzaldehyde was purchased from Alfa Aesar and used as received 
4-Bromoanisole was purchased from Alfa Aesar and used as received 
4-Bromobenzaldehyde was purchased from Alfa Aesar and used as received 
4-Bromobenzotrifluoride was purchased from Matrix Scientific and sparged before use 
1-Butyne was purchased from Sigma Aldrich and condensed before use 
(But-3-yn-1-yloxy)(tert-butyl)dimethylsilane was synthesized according to a previous literature 
procedure64 
Calcium hydride was purchased from Acros and used without further purification 
Chloroform–d was purchased from Cambridge Isotope Laboratories and used without further 
purification 
Cyclohexylacetylene was purchased from Sigma Aldrich and used as received 
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Cyclopropylacetylene was purchased from Alfa Aesar and used as received 
Diborylmethane was synthesized according to a published literature procedure
65
 
2,6-Dichloronicotinaldehyde was purchased from Sigma Aldrich and used as received 
Dihydrocinnamaldehyde was purchased from Alfa Aesar, dried over CaH2, distilled under 
reduced pressure, sparged with dry N2, and stored at -20 °C 
1,4-Dioxane was purchased from Alfa Aesar and used as received 
2-Fluorobenzaldehyde was purchased from Alfa Aesar and used as received 
3-Formylbenzoic Acid was purchased from Matrix Scientific and used as received 
2-Furylaldehyde was purchased from Alfa Aesar and used as received 
Geranial was synthesized according to a published literature procedure66 
1-Hexyne was purchased from Alfa Aesar and used as received 
Iodine was purchased from Sigma Aldrich and used as received 
Isovaleraldehyde was purchased from Alfa Aesar, dried over CaH2, distilled under reduced 
pressure, sparged with dry N2, and stored at -20 °C 
Lithium 2,2,6,6-tetramethylpiperidide was synthesized according to a published literature 
procedure67 
Methanol–d4 was purchased from Cambridge Isotope Laboratories and stored over molecular 
sieves 
4-Methoxybenzylamine was purchased from TCI America and used as received 
2-Naphthaldehyde was purchased from Alfa Aesar and used as received 
n-Butyllithium was purchased from Acros and titrated with phenanthroline/sec-butanol 
Palladium acetate was purchased from Strem and stored in an air-free glovebox 
4-Phenyl-1-butyne was purchased from Acros and used as received 
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Propyne was purchased from Sigma Aldrich and condensed before use 
Sodium bicarbonate was purchased from BDH Chemicals and used as received 
Sodium cyanoborohydride was purchased from Sigma Aldrich and used as received 
Sodium perborate tetrahydrate was purchased from Sigma Aldrich and used as received 
tert-Butyldimethylsilyl chloride was purchased from Alfa Aesar and used as received 
Tetrakis(triphenylphosphine)palladium(0) was purchased from Strem and stored at -20 °C in 
an air free glovebox 
2-Thiophenecarboxaldehyde was purchased from Alfa Aesar and used as received 
trans-Cinnamaldehyde was purchased from Alfa Aesar and used as received 
trans-α-Methylcinnamaldehyde was purchased from Alfa Aesar and used as received 
Triethylaluminum (1.0 M solution) was purchased from Sigma Aldrich and used as received 
3-Trifluoromethylbenzaldehyde was purchased from Alfa Aesar and used as received 
4-Trifluoromethylbenzaldehyde was purchased from Alfa Aesar and used as received 
Trimethylaluminum (2.0 M solution) was purchased from Sigma Aldrich and used as received 
Tri-tert-butylphosphonium tetrafluoroborate was purchased from Strem and used as received 













Procedure: 3.49 was synthesized according to a modified literature procedure.68,69 In an N2-filled 
glovebox, a 50 mL flask equipped with a magnetic stir bar was charged with Pd(OAc)2 (9.9 mg, 
0.04 mmol) and cataCXium® A (19.8 mg, 0.06 mmol). The flask was sealed with a rubber septum, 
taped with electrical tape, and taken out of the glovebox, where it was placed under a positive 
pressure of N2. The flask was then charged with benchtop 1,2-dimethoxyethane (11.1 mL). Once 
addition was complete, (R)-3,3’-Br-H8 BINOL (500 mg, 1.11 mmol) and (3,5-
dimethylphenyl)boronic acid (498 mg, 3.32 mmol) were added to the flask as solids. After, 5.5 mL 
of a 1M aqueous solution of K2CO3 was quickly added to the suspension. The flask was fitted with 
a condenser and heated to reflux under N2, where it was allowed to stir for an additional 18 hours. 
Once complete, the reaction was allowed to cool to room temperature and extracted 3x with 
dichloromethane. The combined organics were washed with saturated aqueous ammonium 
chloride and brine solutions, dried over sodium sulfate, filtered and concentrated in vacuo to yield 
a crude brown solid. Purification by silica gel chromatography (4:1 to 1:1 hexanes:DCM) provided 






























110 °C, 4 h
3.49
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crystalline white solid in 76% yield (424 mg). Spectral data of this compound matched previous 
reports.70 
 An 8 mL reaction vial equipped with a magnetic stir bar was charged with (R)-3,3'-bis(3,5-
dimethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diol (200 mg, 0.4 mmol). 
The vial was sealed with a septa cap and purged with N2 for 10 minutes. After, dry toluene (2.3 
mL) was added to the vial under N2, followed by hexamethylphosphorus triamide (72 µL, 0.4 
mmol). The solution was heated to 110 °C and allowed to stir for 4 hours. After, the reaction was 
allowed to cool to room temperature and concentrated in vacuo. Purification via silica gel 
chromatography (4:1 hexanes:DCM) provided pure phosphoramidite 3.49 as a crystalline white 
solid in 52% yield (120 mg). 1H NMR (500 MHz, Chloroform-d) 1H NMR (500 MHz, 
Chloroform-d) δ 7.24 (s, 2H), 7.19 (s, 2H), 7.14 (s, 1H), 7.08 (s, 1H), 6.92 (d, J = 9.2 Hz, 2H), 
2.93 – 2.78 (m, 4H), 2.68 (qd, J = 11.2, 9.7, 6.1 Hz, 1H), 2.39 (dt, J = 10.8, 5.8 Hz, 1H), 2.34 (s, 
6H), 2.32 (s, 6H), 1.93 (s, 3H), 1.91 (s, 3H), 1.86 – 1.77 (m, 6H), 1.70 – 1.59 (m, 2H), 1.33 – 1.22 
(m, 2H). 13C NMR (151 MHz, CDCl3) δ 145.5, 144.7, 138.3, 138.2, 137.2, 137.1, 136.8, 136.8, 
133.5, 133.1, 132.1, 132.1, 131.2, 130.7, 130.3, 130.3, 130.0, 129.7, 128.5, 128.2, 127.6, 127.5, 
127.4, 53.5, 34.4, 34.3, 29.3, 29.3, 27.8, 27.7, 23.1, 23.0, 22.9, 22.8, 21.4, 21.4, 1.1. 31P NMR 
(202 MHz, CDCl3) δ 140.4. IR (υ/cm-1): 2926.45 (s), 2858.95 (m), 1602.56 (m), 1448.28 (s), 
1264.11 (m), 1228.43 (s), 1192.76 (s). HRMS (ESI+): calcd for C38H43NO2P+ 576.3031, found: 







n General Procedure A for the Synthesis of PMB-protected Imines	
	
Procedure: A flame-dried 20 mL scintillation vial equipped with a magnetic stirbar was charged 
with 4 Å molecular sieves. The vial was allowed to cool under vacuum for 10 minutes. The vial 
was then back-filled with N2 and purged for 5 minutes. Dry dichloromethane was added to the vial 
(0.8M), followed by the corresponding aldehyde (5.0 mmol) and 4-methoxybenzylamine (685 mg, 
5.0 mmol, 650 µL). Once addition was complete, the vial was capped and sealed with electrical 




(E)-N-(4-methoxybenzyl)-1-phenylmethanimine (3.54). Following General Procedure A, imine 
3.54 was isolated as a pale yellow oil in 61% yield (690 mg) and used without further purification. 
Spectral data matched previous reports.71 
 
	
(E)-1-(4-bromophenyl)-N-(4-methoxybenzyl)methanimine (S1). Following General Procedure 
A, imine S1 was isolated as a white solid in 71% yield (1.08 g) and used without further 
4Å molecular sieves

















purification. 1H NMR (500 MHz, Chloroform-d) δ 8.31 (s, 1H), 7.66 – 7.61 (m, 2H), 7.56 – 7.52 
(m, 2H), 7.25 – 7.23 (m, 2H), 6.91 – 6.86 (m, 2H), 4.76 – 4.73 (m, 2H), 3.80 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 160.2, 158.8, 135.1, 131.8, 131.1, 129.7, 129.2, 125.1, 114.0, 64.5, 55.3. IR 
(υ/cm-1): 2964.05 (m), 2841.60 (m), 2806.88 (m), 1644.02 (m), 1610.27 (m), 1586.16 (m), 1510.95 




(E)-N-(4-methoxybenzyl)-1-(4-methoxyphenyl)methanimine (S2). Following General 
Procedure A, imine S2 was isolated as a pale yellow oil in 71% yield (907 mg) and used without 
further purification. Spectral data matched previous reports.72 
 
	
(E)-N-(4-methoxybenzyl)-1-(4-(trifluoromethyl)phenyl)methanimine (S3). Following General 
Procedure A, imine S3 was isolated as a white solid in 55% yield (805 mg) and used without 















Methyl (E)-3-(((4-methoxybenzyl)imino)methyl)benzoate (S4). Following General Procedure 
A, imine S4 was isolated as a white solid in 60% yield (852 mg) and used without further 
purification. 1H NMR (600 MHz, Chloroform-d) δ 8.40 (s, 1H), 8.38 (t, J = 1.7 Hz, 1H), 8.11 – 
8.07 (m, 1H), 8.01 (dt, J = 7.7, 1.5 Hz, 1H), 7.49 (t, J = 7.7 Hz, 1H), 7.27 – 7.24 (m, 2H), 6.91 – 
6.88 (m, 2H), 4.89 – 4.71 (m, 2H), 3.93 (s, 3H), 3.81 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 166.7, 
160.5, 158.8, 136.6, 132.1, 131.6, 131.0, 130.7, 129.6, 129.3, 128.7, 114.0, 64.5, 55.3, 52.22.	IR 
(υ/cm-1): 2951.52 (m), 2835.81 (m), 1723.09 (s), 1644.98 (m), 1611.23 (m), 1511.92 (s), 1441.53 




(E)-N-(4-methoxybenzyl)-1-(3-(trifluoromethyl)phenyl)methanimine (S5). Following General 
Procedure A, imine S5 was isolated as a pale yellow oil in 71% yield (1.04 g) and used without 
further purification. 1H NMR (600 MHz, Chloroform-d) δ 8.40 (s, 1H), 8.05 (d, J = 1.7 Hz, 1H), 
7.94 (dt, J = 7.8, 1.3 Hz, 1H), 7.71 – 7.65 (m, 1H), 7.53 (t, J = 7.8 Hz, 1H), 7.28 – 7.22 (m, 2H), 
6.93 – 6.88 (m, 2H), 4.82 – 4.77 (m, 2H), 3.81 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 159.9, 
158.8, 136.9, 131.4, 131.3, 131.0, 130.8, 129.3, 129.1, 127.1 (q, J = 3.8 Hz), 124.9 (q, J = 3.8 Hz), 
















(E)-N-(4-methoxybenzyl)-1-(naphthalen-2-yl)methanimine (S5). Following General Procedure 
A, imine S5 was isolated as a white solid in 62% yield (859 mg) and used without further 
purification. 1H NMR (600 MHz, Chloroform-d) δ 8.53 (d, J = 1.5 Hz, 1H), 8.07 (s, 1H), 8.04 (dd, 
J = 8.5, 1.7 Hz, 1H), 7.91 – 7.88 (m, 1H), 7.85 (dd, J = 7.8, 4.4 Hz, 2H), 7.57 – 7.47 (m, 2H), 7.33 
– 7.28 (m, 2H), 6.94 – 6.87 (m, 2H), 4.85 – 4.81 (m, 2H), 3.81 (s, 3H). 13C NMR (151 MHz, 
CDCl3) δ 161.6, 158.7, 134.7, 133.9, 133.1, 131.4, 130.0, 129.3, 128.6, 128.4, 127.9, 127.1, 126.4, 
124.0, 114.0, 64.6, 55.3. IR (υ/cm-1): 2896.56 (m), 2871.49 (m), 1638.23 (m), 1610.27 (m), 
1512.88 (s), 1247.72 (s). HRMS (ESI+): calcd for C19H18NO+ 276.1388, found: [M+H+] 276.1368. 
 
	
(E)-1-(2-bromo-4-chlorophenyl)-N-(4-methoxybenzyl)methanimine (S7). Following General 
Procedure A, imine S7 was isolated as white solid in XX% yield (XXX mg) and used without 
further purification. 1H NMR (600 MHz, Chloroform-d) δ 8.67 (d, J = 1.7 Hz, 1H), 8.01 (d, J = 
8.4 Hz, 1H), 7.59 (d, J = 2.0 Hz, 1H), 7.31 (dd, J = 8.5, 2.0 Hz, 1H), 7.27 – 7.24 (m, 2H), 6.90 (d, 
J = 8.4 Hz, 2H), 4.79 (s, 2H), 3.81 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 159.3, 158.8, 137.1, 












1635.34 (m), 1611.23 (m), 1582.31 (s), 1510.95 (s), 1465.63 (s), 1375.96 (m), 1246.75 (s). HRMS 
(ESI+): calcd for C15H14BrClNO+ 337.9947, found: [M+H+] 337.9925. 
	
	
(E)-1-(2-fluorophenyl)-N-(4-methoxybenzyl)methanimine (S8). Following General Procedure 
A, imine S8 was isolated as a pale yellow oil in 72% yield (871 mg) and used without further 
purification. 1H NMR (600 MHz, Chloroform-d) δ 8.70 (d, J = 1.7 Hz, 1H), 8.03 (td, J = 7.6, 1.9 
Hz, 1H), 7.39 (dddd, J = 8.7, 7.3, 5.3, 1.9 Hz, 1H), 7.29 – 7.24 (m, 2H), 7.17 (t, J = 7.5 Hz, 1H), 
7.08 (ddd, J = 10.6, 8.3, 1.1 Hz, 1H), 6.92 – 6.87 (m, 2H), 4.80 – 4.78 (m, 2H), 3.81 (s, 3H). 13C 
NMR (151 MHz, CDCl3) δ 162.3 (d, J = 252.6 Hz), 158.8, 154.9, 154.8, 132.3 (d, J = 8.6 Hz), 
131.19, 129.24, 127.87, 124.32, 123.9 (d, J = 9.6 Hz), 115.7 (d, J = 21.2 Hz), 114.0, 65.0, 55.3. 
IR (υ/cm-1): 2835.82 (m), 1682.59 (m), 1611.23 (s), 1511.92 (s), 1457.92 (m), 1248.68 (s). HRMS 
(ESI+): calcd for C15H15FNO+ 244.1138, found: [M+H+] 244.1120. 
 
	
(E)-1-(furan-2-yl)-N-(4-methoxybenzyl)methanimine (S9). Following General Procedure A, 
imine S9 was isolated as an amber oil in 61% yield (653 mg) and used without further purification. 














(E)-N-(4-methoxybenzyl)-1-(thiophen-2-yl)methanimine (S10). Following General Procedure 
A, imine S10 was isolated as a colorless solid in 68% yield (785 mg) and used without further 
purification. Spectral data matched previous reports.7 
 
	
(E)-1-(2,6-dichloropyridin-3-yl)-N-(4-methoxybenzyl)methanimine (S11). Following General 
Procedure A, imine S11 was isolated as a pale yellow oil in 70% yield (1.03 g) and used without 
further purification. 1H NMR (500 MHz, Chloroform-d) δ 8.67 (s, 1H), 8.35 (dd, J = 8.2, 1.1 Hz, 
1H), 7.30 (dd, J = 8.1, 1.4 Hz, 1H), 7.25 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 4.81 (d, J = 
1.5 Hz, 2H), 3.81 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 158.9, 155.9, 151.8, 150.2, 139.4, 130.4, 
129.3, 128.8, 123.6, 114.1, 64.9, 55.3. IR (υ/cm-1): 2902.34 (m), 2834.85 (m), 1683.55 (m), 
1634.38 (m), 1611.23 (m), 1575.56 (s), 1542.77 (m), 1511.92 (s), 1428.03 (s), 1330.64 (s). HRMS 

















n General Procedure B for the Synthesis of Vinyl Iodides	
	
Procedure: Vinyl iodides were synthesized according to a modified literature procedure.75 A 250 
mL roundbottom flask equipped with a stir bar in an air-free glovebox was charged with 
zirconocene dichloride (20 mol%). The flask was sealed with a septum, taped, and brought out of 
the glovebox, where it was placed under positive pressure of N2 gas. Dry DCM was added to the 
flask, followed by a 2.0M solution of trimethylaluminum in hexanes. The resulting yellow solution 
was cooled to -23 °C in an ethylene glycol/ethanol/dry ice cooling bath for 10 minutes. Once 
cooled, water was carefully added to the stirring solution (WARNING: addition of water evolves 
large amounts of gas, be sure to vent flask before addition!). After addition of water was complete, 
the solution was allowed to stir at -23 °C for 10 minutes. A solution of 1-hexyne (1.0 equiv) in 
DCM was transferred to the stirring mixture via cannula, and the resulting solution was allowed 
to stir for an additional 10 minutes at -23 °C. Lastly, a 0.8M solution of I2 in THF was added 
dropwise to the stirring yellow suspension. Once addition was complete, the yellow reaction was 
allowed to slowly warm to room temperature and stir overnight. The reaction was then cooled to 
0 °C before being quenched with 2 mL of saturated potassium carbonate solution (highly 
exothermic). After stirring for 10 minutes, solid magnesium sulfate was added to the white 
suspension, and the solids were filtered and washed with diethyl ether. The filtrate was then 
concentrated, pushed through a plug of silica (100% pentane), and used without further 
purification. 
 
1) AlMe3 (2.0M in hexanes) (3.0 equiv)
[Cp2ZrCl]2 (20 mol%)
H2O (1.5 equiv)
2) I2 (0.8 M in THF) (1.2 equiv)




n General Procedure C for the Synthesis of bis-Allyl-1,1-organodiboron Reagents via 
Palladium-Catalyzed Cross-Coupling	
	
Procedure: A 500 mL roundbottom flask equipped with a magnetic stir bar in an air-free glovebox 
was charged with tetrakis(triphenylphosphine)palladium(0) (0.05 equiv). Another flask equipped 
with a magnetic stir bar was charged with diborylmethane (1.0 equiv) and lithium-2,2,6,6-
tetramethylpiperidide (1.05 equiv) was added to a third flask. All three flasks were sealed with 
septa, taped and brought out of the glovebox, where they were placed under positive pressure of 
N2 gas. Dry THF was added to the diborylmethane-containing flask and the LTMP-containing 
flask, while dry toluene was added to the palladium-containing flask (96 mL). Both solutions were 
cooled to 0 °C in ice water baths for 10 minutes. After sufficient cooling, the amber LTMP solution 
was cannula transferred to the diborylmethane solution, and the resulting mixture was allowed to 
stir at 0 °C for 10 minutes. Then, the deprotonated diborylmethane solution was cannula 
transferred to the Pd(PPh3)4 solution. Once addition was complete, the corresponding vinyl halide 
(1.2 equiv) was quickly added to the mixture via syringe. The flask was fitted with an oven-dried 
condenser, placed under N2 and heated to 80 °C in an oil bath. The reaction was allowed to stir at 
this temperature for 18 hours. Afterwards, the reaction was allowed to cool to room temperature 
before the addition of saturated aqueous ammonium chloride solution. The biphasic mixture was 
separated and the aqueous layer was extracted with diethyl ether (3x). The organics were then 
combined, dried over magnesium sulfate, filtered and concentrated to give the crude bis-allyl-1,1-
organodiboron reagent as an amber oil. 
1) LTMP, 0 °C, 10 min, THF
2) Pd(PPh3)4 (5 mol%)
















Following General Procedure C using 2.0 g of diborylmethane (7.46 mmol), 1.15 g of LTMP (7.83 
mmol), 431 mg of Pd(PPh3)4 (0.37 mmol), 1.21 g of 1-bromo-2-methyl-1-propene (8.96 mmol, 
917 µL), 52 mL of dry THF (17 mL for DBM flask, 34 mL for LTMP flask), and 96 mL of dry 
toluene, the crude product was purified via silica gel chromatography (10:1 hexanes:Et2O) to give 
1.14 g (47% yield) of the desired cross-coupled product as a yellow oil. 1H NMR (600 MHz, 
Chloroform-d) δ 5.37 (dt, J = 9.2, 1.5 Hz, 1H), 1.83 (d, J = 9.1 Hz, 1H), 1.69 (d, J = 1.4 Hz, 3H), 
1.54 (d, J = 1.3 Hz, 3H), 1.22 (s, 24H). 13C NMR (151 MHz, CDCl3) δ 130.3, 119.5, 83.1, 25.7, 
24.7, 24.7, 18.0. IR (υ/cm-1): 2978.52 (s), 2927.41 (m), 1371.14 (s), 1355.71 (s), 1317.14 (s), 





3.31). Following General Procedure C using 1.0 g of diborylmethane (3.73 mmol), 577 mg of 
















(4.48 mmol, 732 µL), 24 mL of dry THF (8 mL for DBM flask, 16 mL for LTMP flask), and 48 
mL of dry toluene, the crude product was purified via silica gel chromatography (10:1 
hexanes:Et2O) to give 1.00 g (74% yield) of the desired cross-coupled product as an orange oil. 1H 
NMR (600 MHz, Chloroform-d) δ 5.37 (dd, J = 9.4, 1.3 Hz, 1H), 1.98 (td, J = 7.4, 1.1 Hz, 2H), 
1.84 (d, J = 9.3 Hz, 1H), 1.37 – 1.31 (m, 2H), 1.29 – 1.23 (m, 2H), 1.22 (s, 12H), 1.21 (s, 12H), 
0.86 (t, J = 7.3 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 134.0, 119.5, 83.0, 65.9, 39.5, 30.4, 24.7, 
24.6, 22.2, 15.9, 15.3, 14.1. IR (υ/cm-1): 2977.55 (s), 2929.34 (s), 2871.49 (m), 1467.56 (m), 





3-en-1-yl)oxy)silane ((E)-3.32). Following General Procedure C using 400 mg of diborylmethane 
(1.49 mmol), 230 mg of LTMP (1.57 mmol), 86 mg of Pd(PPh3)4 (0.07 mmol), 580 mg of (E)-tert-
butyl((4-iodo-3-methylbut-3-en-1-yl)oxy)dimethylsilane (1.78 mmol), 10 mL of dry THF (3 mL 
for DBM flask, 7 mL for LTMP flask), and 20 mL of dry toluene, the crude product was purified 
via silica gel chromatography (10:1 hexanes:Et2O) to give 350 mg (50% yield) of the desired cross-
coupled product as an orange oil. 1H NMR (600 MHz, Chloroform-d) δ 5.42 (dd, J = 9.3, 1.3 Hz, 
1H), 3.63 (t, J = 7.4 Hz, 2H), 2.26 – 2.20 (m, 2H), 1.84 (d, J = 9.2 Hz, 1H), 1.22 (s, 12H), 1.21 (s, 









34.7, 31.6, 26.0, 24.7, 24.6, 22.7, 18.4, 16.7, 14.1, -5.2. IR (υ/cm-1): 2978.52 (s), 2956.34 (s), 
2930.31 (s), 2857.02 (s), 1471.42 (m), 1371.14 (s), 1319.07 (s), 1265.07 (m). HRMS (ESI+): calcd 




((E)-3.33). Following General Procedure C using 500 mg of diborylmethane (1.87 mmol), 288 mg 
of LTMP (1.96 mmol), 108 mg of Pd(PPh3)4 (0.09 mmol), 545 mg of (E)-(4-iodo-3-methylbut-3-
en-1-yl)benzene (2.0 mmol, 1.1 equiv), 13 mL of dry THF (4 mL for DBM flask, 9 mL for LTMP 
flask), and 24 mL of dry toluene, the crude product was purified via silica gel chromatography 
(10:1 hexanes:Et2O) to give 190 mg (12% yield) of the desired cross-coupled product as an orange 
oil. 1H NMR (600 MHz, Chloroform-d) δ 7.24 (d, J = 7.5 Hz, 2H), 7.20 – 7.17 (m, 2H), 7.17 – 
7.13 (m, 1H), 5.46 (dd, J = 9.3, 1.7 Hz, 1H), 2.72 – 2.66 (m, 2H), 2.33 – 2.27 (m, 2H), 1.85 (d, J 
= 9.3 Hz, 1H), 1.23 (s, 12H), 1.22 (s, 12H). 13C NMR (151 MHz, CDCl3) δ 142.8, 133.4, 128.4, 
128.2, 125.5, 120.2, 83.1, 41.7, 35.2, 24.7, 24.6, 16.3. IR (υ/cm-1): 2977.55 (m), 2931.27 (m), 
1455.03 (m), 1347.03 (s), 1319.07 (s), 1140.69 (s). HRMS (ESI+): calcd for C24H38B2O4Na 












3.34). Following General Procedure C using 652 mg of diborylmethane (2.43 mmol), 376 mg of 
LTMP (2.56 mmol), 141 mg of Pd(PPh3)4 (0.12 mmol), 730 mg of (E)-(1-iodoprop-1-en-2-
yl)cyclohexane (2.92 mmol, 1.2 equiv), 16 mL of dry THF (5 mL for DBM flask, 11 mL for LTMP 
flask), and 32 mL of dry toluene, the crude product was purified via silica gel chromatography 
(10:1 hexanes:Et2O) to give 430 mg (45% yield) of the desired cross-coupled product as a yellow 
solid. 1H NMR (500 MHz, Chloroform-d) δ 5.42 (d, J = 9.1 Hz, 1H), 1.92 (ddd, J = 11.5, 8.3, 3.1 
Hz, 1H), 1.84 (d, J = 9.1 Hz, 1H), 1.77 – 1.70 (m, 2H), 1.68 – 1.59 (m, 4H), 1.24 – 1.23 (m, 28H) 
1.19 – 1.09 (m, 1H). 13C NMR (151 MHz, CDCl3) δ 139.4, 117.8, 83.0, 47.7, 32.0, 26.8, 26.4, 
24.7, 24.6, 13.9. IR (υ/cm-1): 2977.55 (m), 2925.48 (m), 2852.20 (m), 1370.18 (s), 1317.14 (s), 


















LTMP (1.96 mmol), 108 mg of Pd(PPh3)4 (0.09 mmol), 663 mg of (E)-(1-iodoprop-1-en-2-
yl)cyclopropane (3.19 mmol, 1.7 equiv), 13 mL of dry THF (4 mL for DBM flask, 9 mL for LTMP 
flask), and 24 mL of dry toluene, the crude product was purified via silica gel chromatography 
(10:1 hexanes:Et2O) to give 189 mg (29% yield) of the desired cross-coupled product as a yellow 
solid. 1H NMR (600 MHz, Chloroform-d) δ 5.49 (dt, J = 9.2, 1.4 Hz, 1H), 1.87 (d, J = 9.2 Hz, 
1H), 1.44 (d, J = 1.3 Hz, 3H), 1.44 – 1.40 (m, 1H), 1.24 (s, 12H), 1.24 (s, 12H), 0.52 – 0.47 (m, 
2H), 0.45 – 0.41 (m, 2H). 13C NMR (151 MHz, CDCl3) δ 134.2, 124.9, 118.5, 83.1, 82.9, 24.9, 
24.7, 24.6, 24.5, 18.9, 13.9, 4.1. IR (υ/cm-1): 2978.52 (m), 2930.31 (m), 1370.18 (s), 1317.14 (s), 




yl)oxy)dimethylsilane ((E)-3.36). Following General Procedure C using 400 mg of 
diborylmethane (1.49 mmol), 230 mg of LTMP (1.57 mmol), 108 mg of Pd(PPh3)4 (0.07 mmol), 
508 mg of (E)-tert-butyl((3-(iodomethylene)pentyl)oxy)dimethylsilane (1.49 mmol, 1.0 equiv), 10 
mL of dry THF (3 mL for DBM flask, 7 mL for LTMP flask), and 20 mL of dry toluene, the crude 
product was purified via silica gel chromatography (10:1 hexanes:Et2O) to give 232 mg (32 
%yield) of the desired cross-coupled product as an orange oil. 1H NMR (500 MHz, Chloroform-
d) δ 5.38 (d, J = 9.9 Hz, 1H), 3.64 (t, J = 7.6 Hz, 2H), 2.29 – 2.21 (m, 2H), 1.99 (q, J = 7.6 Hz, 









(151 MHz, CDCl3) δ 136.2, 121.2, 83.1, 63.5, 40.1, 26.0, 24.7, 24.6, 23.4, 18.4, 12.8, -5.2. IR 
(υ/cm1): 2977.55 (m), 2930.31 (m), 2857.99 (m), 1471.42 (m), 1371.14 (s), 1320.04 (s), 1259.29 




((E)-3.37). Following General Procedure C using 500 mg of diborylmethane (1.87 mmol), 288 mg 
of LTMP (1.96 mmol), 108 mg of Pd(PPh3)4 (0.09 mmol), 740 mg of (E)-(3-
(iodomethylene)pentyl)benzene (2.59 mmol, 1.4 equiv), 13 mL of dry THF (4 mL for DBM flask, 
9 mL for LTMP flask), and 24 mL of dry toluene, the crude product was purified via silica gel 
chromatography (10:1 hexanes:Et2O) to give 330 mg (41 %yield) of the desired cross-coupled 
product as an orange oil. 1H NMR (600 MHz, Chloroform-d) δ 7.28 – 7.23 (m, 2H), 7.19 (d, J = 
7.5 Hz, 2H), 7.15 (t, J = 7.4 Hz, 1H), 5.42 (d, J = 9.9 Hz, 1H), 2.69 (dd, J = 9.8, 6.9 Hz, 2H), 2.36 
– 2.26 (m, 2H), 2.03 (q, J = 7.6 Hz, 2H), 1.91 (d, J = 9.8 Hz, 1H), 1.23 (s, 12H), 1.22 (s, 12H), 
0.95 (td, J = 7.6, 1.7 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 143.0, 138.8, 128.4, 128.2, 125.5, 
119.6, 83.1, 38.6, 35.3, 34.1, 24.7, 24.6, 23.1, 22.4, 14.1, 12.8. IR (υ/cm-1): 2976.59 (m), 2932.23 
(m), 1455.03 (m), 1371.14 (s), 1350.89 (s), 1320.04 (s), 1266.04 (m), 1139.72 (s). HRMS (ESI+): 












3.85). Following General Procedure C using 500 mg of diborylmethane (1.87 mmol), 288 mg of 
LTMP (1.96 mmol), 108 mg of Pd(PPh3)4 (0.09 mmol), 439 mg of (E)-1-iodo-2-methylbut-1-ene 
(2.24 mmol, 1.2 equiv), 13 mL of dry THF (4 mL for DBM flask, 9 mL for LTMP flask), and 24 
mL of dry toluene, the crude product was purified via silica gel chromatography (10:1 
hexanes:Et2O) to give 270 mg (43 %yield) of the desired cross-coupled product as a yellow solid. 
1H NMR 1H NMR (600 MHz, Chloroform-d) δ 5.38 (d, J = 9.1 Hz, 1H), 2.00 (q, J = 7.5 Hz, 2H), 
1.82 (d, J = 9.1 Hz, 1H), 1.54 (s, 3H), 1.22 (d, J = 3.2 Hz, 24H), 0.96 (t, J = 7.4 Hz, 3H). 13C NMR 
(151 MHz, CDCl3) δ 135.9, 118.4, 83.0, 32.5, 24.7, 24.6, 15.8, 13.2. IR (υ/cm-1): 2977.55 (m), 
2930.31 (m), 1370.18 (m), 1317.14 (s), 1139.72 (s). HRMS (ESI+): calcd for C18H34B2O4Na 




3.85). Following General Procedure C using 500 mg of diborylmethane (1.87 mmol), 288 mg of 
LTMP (1.96 mmol), 108 mg of Pd(PPh3)4 (0.09 mmol), 500 mg of (E)-1-iodo-2-methylbut-1-ene 
















mL of dry toluene, the crude product was purified via silica gel chromatography (10:1 
hexanes:Et2O) to give 242 mg (39 %yield) of the desired cross-coupled product as a yellow oil. 1H 
NMR (600 MHz, Chloroform-d) δ 5.36 – 5.31 (m, 1H), 1.96 (q, J = 7.6 Hz, 2H), 1.87 (d, J = 9.5 
Hz, 1H), 1.67 (d, J = 1.4 Hz, 3H), 1.22 (s, 24H), 0.92 (t, J = 7.6 Hz, 3H). 13C NMR (151 MHz, 
CDCl3) δ 135.5, 118.9, 83.1, 31.6, 24.8, 24.7, 24.6, 22.9, 22.7, 14.1, 12.4. IR (υ/cm-1): 2977.55 
(s), 2937.23 (m), 1371.14 (s), 1346.07 (m), 1319.07 (s), 1265.07 (m), 1139.72 (s). HRMS (ESI+): 
calcd for C18H34B2O4Na 359.2541, found: [M+Na+] 359.2526.	
 
n General Procedure I for the Enantioselective Reverse Prenylation of PMB-Protected 
Imines (Liquid Imines)	
	
Procedure: In an N2-filled glovebox, an 8-mL vial equipped with a magnetic stir bar was charged 
with CuOt-Bu (0.3 mg, 0.0025 mmol) and (R)-3,3’-(3,5-Xylyl) H8 Monophos (3.49, 2.9 mg, 0.005 
mmol) and dissolved in 400 µL of dry THF. The reaction was allowed to stir at ambient 
temperature for 60 minutes, after which the vial was sealed with a septa cap, taped, and brought 





























ice/acetone bath and allowed to stir for an additional 10 minutes. Once cooled, bis-prenyl 1,1-
organodiboron reagent (19.3 mg, 0.06 mmol) was added via µL syringe, followed by amine (0.05 
mmol) and methanol-d4 (1.8 mg, 0.05 mmol). After additions were complete, the reaction was 
transferred to an isopropanol cryobath, where it was allowed to warm to -40 °C and stir for 18 
hours. Reactions were quenched via the addition of 1 mL of a saturated aqueous solution of 
ammonium chloride. The aqueous layer was extracted three times with diethyl ether, and the 
combined organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. 
Conversions were determined by 1H NMR, using hexamethyldisiloxane as an internal standard. 
 
n General Procedure II for the Enantioselective Reverse Prenylation of PMB-Protected 
Imines (Solid Imines)	
	
Procedure: In an N2-filled glovebox, an 8-mL vial equipped with a magnetic stir bar was charged 
with CuOt-Bu (0.3 mg, 0.0025 mmol) and (R)-3,3’-(3,5-Xylyl) H8 Monophos (3.49, 2.9 mg, 0.005 
mmol) and dissolved in 300 µL of dry THF. The reaction was allowed to stir at ambient 





























(0.05 mmol) and dissolved in 100 µL of dry THF. Both vials were sealed with septa caps, taped, 
and brought out of the glovebox, where they were placed under N2. The catalyst containing vial 
was cooled to -78 °C in a dry ice/acetone bath and allowed to stir for an additional 10 minutes. 
Once cooled, bis-prenyl 1,1-organodiboron reagent (19.3 mg, 0.06 mmol) was added via µL 
syringe. After addition was complete, the THF-solution of amine was cannula transferred into the 
reaction vial. Methanol-d3 (1.8 mg, 0.05 mmol) was added last, and after additions were complete, 
the reaction was transferred to an isopropanol cryobath, where it was allowed to warm to -40 °C 
and stir for 18 hours. Reactions were quenched via the addition of 1 mL of a saturated aqueous 
solution of ammonium chloride. The aqueous layer was extracted three times with diethyl ether, 
and the combined organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. 




dioxaborolan-2-yl)but-3-en-1-amine (3.55). Following General Procedure I, the crude reaction 
mixture was purified via silica gel column chromatography (10:1 to 4:1 Hex:EtOAc, Curcumin 
stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 80% yield 
(16.8 mg). 1H NMR (500 MHz, Chloroform-d) δ 7.35 – 7.23 (m, 5H), 7.11 (d, J = 8.3 Hz, 2H), 
6.82 (d, J = 8.5 Hz, 2H), 6.62 (d, J = 18.3 Hz, 1H), 5.46 (d, J = 18.3 Hz, 1H), 3.80 (s, 3H), 3.56 
(d, J = 13.4 Hz, 1H), 3.43 (s, 1H), 3.29 (d, J = 13.4 Hz, 1H), 1.29 (s, 12H), 0.96 (s, 3H), 0.86 (s, 









83.1, 69.4, 65.9, 55.2, 50.9, 42.7, 26.2, 24.9, 24.8, 24.8, 20.0, 15.3. IR (υ/cm-1): 2975.62 (m), 
2929.34 (m), 1631.48 (s), 1511.92 (m), 1455.03 (m), 1348.96 (s), 1246.75 (m). HRMS (ESI+): 
calcd for C26H37BNO3+ 422.2867, found: [M+H+] 422.2849.  [α]D22 = 27.2 (c = 0.61, CH2Cl2, l = 
100 mm). 












dioxaborolan-2-yl)but-3-en-1-amine (3.58). Following General Procedure II, the crude reaction 
mixture was purified via silica gel column chromatography (10:1 to 4:1 Hex:EtOAc, Curcumin 
stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 72% yield 
(17.9 mg). 1H NMR (400 MHz, Chloroform-d) δ 7.43 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.4 Hz, 
2H), 7.08 (d, J = 8.6 Hz, 2H), 6.82 (d, J = 8.6 Hz, 2H), 6.57 (d, J = 18.3 Hz, 1H), 5.44 (d, J = 18.3 
Hz, 1H), 3.80 (s, 3H), 3.52 (d, J = 13.4 Hz, 1H), 3.38 (s, 1H), 3.26 (d, J = 13.4 Hz, 1H), 1.29 (s, 
12H), 0.93 (s, 3H), 0.85 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 161.3, 158.5, 139.4, 132.7, 131.2, 
130.7, 129.1, 120.7, 113.7, 83.2, 68.8, 55.3, 50.9, 42.6, 26.1, 24.9, 24.8, 20.0.	IR (υ/cm-1): 2975.62 
(m), 2929.34 (m), 1631.48 (s), 1510.95 (m), 1348.96 (s), 1247.72 (m). HRMS (ESI+): calcd for 
C26H36BBrNO3+ 500.1972, found: [M+H+] 500.1951.  [α]D22 = 44.2 (c = 0.45, CH2Cl2, l = 100 
mm).	


















dioxaborolan-2-yl)but-3-en-1-amine (3.59). Following General Procedure I, the crude reaction 
mixture was purified via silica gel column chromatography (10:1 to 4:1 to 1:1 Hex:EtOAc, 
Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 
71% yield (16.0 mg). 1H NMR (600 MHz, Chloroform-d) δ 7.22 (d, J = 8.5 Hz, 2H), 7.10 (d, J = 
8.5 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 6.81 (d, J = 8.6 Hz, 2H), 6.61 (d, J = 18.3 Hz, 1H), 5.44 (d, 
J = 18.3 Hz, 1H), 3.81 (s, 3H), 3.79 (s, 3H), 3.54 (d, J = 13.4 Hz, 1H), 3.37 (s, 1H), 3.28 (d, J = 
13.5  Hz, 1H), 1.29 (s, 12H), 0.94 (s, 3H), 0.84 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 162.1, 
158.6, 158.4, 133.1, 132.1, 130.4, 129.1, 113.6, 112.9, 83.1, 75.0, 68.7, 55.2, 55.2, 50.8, 42.8, 26.2, 










(m), 1348.96 (s), 1246.75 (m). HRMS (ESI+): calcd for C27H39BNO4+ 452.2972, found: [M+H+] 
452.2956. [α]D22 = 24.3 (c = 0.20, CH2Cl2, l = 100 mm). 












(4-(trifluoromethyl)phenyl)but-3-en-1-amine (3.60). Following General Procedure II, the crude 
reaction mixture was purified via silica gel column chromatography (10:1 to 4:1 Hex:EtOAc, 
Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 
74% yield (18.2 mg). 1H NMR (600 MHz, Chloroform-d) δ 7.56 (d, J = 8.1 Hz, 2H), 7.44 (d, J = 
8.0 Hz, 2H), 7.09 (d, J = 8.5 Hz, 2H), 6.82 (d, J = 8.6 Hz, 2H), 6.58 (d, J = 18.3 Hz, 1H), 5.45 (d, 
J = 18.3 Hz, 1H), 3.80 (s, 3H), 3.53 (d, J = 13.5 Hz, 1H), 3.49 (s, 1H), 3.27 (d, J = 13.4 Hz, 1H), 
1.29 (s, 12H), 0.95 (s, 3H), 0.87 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 161.0, 158.5, 144.7, 
132.5, 129.8, 129.3, 129.1, 125.3, 124.5 (q, J = 3.8 Hz), 123.5, 113.7, 83.2, 69.1, 55.2, 51.0, 42.6, 
26.0, 24.9, 24.7, 20.1. IR (υ/cm-1): 2976.59 (m), 2931.27 (m), 1631.48 (s), 1614.13 (m), 1511.92 
(m), 1324.86 (m). HRMS (ESI+): calcd for C27H36BF3NO3+ 490.2740, found: [M+H+] 490.2719. 
[α]D22 = 28.9 (c = 0.36, CH2Cl2, l = 100 mm).	


















dioxaborolan-2-yl)but-3-en-1-yl)benzoate (3.61). Following General Procedure II, the crude 
reaction mixture was purified via silica gel column chromatography (10:1 to 4:1 Hex:EtOAc, 
Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 
51% yield (12.2 mg). 1H NMR (500 MHz, Chloroform-d) δ 7.96 (s, 1H), 7.96 – 7.92 (m, 1H), 
7.55 (s, 1H), 7.39 (t, J = 7.6 Hz, 1H), 7.10 (d, J = 8.4 Hz, 2H), 6.82 (d, J = 8.6 Hz, 2H), 6.59 (d, J 
= 18.3 Hz, 1H), 5.44 (d, J = 18.4 Hz, 1H), 3.92 (s, 3H), 3.80 (s, 3H), 3.53 (d, J = 14.0 Hz, 1H), 
3.50 (s, 1H), 3.28 (d, J = 13.4 Hz, 1H), 1.29 (s, 12H), 0.95 (s, 3H), 0.87 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 167.4, 161.2, 158.5, 134.0, 130.6, 129.6, 129.2, 128.4, 127.7, 113.7, 83.2, 69.2, 
55.3, 52.1, 50.9, 42.6, 29.7, 29.1, 26.0, 24.9, 24.8, 24.8, 24.8, 24.6, 20.2. IR (υ/cm-1): 2975.62 (s), 










calcd for C28H39BNO5+ 480.2921, found: [M+H+] 480.2909. [α]D22 = 24.8 (c = 0.45, CH2Cl2, l = 
100 mm). 











(3-(trifluoromethyl)phenyl)but-3-en-1-amine (3.62). Following General Procedure I, the crude 
reaction mixture was purified via silica gel column chromatography (10:1 to 4:1 Hex:EtOAc, 
Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 
60% yield (14.6 mg). 1H NMR (500 MHz, Chloroform-d) δ 7.57 (s, 1H), 7.54 – 7.47 (m, 2H), 
7.41 (t, J = 7.7 Hz, 1H), 7.09 (d, J = 8.2 Hz, 2H), 6.86 – 6.78 (m, 2H), 6.57 (d, J = 18.4 Hz, 1H), 
5.42 (d, J = 18.3 Hz, 1H), 3.80 (s, 3H), 3.53 (d, J = 13.4 Hz, 1H), 3.49 (s, 1H), 3.28 (d, J = 13.4 
Hz, 1H), 1.29 (s, 12H), 0.95 (s, 3H), 0.88 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 160.7, 158.6, 
132.8, 130.0, 129.8, 129.2, 127.9, 126.1, 125.3, 123.9, 123.5, 113.7, 83.2, 69.3, 55.3, 51.0, 42.6, 
31.9, 29.7, 25.6, 24.8, 24.7, 20.6. IR (υ/cm-1): 2976.59 (m), 2931.27 (m), 1631.48 (s), 1511.92 
(m), 1349.93 (m), 1326.79 (m). HRMS (ESI+): calcd for C27H36BF3NO3+ 490.2740, found: 
[M+H+] 490.2722. [α]D22 = 28.3 (c = 0.38, CH2Cl2, l = 100 mm). 



















dioxaborolan-2-yl)but-3-en-1-amine (3.63). Following General Procedure II, the crude reaction 









stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 67% yield 
(15.7 mg). 1H NMR (500 MHz, Chloroform-d) δ 7.87 – 7.81 (m, 2H), 7.79 (d, J = 8.5 Hz, 1H), 
7.75 (s, 1H), 7.53 – 7.49 (m, 1H), 7.49 – 7.42 (m, 2H), 7.14 – 7.09 (m, 2H), 6.85 – 6.80 (m, 2H), 
6.68 (d, J = 18.3 Hz, 1H), 5.49 (d, J = 18.3 Hz, 1H), 3.80 (s, 3H), 3.60 (s, 1H), 3.58 (d, J = 13.4 
Hz, 1H), 3.32 (d, J = 13.5 Hz, 1H), 1.31 (s, 12H), 1.02 (s, 3H), 0.91 (s, 3H). 13C NMR (151 MHz, 
CDCl3) δ 161.8, 158.5, 133.0, 133.0, 129.3, 128.5, 127.9, 127.7, 127.6, 127.0, 125.7, 125.5, 113.7, 
83.2, 69.4, 55.3, 53.4, 50.9, 43.0, 29.7, 26.2, 24.9, 24.8, 24.6, 20.4, 14.1. IR (υ/cm-1): 2974.66 (s), 
2929.34 (m), 1630.52 (s), 1510.95 (m), 1348.96 (s), 1246.75 (m). HRMS (ESI+): calcd for 
C30H39BNO3+ 472.3023, found: [M+H+] 472.3005. [α]D22 = 39.4 (c = 0.53, CH2Cl2, l = 100 mm). 











tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-amine (3.64). Following General Procedure II, 
the crude reaction mixture was purified via silica gel column chromatography (10:1 to 4:1 
Hex:EtOAc, Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a 
colorless oil in 52% yield (13.8 mg). 1H NMR (500 MHz, Chloroform-d) δ 7.54 (d, J = 2.3 Hz, 
1H), 7.53 (d, J = 8.5 Hz, 1H), 7.28 (dd, J = 8.5, 2.2 Hz, 1H), 7.10 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 
8.6 Hz, 2H), 6.65 (d, J = 18.4 Hz, 1H), 5.44 (d, J = 18.4 Hz, 1H), 4.10 (s, 1H), 3.79 (s, 3H), 3.41 
(d, J = 13.3 Hz, 1H), 3.27 (d, J = 13.3 Hz, 1H), 1.29 (s, 12H), 0.99 (s, 3H), 0.96 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 160.7, 158.5, 138.7, 133.1, 132.6, 132.0, 131.3, 129.3, 127.2, 126.7, 113.6, 
83.2, 65.7, 55.3, 50.9, 43.8, 25.5, 24.9, 24.8, 20.3. IR (υ/cm-1): 2974.66 (m), 2926.45 (m), 1630.52 











C26H35BBrClNO3+ 534.1582, found: [M+H+] 534.1566. [α]D22 = 14.9 (c = 0.20, CH2Cl2, l = 100 
mm). 
Phenomenex Cell-3 Column; 98:2 CO2:MeOH; 2.0 mL/min; 35 °C; 210 nm 
 
Racemic Material (from reaction between equimolar amounts of (R)- and (S)-H8-Monophos) 
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mixture was purified via silica gel column chromatography (10:1 to 4:1 Hex:EtOAc, Curcumin 
stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 53% yield 
(11.6 mg). 1H NMR (500 MHz, Chloroform-d) δ 7.51 (s, 1H), 7.25 – 7.19 (m, 1H), 7.16 – 7.10 
(m, 3H), 7.00 (ddd, J = 10.4, 8.1, 1.2 Hz, 1H), 6.82 (d, J = 8.6 Hz, 2H), 6.66 (d, J = 18.3 Hz, 1H), 
5.44 (d, J = 18.4 Hz, 1H), 3.94 (s, 1H), 3.79 (s, 3H), 3.51 (d, J = 13.2 Hz, 1H), 3.30 (d, J = 13.2 
Hz, 1H), 1.29 (s, 12H), 0.97 (s, 3H), 0.93 (d, J = 1.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
161.3, 160.7 (d, J = 227.2 Hz), 158.4, 132.8, 130.1, 129.2, 128.2 (d, J = 8.5 Hz), 123.6 (d, J = 3.2 
Hz), 114.9 (d, J = 23.6 Hz), 113.6, 83.1, 55.2, 51.1, 43.2, 25.4, 24.9, 24.8, 20.2. IR (υ/cm-1): 
2975.62 (m), 2931.27 (m), 1631.48 (s), 1511.92 (m), 1456.96 (m), 1348.96 (s), 1246.75 (m). 
HRMS (ESI+): calcd for C26H36BFNO3+ 440.2772, found: [M+H+] 440.2756. [α]D22 = 31.9 (c = 
0.37, CH2Cl2, l = 100 mm). 










dioxaborolan-2-yl)but-3-en-1-amine (3.66). Following General Procedure I, the crude reaction 
mixture was purified via silica gel column chromatography (10:1 to 4:1 Hex:EtOAc, Curcumin 
stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 87% yield 
(17.9 mg). 1H NMR (600 MHz, Chloroform-d) δ 7.37 (s, 1H), 7.15 (d, J = 8.1 Hz, 2H), 6.86 – 
6.78 (m, 2H), 6.62 (dd, J = 18.4, 2.0 Hz, 1H), 6.37 – 6.30 (m, 1H), 6.15 (d, J = 3.1 Hz, 1H), 5.50 
– 5.40 (m, 1H), 3.80 (d, J = 1.9 Hz, 3H), 3.67 (d, J = 13.4 Hz, 1H), 3.43 (d, J = 2.0 Hz, 1H), 3.34 
(d, J = 13.4 Hz, 1H), 1.29 (s, 12H), 1.03 (s, 3H), 0.94 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 
161.1, 154.9, 141.4, 132.5, 129.3, 113.6, 109.8, 108.3, 83.1, 63.1, 55.2, 50.8, 42.6, 25.4, 24.9, 24.8, 
21.7. IR (υ/cm-1): 2975.62 (s), 2930.31 (m), 1632.45 (m), 1511.92 (m), 1348.96 (s), 1246.75 (m). 
HRMS (ESI+): calcd for C24H35BNO4+ 412.2659, found: [M+H+] 412.2642. [α]D22 = 28.0 (c = 



















(thiophen-2-yl)but-3-en-1-amine (3.67). Following General Procedure II, the crude reaction 
mixture was purified via silica gel column chromatography (10:1 to 4:1 Hex:EtOAc, Curcumin 










(16.1 mg). 1H NMR (600 MHz, Chloroform-d) δ 7.24 (dd, J = 5.0, 1.2 Hz, 1H), 7.14 (d, J = 8.5 
Hz, 2H), 6.97 (dd, J = 5.1, 3.4 Hz, 1H), 6.88 (dd, J = 3.6, 1.2 Hz, 1H), 6.83 (d, J = 8.6 Hz, 2H), 
6.60 (d, J = 18.3 Hz, 1H), 5.49 (d, J = 18.3 Hz, 1H), 3.80 (s, 3H), 3.68 (m, 2H), 3.39 (d, J = 13.5 
Hz, 1H), 1.29 (s, 12H), 1.04 (s, 3H), 0.93 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 161.2, 158.5, 
145.4, 132.6, 129.3, 126.4, 125.9, 124.2, 113.6, 83.2, 65.2, 55.2, 50.9, 42.6, 26.2, 24.9, 24.8, 20.3. 
IR (υ/cm-1): 2924.52 (m), 2852.20 (m), 1630.52 (s), 1511.92 (m), 1463.71 (m), 1348.96 (s). 
HRMS (ESI+): calcd for C24H35BNO3S+ 428.2431, found: [M+H+] 428.2420. [α]D22 = 61.3 (c = 
0.02, CH2Cl2, l = 100 mm). 










tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-amine (3.68). Following General Procedure I, 
the crude reaction mixture was purified via silica gel column chromatography (10:1 to 4:1 
Hex:EtOAc, Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a 
colorless oil in 84% yield (20.6 mg). 1H NMR (600 MHz, Chloroform-d) δ 7.96 (d, J = 8.0 Hz, 
1H), 7.28 (dd, J = 5.5, 2.6 Hz, 1H), 7.09 (dd, J = 8.5, 2.9 Hz, 2H), 6.87 – 6.80 (m, 2H), 6.63 (d, J 
= 18.4 Hz, 1H), 5.46 (d, J = 18.4 Hz, 1H), 4.08 (s, 1H), 3.82 (s, 3H), 3.45 (d, J = 13.4 Hz, 1H), 
3.33 – 3.27 (m, 1H), 1.32 (s, 12H), 0.99 (s, 3H), 0.97 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 
159.9, 158.6, 151.2, 148.5, 141.9, 134.2, 132.0, 129.3, 122.8, 113.7, 83.4, 63.2, 55.3, 51.1, 43.9, 
25.3, 24.9, 24.8, 19.9. IR (υ/cm-1): 2974.66 (m), 2928.38 (m), 1632.45 (m), 1546.63 (m), 1511.92 
(m), 1348.96 (s). HRMS (ESI+): calcd for C25H34BCl2N2O3+ 490.1961, found: [M+H+] 491.2008. 
[α]D22 = 37.2 (c = 0.62, CH2Cl2, l = 100 mm). 


















1,3,2-dioxaborolan-2-yl)vinyl)hexan-1-amine (3.69). Following General Procedure I, the crude 
reaction mixture was purified via silica gel column chromatography (10:1 to 4:1 Hex:EtOAc, 
Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 











2H), 7.12 (d, J = 8.2 Hz, 2H), 7.10 (d, J = 8.5 Hz, 2H), 6.82 (d, J = 8.5 Hz, 2H), 6.51 (d, J = 18.4 
Hz, 1H), 5.30 (d, J = 18.5 Hz, 1H), 3.80 (s, 3H), 3.54 (d, J = 13.3 Hz, 1H), 3.39 (s, 1H), 3.25 (d, J 
= 13.3 Hz, 1H), 1.42 – 1.34 (m, 1H), 1.28 (s, 12H), 1.27 – 1.23 (m, 1H), 1.19 (qd, J = 7.3, 3.4 Hz, 
2H), 1.12 – 1.04 (m, 2H), 0.95 (s, 3H), 0.82 (t, J = 7.3 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 
159.3, 158.5, 139.7, 132.6, 131.1, 130.5, 129.2, 120.6, 113.6, 83.1, 69.1, 55.3, 50.8, 45.4, 35.9, 
26.3, 24.9, 24.7, 23.5, 20.3, 14.1. IR (υ/cm-1): 2956.34 (s), 2931.27 (m), 1630.52 (m), 1511.92 
(m), 1463.71 (m), 1349.93 (m). HRMS (ESI+): calcd for C29H42BBrNO3+ 542.2441, found: 
[M+H+] 542.2414.  [α]D22 = 28.1 (c = 0.34, CH2Cl2, l = 100 mm). 











(3.70). Following General Procedure I, the crude reaction mixture was purified via silica gel 
column chromatography (10:1 to 4:1 Hex:EtOAc, Curcumin stain visualization) to yield the 1-
amino-3-alkenylboronate ester as a colorless oil in 86% yield (27.8 mg) and >20:1 d.r. 1H NMR 
(600 MHz, Chloroform-d) δ 7.41 (d, J = 8.4 Hz, 2H), 7.12 (d, J = 8.3 Hz, 2H), 7.10 (d, J = 8.6 Hz, 











3.57 – 3.49 (m, 3H), 3.39 (s, 1H), 3.26 (d, J = 13.3 Hz, 1H), 1.70 – 1.59 (m, 4H), 1.27 (s, 6H), 
1.26 (s, 6H), 0.97 (s, 3H), 0.84 (s, 9H), -0.02 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 158.8, 158.5, 
139.4, 132.5, 131.1, 130.6, 129.2, 120.7, 113.6, 83.1, 69.3, 60.1, 55.3, 50.8, 44.5, 39.1, 26.0, 24.8, 
24.8, 20.4, 18.3, -5.2. IR (υ/cm-1): 2954.41 (m), 2927.41 (m), 2855.10 (m), 1630.52 (s), 1511.92 
(m), 1462.74 (m), 1350.89 (m). HRMS (ESI+): calcd for C33H52BBrNO4Si+ 644.2942, found: 
[M+H+] 644.2925. [α]D22 = 13.5 (c = 0.78, CH2Cl2, l = 100 mm). 










1,3,2-dioxaborolan-2-yl)but-3-en-1-amine (3.71). Following General Procedure I, the crude 
reaction mixture was purified via silica gel column chromatography (10:1 to 4:1 Hex:EtOAc, 
Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a colorless oil in 
59% yield (14.9 mg) and >20:1 d.r. 1H NMR (600 MHz, Chloroform-d) δ 7.30 – 7.05 (m, 8H), 
6.87 – 6.81 (m, 2H), 6.74 (dd, J = 18.5, 4.0 Hz, 1H), 6.33 (d, J = 4.0 Hz, 1H), 6.13 (d, J = 4.2 Hz, 











1H), 3.34 (d, J = 12.9 Hz, 1H), 2.53 – 2.28 (m, 2H), 1.77 – 1.54 (m, 2H), 1.29 (s, 12H), 1.16 (s, 
3H). 13C NMR (151 MHz, CDCl3) δ 158.6, 158.5, 155.0, 143.1, 141.3, 132.5, 129.4, 128.4, 128.2, 
125.5, 113.6, 109.7, 108.5, 83.1, 63.0, 55.3, 50.8, 45.7, 39.2, 30.6, 24.9, 24.8, 20.2. IR (υ/cm-1): 
2975.62 (s), 2927.41 (m), 1631.48 (m), 1511.92 (m), 1455.03 (m), 1348.96 (s), 1246.75 (m). 
HRMS (ESI+): calcd for C31H41BNO4+ 502.3129, found: [M+H+] 502.3116.  [α]D22 = 5.4 (c = 0.60, 
CH2Cl2, l = 100 mm). 











Following General Procedure II, the crude reaction mixture was purified via silica gel column 
chromatography (10:1 to 4:1 Hex:EtOAc, Curcumin stain visualization) to yield the 1-amino-3-
alkenylboronate ester as a colorless oil in 82% yield (26.6 mg) and >20:1 d.r. 1H NMR (600 MHz, 
Chloroform-d) δ 7.56 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 7.9 Hz, 2H), 7.11 (d, J = 8.5 Hz, 2H), 6.82 
(d, J = 8.6 Hz, 2H), 6.48 (d, J = 18.7 Hz, 1H), 5.42 (d, J = 18.6 Hz, 1H), 3.80 (s, 3H), 3.58 (s, 1H), 
3.55 – 3.44 (m, 3H), 3.22 (d, J = 13.2 Hz, 1H), 1.83 (dq, J = 14.5, 7.4 Hz, 1H), 1.59 (ddd, J = 13.9, 
9.4, 6.2 Hz, 1H), 1.42 (dq, J = 23.1, 7.6 Hz, 2H), 1.28 (m, 15H), 0.83 (s, 9H), 0.77 (t, J = 7.4 Hz, 
3H), -0.03 (s, 3H), -0.04 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 158.6, 157.6, 145.0, 132.4, 129.7, 
129.4, 125.2, 124.5 (q, J = 3.8 Hz) 123.4, 113.6, 83.2, 66.1, 59.7, 55.3, 50.6, 46.8, 36.2, 26.0, 25.1, 
24.9, 24.9, 24.8, 18.3, 8.0, -5.3, -5.3. IR (υ/cm-1): 2955.38 (m), 2930.31 (m), 2857.02 (m), 1627.63 
(m), 1615.09 (m), 1512.88 (s), 1350.89 (m), 1325.82 (s). HRMS (ESI+): calcd for 
C35H54BF3NO4Si+ 648.3862, found: [M+H+] 648.3824. [α]D22 = 23.1 (c = 1.07, CH2Cl2, l = 100 
mm). 




















tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-amine (3.73). Following General Procedure II, 
the crude reaction mixture was purified via silica gel column chromatography (10:1 to 4:1 
Hex:EtOAc, Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a 
colorless oil in 67% yield (19.8 mg) and >20:1 d.r. 1H NMR (600 MHz, Chloroform-d) δ 7.72 (d, 
J = 8.0 Hz, 1H), 7.25 (d, J = 8.1 Hz, 1H), 7.22 (t, J = 7.5 Hz, 2H), 7.16 – 7.11 (m, 3H), 7.07 – 7.03 
(m, 2H), 6.83 (d, J = 8.5 Hz, 2H), 6.49 (d, J = 18.6 Hz, 1H), 5.49 (d, J = 18.7 Hz, 1H), 4.25 (s, 
1H), 3.80 (s, 3H), 3.49 (d, J = 13.1 Hz, 1H), 3.25 (d, J = 13.2 Hz, 1H), 2.47 (dt, J = 13.3, 6.8 Hz, 
1H), 2.32 (td, J = 13.3, 4.2 Hz, 1H), 1.99 (dt, J = 15.0, 7.6 Hz, 1H), 1.88 (td, J = 13.4, 5.0 Hz, 1H), 
1.60 (dq, J = 14.6, 7.4 Hz, 2H), 1.30 (s, 12H), 0.83 (t, J = 7.4 Hz, 3H). 13C NMR (151 MHz, 
CDCl3) δ 158.8, 156.3, 151.3, 148.4, 142.3, 141.3, 134.8, 131.9, 129.5, 128.3, 128.1, 125.8, 122.8, 
113.7, 83.3, 75.0, 60.3, 55.3, 50.7, 48.6, 34.7, 33.6, 31.6, 29.8, 24.91, 24.9, 24.8, 24.8, 24.2, 22.7, 
20.7, 14.1, 7.5. IR (υ/cm-1): 2974.66 (m), 2932.23 (m), 1627.63 (m), 1612.20 (m), 1511.92 (s), 
1455.03 (m), 1348.96 (s). HRMS (ESI+): calcd for C33H42BCl2N2O3+ 595.2660, found: [M+H+] 
595.2629. [α]D22 = 17.4 (c = 1.27, CH2Cl2, l = 100 mm). 



















tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-amine (3.74). Following General Procedure I, 










Hex:EtOAc, Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a 
colorless oil in 62% yield (14.8 mg) and >20:1 d.r. 1H NMR (500 MHz, Chloroform-d) δ 7.37 (d, 
J = 1.7 Hz, 1H), 7.18 (d, J = 8.4 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 6.61 (d, J = 18.5 Hz, 1H), 6.32 
(dd, J = 3.2, 1.8 Hz, 1H), 6.08 (d, J = 3.1 Hz, 1H), 5.39 (d, J = 18.5 Hz, 1H), 3.80 (s, 3H), 3.65 – 
3.60 (m, 2H), 3.28 (d, J = 13.3 Hz, 1H), 1.77 – 1.52 (m, 7H), 1.42 – 1.35 (m, 1H), 1.27 (s, 12H), 
1.14 – 1.01 (m, 5H), 0.88 (td, J = 11.5, 9.4, 3.1 Hz, 2H).	13C NMR (126 MHz, CDCl3) δ 158.5, 
158.4, 155.4, 141.1, 132.7, 129.4, 113.5, 109.6, 108.2, 82.9, 59.7, 55.3, 50.4, 48.9, 43.4, 28.1, 27.4, 
27.1, 26.9, 26.8, 24.9, 24.7, 15.5. IR (υ/cm-1): 2976.59 (m), 2927.41 (s), 2852.20 (m), 1631.48 
(m), 1511.92 (m), 1450.21 (m), 1348.96 (s), 1246.75 (m). HRMS (ESI+): calcd for C29H43BNO4+ 
480.3280, found: [M+H+] 480.3254. [α]D22 = 29.6 (c = 0.63, CH2Cl2, l = 100 mm). 










dioxaborolan-2-yl)-1-(thiophen-2-yl)but-3-en-1-amine (3.75). Following General Procedure II, 
the crude reaction mixture was purified via silica gel column chromatography (10:1 to 4:1 
Hex:EtOAc, Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as a 
colorless oil in 75% yield (17.1 mg) and >20:1 d.r. 1H NMR (500 MHz, Chloroform-d) δ 7.22 
(dd, J = 5.1, 1.2 Hz, 1H), 7.19 – 7.13 (m, 2H), 6.94 (dd, J = 5.0, 3.5 Hz, 1H), 6.86 (dd, J = 3.5, 1.1 
Hz, 1H), 6.84 (d, J = 8.6 Hz, 2H), 6.58 (d, J = 18.4 Hz, 1H), 5.52 (d, J = 18.4 Hz, 1H), 3.80 (s, 
3H), 3.79 (s, 1H), 3.75 (d, J = 13.4 Hz, 1H), 3.42 (d, J = 13.5 Hz, 1H), 1.28 (s, 12H), 0.96 – 0.85 
(m, 1H), 0.70 (s, 3H), 0.37 – 0.30 (m, 2H), 0.16 – 0.07 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 










24.9, 24.8, 24.8, 16.8, 15.7, 1.6, 0.5. IR (υ/cm-1): 2976.59 (m), 2928.38 (m), 2854.13 (m), 1631.48 
(m), 1612.20 (m), 1511.92 (s), 1462.74 (m), 1348.96 (s). HRMS (ESI+): calcd for C26H37BNSO3+ 
454.2582, found: [M+H+] 454.2556. [α]D22 = 14.2 (c = 0.67, CH2Cl2, l = 100 mm). 










tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-amine ((R,S)-3.86). Following General 
Procedure II, the crude reaction mixture was purified via silica gel column chromatography (10:1 
to 4:1 Hex:EtOAc, Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as 
a colorless oil in 52% yield (12.7 mg) and >20:1 d.r. 1H NMR (600 MHz, Chloroform-d) δ 7.86 
– 7.81 (m, 2H), 7.79 (d, J = 8.5 Hz, 1H), 7.75 (s, 1H), 7.52 (d, J = 8.5 Hz, 1H), 7.49 – 7.43 (m, 
2H), 7.12 – 7.07 (m, 2H), 6.85 – 6.81 (m, 2H), 6.55 (d, J = 18.4 Hz, 1H), 5.50 (d, J = 18.4 Hz, 
1H), 3.80 (s, 3H), 3.60 (s, 1H), 3.56 (d, J = 13.5 Hz, 1H), 3.31 (d, J = 13.5 Hz, 1H), 1.44 (dt, J = 
13.6, 7.4 Hz, 1H), 1.32 (d, J = 2.2 Hz, 12H), 1.16 (dq, J = 14.7, 7.4 Hz, 1H), 0.97 (s, 3H), 0.65 (t, 
J = 7.5 Hz, 3H).	13C NMR (151 MHz, CDCl3) δ 136.2, 121.2, 83.1, 63.5, 40.1, 26.0, 24.7, 24.6, 
23.4, 18.4, 12.8, -5.2. IR (υ/cm-1): 2972.73 (m), 2929.34 (m), 1629.55 (m), 1510.95 (s), 1460.81 
(m), 1349.93 (s). HRMS (ESI+): calcd for C31H41BNO3+ 486.3174, found: [M+H+] 486.3149. 
[α]D22 = 38.0  (c = 0.64, CH2Cl2, l = 100 mm).	


























Procedure II, the crude reaction mixture was purified via silica gel column chromatography (10:1 
to 4:1 Hex:EtOAc, Curcumin stain visualization) to yield the 1-amino-3-alkenylboronate ester as 
a colorless oil in 63% yield (16.3 mg) and >20:1 d.r. 1H NMR (500 MHz, Chloroform-d) δ 7.86 
– 7.79 (m, 2H), 7.77 (d, J = 8.5 Hz, 1H), 7.67 (d, J = 1.5 Hz, 1H), 7.48 – 7.44 (m, 2H), 7.44 – 7.41 
(m, 1H), 7.13 (d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 6.62 (d, J = 18.5 Hz, 1H), 5.35 (d, J = 
18.5 Hz, 1H), 3.80 (s, 3H), 3.63 – 3.58 (m, 2H), 3.31 (d, J = 13.4 Hz, 1H), 1.56 – 1.36 (m, 2H), 
1.27 (d, J = 6.5 Hz, 12H), 1.03 (s, 3H), 0.72 (t, J = 7.5 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
159.4, 158.4, 138.3, 133.0, 132.9, 132.8, 129.3, 128.3, 127.9, 127.6, 127.5, 126.9, 125.7, 125.4, 
113.6, 83.0, 69.7, 55.3, 50.9, 46.1, 28.9, 24.9, 24.7, 19.8, 8.7.	IR (υ/cm-1): 2974.66 (m), 2931.27 
(m), 1629.55 (m), 1510.95 (m), 1458.89 (m), 1349.93 (s). HRMS (ESI+): calcd for C31H41BNO3+ 
486.3174, found: [M+H+] 486.3148. [α]D22 = 51.6 (c = 0.55, CH2Cl2, l = 100 mm).	










(trifluoromethyl)phenyl)but-3-en-1-amine (3.77). Styrene-derivative 3.77 was synthesized 
according to a literature procedure.76 An 8 mL reaction vial was equipped with a magnetic stir bar 
and charged with alkenylboronate 3.71. The vial was placed under vacuum and dried for 10 
minutes before back-filling with N2 gas and purging for 5 minutes. Dry dioxane was added to the 
vial, followed by a 0.9M solution of NaHCO3 in water. Lastly, PdCl2dppf was added to the 
suspension as a solid. The reaction was sealed with a septa cap, heated to 80 °C and allowed to stir 
for 5 h. The reaction was quenched with water and extracted with EtOAc (3x). The combined 
organics were washed with saturated brine solution, dried over MgSO4, filtered and concentrated 




















cross coupled product 3.77 as a clear oil in 66% yield (30.8 mg) 1H NMR (500 MHz, Chloroform-
d) δ 7.58 (d, J = 8.1 Hz, 2H), 7.47 (d, J = 8.1 Hz, 2H), 7.42 (d, J = 1.8 Hz, 1H), 7.29 – 7.24 (m, 
2H), 7.21 (d, J = 8.3 Hz, 2H), 7.17 (t, J = 7.4 Hz, 1H), 7.14 – 7.09 (m, 2H), 6.84 (d, J = 8.6 Hz, 
2H), 6.49 (d, J = 16.3 Hz, 1H), 6.41 (d, J = 16.4 Hz, 1H), 6.36 (dd, J = 3.1, 1.8 Hz, 1H), 6.17 (d, 
J = 3.1 Hz, 1H), 3.80 (s, 3H), 3.69 (d, J = 13.1 Hz, 1H), 3.53 (s, 1H), 3.36 (d, J = 13.1 Hz, 1H), 
2.60 (td, J = 13.0, 5.2 Hz, 1H), 2.44 (td, J = 12.9, 4.7 Hz, 1H), 1.77 (td, J = 13.0, 5.3 Hz, 1H), 1.70 
(td, J = 12.9, 4.7 Hz, 1H), 1.35 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 158.6, 154.9, 142.8, 141.5, 
138.8, 132.4, 129.5, 128.3, 128.0, 126.3, 125.7, 125.5, 125.5, 125.5, 125.4, 113.6, 109.9, 108.7, 
63.2, 55.3, 50.8, 44.4, 40.5, 30.7, 20.5. IR (υ/cm-1): 2934.16 (m), 2835.81 (m), 1614.13 (m), 
1511.92 (s), 1324.86 (s), 1247.72 (m). HRMS (ESI+): calcd for C32H33F3NO2+ 520.2463, found: 




tetramethyl-1,3,2-dioxaborolan-2-yl)pent-3-en-1-amine (3.79). Allylboronic ester 3.79 was 
synthesized according to a literature procedure.77 An 8 mL reaction vial equipped with a magnetic 
stirbar was charged with alkenylboronate 3.73 (31.8 mg, 0.053 mmol) and placed under vacuum 
for ten minutes. The vial was back-filled with N2 gas, capped with a septa cap and purged with N2 
for five minutes. Dry THF (530 µL, 0.1 M) was added to the vial, followed by dibromomethane 
(13.6 mg, 5.4 µL, 0.078 mmol, passed through neutral alumina and sparged before use). The 




B(pin) n-BuLi (1.2 equiv)















added dropwise as a 2.61M solution in hexanes. The resulting solution was allowed to stir at -78 
°C for twenty minutes before being warmed to ambient temperature and allowed to stir for an 
additional two hours. After, the reaction was quenched with 1 mL of a saturated aqueous solution 
of ammonium chloride. The layers were separated and the aqueous layer was extracted with diethyl 
ether (3x). The combined organics were dried over MgSO4, filtered and concentrated in vacuo. 
The crude oil was purified via silica gel chromatography (10:1 to 4:1 hexanes:EtOAc) to reveal 
allylboronic ester 3.79 as a colorless oil in 72% yield (23.4 mg).  1H NMR (500 MHz, Chloroform-
d) δ 7.88 (d, J = 8.1 Hz, 1H), 7.21 (t, J = 7.6 Hz, 3H), 7.14 (m, 3H), 7.07 – 7.01 (m, 3H), 6.82 (d, 
J = 8.6 Hz, 2H), 5.54 (ddd, J = 15.5, 8.2, 6.8 Hz, 1H), 5.19 (d, J = 16.0 Hz, 1H), 4.17 (s, 1H), 3.79 
(s, 3H), 3.48 (d, J = 13.1 Hz, 1H), 3.28 (d, J = 13.1 Hz, 1H), 2.47 (td, J = 13.3, 5.2 Hz, 1H), 2.33 
(td, J = 13.5, 13.1, 4.0 Hz, 1H), 2.15 (dq, J = 14.7, 7.4 Hz, 1H), 1.86 (td, J = 13.1, 5.2 Hz, 1H), 
1.78 – 1.74 (m, 2H), 1.53 (dd, J = 14.1, 7.3 Hz, 1H), 1.22 (s, 6H), 1.20 (s, 6H), 1.04 – 0.97 (m, 
1H), 0.86 (m, 4H).	13C NMR (126 MHz, CDCl3) δ 158.6, 151.4, 148.1, 142.7, 141.3, 135.6, 133.3, 
132.2, 129.4, 128.3, 128.1, 127.7, 125.6, 122.6, 113.6, 83.4, 59.8, 55.3, 50.3, 46.6, 34.6, 29.9, 24.9, 
24.9, 24.8, 7.5. IR (υ/cm-1): 2972.73 (m), 2932.23 (m), 1612.20 (m), 1546.63 (m), 1511.92 (s), 
1455.03 (m), 1420.32 (m), 1350.89 (s). HRMS (ESI+): calcd for C34H44BCl2N2O3+ 609.2822, 
found: [M+H+] 609.2819. [α]D22 = 31.1 (c = 1.17, CH2Cl2, l = 100 mm).	
 
 
(R)-N-(4-methoxybenzyl)-2,2-dimethyl-1-phenylbut-3-en-1-amine (3.80). Homoallylic amine 3.80 
was synthesized according to a literature procedure.78 An amber 8 mL reaction vial equipped with 




B(pin) AgF (2 equiv)
THF:MeOH:H2O (0.1 M)







water (44 µL) were added to the vial, followed by a solution of alkenylboronate 3.55 (18.7 mg, 
0.044 mmol) in THF (220 µL). The reaction was capped, sealed with electrical tape, heated to 60 
°C and allowed to stir for 1.5 hours. After, the reaction was allowed to cool to ambient temperature 
before being diluted with diethyl ether and passed through a short silica gel plug. The filtrate was 
collected and concentrated in vacuo. The crude oil was purified via silica gel chromatography (4:1 
to 1:1 hexanes:EtOAc) to reveal homoallylic amine 3.80 as a colorless oil in 67% yield (8.8 mg). 
1H NMR (500 MHz, Chloroform-d) δ 7.34 – 7.30 (m, 4H), 7.28 – 7.26 (m, 1H), 7.12 (d, J = 8.5 
Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 5.81 (dd, J = 17.5, 10.7 Hz, 1H), 5.06 (dd, J = 10.8, 1.4 Hz, 1H), 
5.02 (dd, J = 17.4, 1.4 Hz, 1H), 3.80 (s, 3H), 3.56 (d, J = 13.3 Hz, 1H), 3.37 (s, 1H), 3.29 (d, J = 
13.3 Hz, 1H), 0.93 (s, 3H), 0.90 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 158.4, 146.7, 140.4, 133.0, 
129.5, 129.2, 127.5, 126.9, 113.6, 113.0, 69.7, 55.3, 51.0, 41.2, 26.6, 20.8. IR (υ/cm-1): 2957.30 
(m), 2931.27 (m), 1611.23 (m), 1510.95 (s), 1453.10 (m), 1246.75 (s). HRMS (ESI+): calcd for 
C20H26NO+ 296.2014, found: [M+H+] 296.1998. [α]D22 = 40.2 (c = 0.37, CH2Cl2, l = 100 mm).	
 
	
(R)-2-(4-bromophenyl)-1-(4-methoxybenzyl)-3,3-dimethylpyrrolidine (3.82). An 8 mL 
reaction vial equipped with a magnetic stir bar was charged with alkenylboron 3.58 (14.5 mg, 0.03 
mmol). NaBO3•4H2O (13.4 mg, 0.087 mmol) was added to the vial as a solid, followed by 0.5 mL 
of a 1:1 mixture of THF and H2O. The vial was capped and the slurry was allowed to stir vigorously 






O 1) NaBO3•4H2OTHF:H2O (1:1), 22 °C, 3 h
2) NaBH3CN (1.5 equiv)
AcOH (10% in MeOH)








The layers were separated, and the aqueous layer was extracted with diethyl ether (3x). The 
combined organics were dried over MgSO4, filtered and concentrated. 
 To the vial containing crude product, 0.5 mL of acetic acid solution (10% v/v in methanol) 
was added. The solution was cooled to 0 °C in an ice bath before NaBH3CN (2.7 mg, 0.04 mmol) 
was added as a solid. The solution was allowed to warm to 22 °C and allowed to stir for an 
additional three hours. The reaction was quenched with a 1M solution of K2CO3 (2 mL) and the 
layers were separated. The aqueous layer was extracted with diethyl ether (3x). The organics were 
combined, washed with water and brine, dried over MgSO4, filtered and concentrated to give crude 
pyrrolidine 3.79. Purification by silica gel chromatography (10:1 hexanes:Et2O) yielded 3.79 as a 
crystalline solid in 49% yield (5.3 mg) over two steps. 1H NMR (600 MHz, Chloroform-d) δ 7.46 
(d, J = 8.2 Hz, 2H), 7.29 (bs, 2H), 7.20 (d, J = 8.5 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 3.80 (s, 3H), 
3.75 (d, J = 13.2 Hz, 1H), 3.15 (s, 1H), 3.05 (ddd, J = 9.6, 7.7, 4.7 Hz, 1H), 3.01 (d, J = 13.2 Hz, 
1H), 2.27 (td, J = 9.3, 7.7 Hz, 1H), 1.70 – 1.61 (m, 2H), 1.03 (s, 3H), 0.64 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 158.4, 139.6, 131.7, 131.0, 129.5, 120.5, 113.5, 78.5, 57.9, 55.3, 50.8, 41.5, 39.2, 
28.1, 25.7. IR (υ/cm-1): 2953.45 (m), 1611.23 (m), 1510.95 (s), 1463.71 (m), 1365.35 (m), 1246.75 
(s). HRMS (ESI+): calcd for C20H25BrNO+ 374.1120, found: [M+H+] 374.1098. [α]D22 = 12.9  (c 






(2R,3S)-2-(4-bromophenyl)-3-butyl-1-(4-methoxybenzyl)-3-methylpyrrolidine (3.84). Following the 
same procedure as 3.82, pyrrolidine 3.84 was isolated as a clear, colorless oil in 57% yield (18.5 
mg) over two steps. 1H NMR (600 MHz, Chloroform-d) δ 7.46 (d, J = 7.9 Hz, 2H), 7.26 (bs, 2H), 
7.22 – 7.16 (m, 2H), 6.87 – 6.80 (m, 2H), 3.80 (s, 3H), 3.75 (d, J = 13.2 Hz, 1H), 3.18 (s, 1H), 
3.03 – 2.96 (m, 2H), 2.26 (dt, J = 9.5, 8.5 Hz, 1H), 1.77 (dt, J = 12.5, 8.1 Hz, 1H), 1.51 (ddd, J = 
12.3, 8.5, 3.6 Hz, 1H), 1.18 – 1.06 (m, 4H), 1.02 (s, 3H), 1.01 – 0.95 (m, 2H), 0.78 (t, J = 7.1 Hz, 
3H), 0.58 (tdd, J = 10.9, 6.5, 4.0 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 158.4, 139.6, 131.6, 
130.9, 129.6, 120.5, 113.5, 80.0, 57.9, 55.3, 51.1, 44.4, 37.6, 36.3, 26.7, 25.4, 23.6, 14.2. IR (υ/cm-
1): 2953.45 (s), 2930.31 (s), 2868.59 (m), 1612.20 (m), 1510.95 (s), 1483.96 (m), 1246.75 (s). 
HRMS (ESI+): calcd for C23H31BrNO+ 416.1589, found: [M+H+] 416.1570. [α]D22 = 18.1 (c = 




methylpyrrolidine (3.84). Following the same procedure as 3.82, pyrrolidine 3.84 was isolated as 
a clear, colorless oil in 47% yield (6.2 mg) over two steps. 1H NMR (500 MHz, Chloroform-d) δ 






O 1) NaBO3•4H2OTHF:H2O (1:1), 22 °C, 3 h
2) NaBH3CN (1.5 equiv)
AcOH (10% in MeOH)













O 1) NaBO3•4H2OTHF:H2O (1:1), 22 °C, 3 h
2) NaBH3CN (1.5 equiv)
AcOH (10% in MeOH)









3H), 3.76 (d, J = 13.2 Hz, 1H), 3.55 (ddd, J = 10.4, 8.6, 5.9 Hz, 1H), 3.45 (ddd, J = 10.3, 8.6, 5.9 
Hz, 1H), 3.17 (s, 1H), 3.06 – 3.02 (m, 1H), 3.00 (d, J = 13.3 Hz, 1H), 2.27 (q, J = 8.6 Hz, 1H), 
1.88 (dt, J = 12.6, 7.9 Hz, 1H), 1.56 – 1.52 (m, 1H), 1.45 (ddd, J = 14.0, 8.6, 5.9 Hz, 1H), 1.05 (s, 
3H), 0.96 – 0.89 (m, 1H), 0.83 (s, 9H), -0.04 (s, 5H). 13C NMR (126 MHz, CDCl3) δ 158.4, 139.3, 
131.6, 131.1, 129.5, 120.7, 113.5, 80.1, 77.3, 77.0, 76.8, 60.4, 57.8, 55.3, 51.0, 43.6, 40.3, 36.6, 
26.0, 25.6, 18.3, -5.3. IR (υ/cm-1): 2953.45 (m), 2928.38 (m), 2856.06 (m), 1510.95 (s), 1248.68 
(s). HRMS (ESI+): calcd for C27H41BrNO2Si+ 518.2090, found: [M+H+] 518.2074. [α]D22 = 16.3 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































n Crystal Structure Data for 3.82 
 
Identification Code: JG_7_6_2018 
Empirical Formula: C20H24BrNO 
Formula Weight: 374.31 
Measurement Temperature: 100 K 
Radiation Type: CuKa 
Wavelength: 1.54178 
Crystal System: orthorhombic 
Space Group: P212121 
Unit Cell Dimensions: a = 5.84220(10) Å;  
α = 90° 
              b = 9.8585(2) Å;  
β = 90° 
              c = 31.3192(6) Å;  
γ = 90° 
Volume: 1803.84(6) Å3 
Z: 4 
Density (calculated): 1.378 g/cm3 
Absorption Correction Coefficient: 3.125 
mm-1 
F(000): 776.0 
Crystal size: 0.224 mm x 0.104 mm x 0.091 mm 
Theta Max: 133.196° 
Index Ranges: hmax = 6, kmax = 11, lmax = 37 
Reflections Collected: 25646 
Independent Reflections: 3143 
Goodness-of-fit on F2: 1.052 
R Indicies:  R1 = 0.0206; wR2 = 0.0535 
 
n Table 2: Bond Lengths for 3.82 (Å) 
 
Number Atom1 Atom2 Length 
1 Br1 C20 1.900(3) 
2 C1 H1A 0.98 
3 C1 H1B 0.98 
4 C1 H1C 0.98 
5 C1 O1 1.424(4) 
6 N1 C8 1.454(3) 
7 N1 C9 1.464(4) 
8 N1 C14 1.463(3) 
9 O1 C2 1.378(3) 
10 C2 C3 1.392(4) 
11 C2 C4 1.387(4) 
Figure 1: X-Ray Crystal Structure of 3.82 
	
	 513 
12 C3 H3 0.95 
13 C3 C6 1.397(4) 
14 C4 H4 0.95 
15 C4 C5 1.383(4) 
16 C5 H5 0.95 
17 C5 C7 1.396(3) 
18 C6 H6 0.95 
19 C6 C7 1.380(4) 
20 C7 C8 1.519(4) 
21 C8 H8A 0.99 
22 C8 H8B 0.99 
23 C9 H9A 0.99 
24 C9 H9B 0.99 
25 C9 C10 1.538(4) 
26 C10 H10A 0.99 
27 C10 H10B 0.99 
28 C10 C11 1.549(4) 
29 C11 C12 1.527(4) 
30 C11 C13 1.523(4) 
31 C11 C14 1.559(3) 
32 C12 H12A 0.98 
33 C12 H12B 0.98 
34 C12 H12C 0.98 
35 C13 H13A 0.98 
36 C13 H13B 0.98 
37 C13 H13C 0.98 
38 C14 H14 1 
39 C14 C15 1.509(3) 
40 C15 C16 1.394(4) 
41 C15 C17 1.392(4) 
42 C16 H16 0.95 
43 C16 C19 1.392(3) 
44 C17 H17 0.95 
45 C17 C18 1.387(4) 
46 C18 H18 0.95 
47 C18 C20 1.379(4) 
48 C19 H19 0.95 






n Table 3: Bond Angles for 3.82 (°) 
 
Number Atom1 Atom2 Atom3 Angle 
1 H1A C1 H1B 109.5 
2 H1A C1 H1C 109.5 
3 H1A C1 O1 109.5 
4 H1B C1 H1C 109.5 
5 H1B C1 O1 109.5 
6 H1C C1 O1 109.5 
7 C8 N1 C9 112.3(2) 
8 C8 N1 C14 114.9(2) 
9 C9 N1 C14 104.5(2) 
10 C1 O1 C2 118.0(2) 
11 O1 C2 C3 124.2(2) 
12 O1 C2 C4 115.8(2) 
13 C3 C2 C4 120.1(3) 
14 C2 C3 H3 120.7 
15 C2 C3 C6 118.5(3) 
16 H3 C3 C6 120.8 
17 C2 C4 H4 119.7 
18 C2 C4 C5 120.5(2) 
19 H4 C4 C5 119.8 
20 C4 C5 H5 119.8 
21 C4 C5 C7 120.5(2) 
22 H5 C5 C7 119.8 
23 C3 C6 H6 118.9 
24 C3 C6 C7 122.0(3) 
25 H6 C6 C7 119 
26 C5 C7 C6 118.4(2) 
27 C5 C7 C8 119.8(2) 
28 C6 C7 C8 121.8(2) 
29 N1 C8 C7 112.3(2) 
30 N1 C8 H8A 109.1 
31 N1 C8 H8B 109.1 
32 C7 C8 H8A 109.1 
33 C7 C8 H8B 109.1 
34 H8A C8 H8B 107.9 
35 N1 C9 H9A 110.8 
36 N1 C9 H9B 110.7 
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37 N1 C9 C10 105.0(2) 
38 H9A C9 H9B 108.8 
39 H9A C9 C10 110.7 
40 H9B C9 C10 110.7 
41 C9 C10 H10A 110.5 
42 C9 C10 H10B 110.6 
43 C9 C10 C11 105.9(2) 
44 H10A C10 H10B 108.7 
45 H10A C10 C11 110.6 
46 H10B C10 C11 110.6 
47 C10 C11 C12 109.9(2) 
48 C10 C11 C13 112.8(2) 
49 C10 C11 C14 101.0(2) 
50 C12 C11 C13 109.5(2) 
51 C12 C11 C14 111.6(2) 
52 C13 C11 C14 112.0(2) 
53 C11 C12 H12A 109.5 
54 C11 C12 H12B 109.5 
55 C11 C12 H12C 109.5 
56 H12A C12 H12B 109.5 
57 H12A C12 H12C 109.5 
58 H12B C12 H12C 109.5 
59 C11 C13 H13A 109.5 
60 C11 C13 H13B 109.5 
61 C11 C13 H13C 109.5 
62 H13A C13 H13B 109.5 
63 H13A C13 H13C 109.4 
64 H13B C13 H13C 109.5 
65 N1 C14 C11 102.3(2) 
66 N1 C14 H14 108.4 
67 N1 C14 C15 113.0(2) 
68 C11 C14 H14 108.4 
69 C11 C14 C15 116.0(2) 
70 H14 C14 C15 108.4 
71 C14 C15 C16 121.4(2) 
72 C14 C15 C17 120.2(2) 
73 C16 C15 C17 118.5(2) 
74 C15 C16 H16 119.5 
75 C15 C16 C19 121.0(2) 
76 H16 C16 C19 119.5 
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77 C15 C17 H17 119.4 
78 C15 C17 C18 121.2(2) 
79 H17 C17 C18 119.4 
80 C17 C18 H18 120.6 
81 C17 C18 C20 118.7(2) 
82 H18 C18 C20 120.7 
83 C16 C19 H19 120.7 
84 C16 C19 C20 118.6(2) 
85 H19 C19 C20 120.7 
86 Br1 C20 C18 119.8(2) 
87 Br1 C20 C19 118.3(2) 
88 C18 C20 C19 122.0(2) 
 
 
n Table 4: Torsion Angles for 3.82 (°) 
 
Number Atom1 Atom2 Atom3 Atom4 Torsion 
1 H1A C1 O1 C2 -56.3 
2 H1B C1 O1 C2 -176.3 
3 H1C C1 O1 C2 63.7 
4 C9 N1 C8 C7 71.0(3) 
5 C9 N1 C8 H8A -50.1 
6 C9 N1 C8 H8B -167.8 
7 C14 N1 C8 C7 -169.8(2) 
8 C14 N1 C8 H8A 69.1 
9 C14 N1 C8 H8B -48.6 
10 C8 N1 C9 H9A 41 
11 C8 N1 C9 H9B -79.9 
12 C8 N1 C9 C10 160.6(2) 
13 C14 N1 C9 H9A -84.2 
14 C14 N1 C9 H9B 155 
15 C14 N1 C9 C10 35.4(3) 
16 C8 N1 C14 C11 -170.6(2) 
17 C8 N1 C14 H14 -56.2 
18 C8 N1 C14 C15 64.0(3) 
19 C9 N1 C14 C11 -47.1(2) 
20 C9 N1 C14 H14 67.3 
21 C9 N1 C14 C15 -172.6(2) 
22 C1 O1 C2 C3 -7.6(4) 
23 C1 O1 C2 C4 172.0(2) 
24 O1 C2 C3 H3 -0.6 
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25 O1 C2 C3 C6 179.4(3) 
26 C4 C2 C3 H3 179.8 
27 C4 C2 C3 C6 -0.3(4) 
28 O1 C2 C4 H4 1.3 
29 O1 C2 C4 C5 -178.6(2) 
30 C3 C2 C4 H4 -179 
31 C3 C2 C4 C5 1.0(4) 
32 C2 C3 C6 H6 179.1 
33 C2 C3 C6 C7 -0.9(4) 
34 H3 C3 C6 H6 -0.9 
35 H3 C3 C6 C7 179 
36 C2 C4 C5 H5 179.3 
37 C2 C4 C5 C7 -0.6(4) 
38 H4 C4 C5 H5 -0.6 
39 H4 C4 C5 C7 179.4 
40 C4 C5 C7 C6 -0.5(4) 
41 C4 C5 C7 C8 -178.1(2) 
42 H5 C5 C7 C6 179.5 
43 H5 C5 C7 C8 1.9 
44 C3 C6 C7 C5 1.3(4) 
45 C3 C6 C7 C8 178.8(3) 
46 H6 C6 C7 C5 -178.7 
47 H6 C6 C7 C8 -1.2 
48 C5 C7 C8 N1 -154.3(2) 
49 C5 C7 C8 H8A -33.2 
50 C5 C7 C8 H8B 84.5 
51 C6 C7 C8 N1 28.2(3) 
52 C6 C7 C8 H8A 149.4 
53 C6 C7 C8 H8B -93 
54 N1 C9 C10 H10A -129.4 
55 N1 C9 C10 H10B 110.2 
56 N1 C9 C10 C11 -9.6(3) 
57 H9A C9 C10 H10A -9.8 
58 H9A C9 C10 H10B -130.2 
59 H9A C9 C10 C11 110 
60 H9B C9 C10 H10A 111.1 
61 H9B C9 C10 H10B -9.4 
62 H9B C9 C10 C11 -129.1 
63 C9 C10 C11 C12 100.2(2) 
64 C9 C10 C11 C13 -137.4(2) 
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65 C9 C10 C11 C14 -17.7(3) 
66 H10A C10 C11 C12 -140 
67 H10A C10 C11 C13 -17.6 
68 H10A C10 C11 C14 102.1 
69 H10B C10 C11 C12 -19.6 
70 H10B C10 C11 C13 102.9 
71 H10B C10 C11 C14 -137.5 
72 C10 C11 C12 H12A 63.6 
73 C10 C11 C12 H12B -56.5 
74 C10 C11 C12 H12C -176.5 
75 C13 C11 C12 H12A -60.8 
76 C13 C11 C12 H12B 179.2 
77 C13 C11 C12 H12C 59.2 
78 C14 C11 C12 H12A 174.7 
79 C14 C11 C12 H12B 54.7 
80 C14 C11 C12 H12C -65.3 
81 C10 C11 C13 H13A 58.8 
82 C10 C11 C13 H13B -61.2 
83 C10 C11 C13 H13C 178.8 
84 C12 C11 C13 H13A -178.5 
85 C12 C11 C13 H13B 61.4 
86 C12 C11 C13 H13C -58.6 
87 C14 C11 C13 H13A -54.3 
88 C14 C11 C13 H13B -174.3 
89 C14 C11 C13 H13C 65.7 
90 C10 C11 C14 N1 39.1(2) 
91 C10 C11 C14 H14 -75.3 
92 C10 C11 C14 C15 162.5(2) 
93 C12 C11 C14 N1 -77.6(2) 
94 C12 C11 C14 H14 168 
95 C12 C11 C14 C15 45.8(3) 
96 C13 C11 C14 N1 159.3(2) 
97 C13 C11 C14 H14 44.9 
98 C13 C11 C14 C15 -77.2(3) 
99 N1 C14 C15 C16 30.7(3) 
100 N1 C14 C15 C17 -149.7(2) 
101 C11 C14 C15 C16 -87.0(3) 
102 C11 C14 C15 C17 92.6(3) 
103 H14 C14 C15 C16 150.8 
104 H14 C14 C15 C17 -29.5 
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105 C14 C15 C16 H16 0.4 
106 C14 C15 C16 C19 -179.6(2) 
107 C17 C15 C16 H16 -179.2 
108 C17 C15 C16 C19 0.8(4) 
109 C14 C15 C17 H17 0 
110 C14 C15 C17 C18 180.0(2) 
111 C16 C15 C17 H17 179.6 
112 C16 C15 C17 C18 -0.4(4) 
113 C15 C16 C19 H19 179.3 
114 C15 C16 C19 C20 -0.7(4) 
115 H16 C16 C19 H19 -0.7 
116 H16 C16 C19 C20 179.3 
117 C15 C17 C18 H18 179.9 
118 C15 C17 C18 C20 -0.0(4) 
119 H17 C17 C18 H18 -0.1 
120 H17 C17 C18 C20 180 
121 C17 C18 C20 Br1 -178.8(2) 
122 C17 C18 C20 C19 0.1(4) 
123 H18 C18 C20 Br1 1.2 
124 H18 C18 C20 C19 -179.9 
125 C16 C19 C20 Br1 179.2(2) 
126 C16 C19 C20 C18 0.3(4) 
127 H19 C19 C20 Br1 -0.8 
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